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1 Analysis of Large Protein Complexes and Their Ligands
1.1 Preface
During the last years an important milestone in scientific progress was the sequencing of several 
eukaryotic genomes. The resulting availability of the primary structure of many proteins opens a 
variety of new possibilities for understanding protein functions. Using computational methods it 
is possible to predict the secondary or even the tertiary structure of proteins. Homology searches 
allow for the comparison of proteins that evolved during evolution. Insights into the function of 
one protein  can often be transferred to  its  homologs.  In  addition,  this  sequence information 
makes it possible to recombinantly produce the protein of interest and analyze it in vitro. 
All proteins need to fold into specific three-dimensional conformations to be able to perform 
their  functions.  For  most  proteins it  is  even not  enough to  be properly folded,  they are  not 
functional in their isolated state and need at least one interaction partner to perform their task in 
the living cell. 
Most cellular functions like DNA replication, transcription and mRNA translation require the 
coordinated action of a large number of proteins that are assembled in an array of multi-protein 
complexes.  In  these  complexes  the  correct  composition  and  structure  is  essential  for 
functionality. Additionally, most biological processes are connected and regulated by dynamic 
signaling  networks  of  interacting  proteins  that  transfer  signals,  ligands  or  impulses  to  a 
downstream effector.
All these facts clearly show that the examination of single isolated proteins will not be sufficient 
to understand most of the cellular processes. It is essential to expand experiments to the analysis 
of protein complexes, their composition, ligands, binding partners and activities. 
1.2 Methods for Structural Analysis
Three dimensional structural information is extremely important for the understanding of protein 
complexes.  However,  even with  the most  advanced light  microscopes  a  fast  and convenient 
determination of protein structures is still not possible. More complicated and time-consuming 
methods have to be used, especially for solving a protein structure at low resolutions.
The  different  methods  structural  biologists  use  to  determine  structures  generally  involve 
measurements on vast numbers of identical molecules at the same time. At present, the mainly 
used  methods  are  nuclear  magnetic  resonance  (NMR),   electron  microscopy  /  electron 
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cryomicroscopy (EM/cryo-EM) and X-ray crystallography.
NMR is performed in aqueous solution, which allows to monitor the binding of ligands to a 
protein or determine the structure of different conformational states of a protein. The biological 
samples  can  be  analyzed  in  vitro close  to  physiological  conditions.  Nowadays  NMR 
spectrometer  with  very  high  magnetic  fields  are  available,  but  even  with  multidimensional 
spectra the method is limited to proteins smaller than 70 kDa because of overlapping signals. To 
analyze large protein complexes, NMR is only suitable in very special cases.
In contrast, EM studies work perfectly especially on large complexes. For EM experiments the 
proteins have to be immobilized, which results in an environment that is less physiological than 
in  NMR  experiments.  Another  disadvantage  of  EM  is  the  limited  resolution.  Although  the 
resolution of the latest structures reaches down to approximately 5-10 Å, it is impossible to fit 
side chains of amino acids into the obtained electron densities. Additionally, flexible parts of the 
molecules can not be visualized, because the different orientations are lost during averaging.
In  this  thesis  two  different  structural  methods  were  used,  X-ray  crystallography  to  obtain 
structures at atomic resolution and Small Angle X-ray Scattering (SAXS) to analyze structures in 
solution, a method that recently became increasingly important in the biological field.
1.2.1 X-ray Crystallography
1.2.1.1 Preface
Structure analysis of proteins using protein crystallography is used since the late 1950s and still 
remains the most widely used method for visualizing atomic structures of proteins and nucleic 
acids. Compared to other methods it possibly provides the most detailed picture of a biological 
molecule.
The number  of  macromolecular  structures  deposited  in  the  Protein  Data  Bank now exceeds 
51 000, with more than 85% determined using crystallographic methods. Thousands of studies 
describing such structures have been published in scientific literature and many Nobel prizes in 
chemistry or medicine have been awarded to protein crystallographers. The progress in structure 
determination has accelerated during the last  years  due to  the introduction of  powerful  new 
algorithms and computer programs for diffraction data collection, structure solution, refinement 
and presentation. The availability of highly energetic X-rays at synchrotrons strongly improved 
data  quality  and  tunable  beamlines  nowadays  allow  for  multi-wavelength  experiments  for 
phasing. 
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To understand the enzymatic mechanisms of proteins in the cell, one single structure is often not 
sufficient. The determination of more structures, for example with different binding partners or 
ligands, can give insights into the mode of function of an enzyme.
With help of structural information at high resolutions a working model can be proposed and 
biochemical activity assays with the wild-type protein in comparison to structure derived mutants 
can be used to verify this model. 
One disadvantage of X-ray crystallography is the fact that the sample has to be in a crystalline 
state. Proteins only form crystals when their shape is very homogeneous and rigid. Flexible loops 
can hinder the crystallization process, so they have to be removed and cannot be visualized. 
Some proteins are even so flexible that it is not at all possible to crystallize them. This of course 
restrains  the method drastically.  As enzymes  can  be interpreted  as  molecular  machines  they 
normally have to be flexible to perform their tasks. 
Therefore  it  has  become  clear  that  it  needs  the  application  of  hybrid  methods  to  answer 
biological questions as completely as possible. In the present thesis X-ray crystallography was 
combined with  SAXS to gain information about the atomic composition of a complex and its 
behavior in solution. 
1.2.1.2 Crystallizing Proteins
The process of crystallizing a protein or protein complex of interest is in most cases the crucial 
step that makes structure determination difficult. However the growth of high quality crystals is 
inevitable for the generation of good diffraction patterns. Crystals are generally solid and consist 
of molecules that are packed in a regularly ordered, repeated pattern extending in all three spatial 
dimensions. In contrast to small molecules like salt, proteins are not very rigid and generally 
have  many  degrees  of  freedom  which  reduces  the  conditions  for  crystallization  drastically. 
Therefore hundreds of different crystallization conditions have to be screened. In general, they 
all consist of three components: First, all proteins are very sensitive to the surrounding pH, why 
the condition contains a buffer to fix the pH of the solution. Second, some precipitant is added 
that lowers the solubility of the proteins. Third,  different additives can change the condition 
slightly and thereby increase the probability of crystallization.
The most common approach is to gradually lower the solubility of the protein, which in this case 
means a slow increase in precipitant and protein concentration.  However,  if  this  is  done too 
quickly,  the protein will  precipitate  from solution and is  useless  for  structure determination. 
Crystal growth in solution consists of two steps: nucleation of a crystal followed by its growth. 
Normally  in  the  initial  screens  only  small  crystals  can  be  found  that  cannot  be  used  for 
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diffraction studies. Therefore the conditions resulting in small crystals have to be refined by 
changing the condition only slightly to improve crystal quality and growth. 
Different  techniques  can  be used  to  achieve  slow  increase  of  protein  and  precipitant 
concentration. Mainly used are the sitting and hanging drop vapor diffusion method. Thereby, a 
drop of protein solution is suspended over a reservoir containing buffer and precipitant. The drop 
slowly equilibrates with the reservoir solution by diffusion, leaving the drop with optimal crystal 
growth conditions. 
1.2.1.3 Structure Determination by X-ray Diffraction
After successful production of a crystal,  it  is mounted in a nylon loop and flash frozen with 
liquid nitrogen so that it can be placed in the X-ray beam and rotated. Freezing is extremely 
important  for  biological  samples  as  it  reduces  the  radiation  damage  caused  by  the  highly 
energetic X-rays, as well as the noise in the Bragg peaks due to thermal motion (Debye-Waller 
effect). However, especially when the water content in a crystal is too high, crystal  packing can 
be damaged during freezing.  Therefore crystals  are  generally pre-soaked in  a  cryoprotectant 
solution prior to freezing. The best suited cryoprotectant is determined by screening different 
candidates like for example glycerol, MPD and 1,4-butanediol. The frozen crystal is exposed to 
an  X-ray beam (nowadays  mainly from synchrotrons)  and  rotated.  The  resulting  diffraction 
patterns are recorded by a detector. 
The  observed  diffraction  results  from the  electrons  in  the  outer  shells  of  all  atoms  in  the 
periodically arranged biomolecule.  The process of diffraction is actually a combination of two 
separate and simultaneous operations, scattering and interference. The scattering depends only 
on the interaction between the X-rays and the protein crystal. When the X-ray photons collide 
with the atoms, the oscillating electric component of the photons induces oscillations mainly in 
the electrons. The oscillating electrons and nuclei then emit secondary "scattered" X-rays of the 
same  energy  as  the  incident  photons.  The  scattered  waves  then  interfere  with  one  another 
because of the periodic nature of the crystalline sample and produce the diffraction pattern. This 
diffraction  pattern  is  directly  related  to  the  electron  distribution  in  the  crystals  and  can  be 
explained by Bragg's law. 
With a detector the position as well as the intensity of every reflection is detected.
The position of each detected reflection corresponds to the overall scattering from one particular 
set of Bragg planes, which are labeled with reciprocal space coordinates (h,k,l), also known as 
Miller indices. Therefore the geometry (space group and cell dimensions) of the unit cell can be 
determined with the knowledge of the positions of the reflections.
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The intensity of every measured reflection is proportional to the square of the structure factor 
amplitude |Fhkl|. The structure factor describes the way in which an incident beam is scattered by 
the atoms of a crystal unit cell:
F hkl= ∑
j=1
all atoms
f j⋅e
2 i hx jky jlz j (1)
Where the sum is over all atoms in the unit cell and fj is the atomic form factor for atom i that 
describes the different scattering powers of the elements. During scattering a difference in phase 
occurs, as the atoms are spatially distributed in the unit cell. This phase shift information is taken 
in account by the exponential term. The scattering power of an atom is additionally influenced by 
the temperature-, B- or Debye-Waller factor, which describes the attenuation of scattering caused 
by thermal motion or quenched disorder. 
The order of the crystals is the reason for a periodicity in the electron density. Therefore it is 
possible to apply an inverse Fourier transformation to the structure factor and obtain the electron 
density ρ:
xyz=
1
V ∑hkl F hkl e
−2 i hxkylz (2)
Where V is the volume of the unit cell and the sum is over all combinations of h, k and l. The 
coordinates x, y and z represent the three-dimensional coordinates of a point within the unit cell. 
With this equation the reciprocal space with coordinates h, k and l is transformed into the real 
space with coordinates x, y and z.
The problem in solving this equation is the structure factor  Fhkl.  From the reflections only the 
amplitudes |Fhkl| and not the corresponding phases are known. The determination of the phases is 
a very central  problem in the structure determination process and is  therefore known as the 
“phase problem”. 
1.2.1.4 The Phase Problem
The phases are evident in the following reformulation of equation (2):
xyz=
1
V ∑hkl
∣F hkl∣e
−2 i hx kylz−hkl  (3)
Where  αhkl is  the corresponding phase to  |Fhkl|.  As it  is  not  possible  to  directly calculate  the 
phases,  indirect  methods  were  developed  over  the  last  years  to  determine  them.  No  direct 
relationship exists between the phases and the amplitudes, only via the molecular structure or 
electron density. Some prior knowledge about the electron density or structure is therefore the 
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basis for all phasing methods. 
Nowadays the mainly used methods are single-wavelength anomalous dispersion (SAD), multi-
wavelength anomalous dispersion (MAD) and molecular replacement. More detailed information 
can be found in textbooks (e.g. Drenth, 1999; McPherson, 2001; Blow, 2002).
In this thesis the phase problem was solved with molecular replacement and this method will be 
discussed in more detail:
Molecular  replacement can only be used,  when the structure is  similar  to an already known 
atomic structure,  e.g.  an apoenzyme structure can be used for structure determination of the 
ligand bound form. For molecular replacement first a Patterson map has to be calculated. The 
Patterson map is an  inter-atomic vector map and can be calculated without phase information. 
The Patterson function is given as equation 4. 
Puvw=
1
V ∑hkl
∣F hkl∣
2e−2hukvlw (4)
The peaks in the Patterson function are the interatomic distances weighted by the product of the 
number of electrons in the atoms concerned.  The Patterson map includes all  the information 
about the structure that can be extracted from the data without the phases. By comparison of the 
calculated Patterson map of the known structure with the one of the new data the phases can be 
estimated. The known model is rotated and translated, until its Patterson map fits the new one 
best.  The  programs  use  maximum  likelihood  based  algorithms  to  evaluate  the  results.  The 
highest  correlation is  obtained when the two Patterson maps (from the known and unknown 
structure) are in a similar orientation. In the translation function, the orientated model can now 
be correctly positioned by translating it to the correct coordinates within the asymmetric unit.
This is followed by the estimation of the new phases by calculating the phase angles implied in 
the model structure that has been correctly orientated and positioned in the cell.  The calculated 
phases αhkl are now attached to the measured structure amplitudes |Fhkl| to receive an estimate of 
the structure factor and of the electron density. 
Usage of these estimated phases results in a model bias coming from the model structure. It is 
therefore essential to calculate a 2 |Fo| - |Fc| electron density map and built a new atomic model 
into  the  density.  This  is  followed  by  iterative  refinement  processes,  trying  to  find  the  best 
agreement between the observed structure factors and the calculated ones. 
1.2.1.5 Refinement
To monitor the quality of the model, the R-factor (for residual or reliability factor) is calculated:
R=∑∣∣Fobs∣−∣F calc∣∣
∑∣F obs∣
 (5)
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With |Fobs| being the experimentally determined, observed structure factor amplitudes and |Fcalc|  
the ones calculated from the model. The higher the R-factor, the more the calculated amplitudes 
differ from the observed ones. Therefore the final goal is always to refine the model until the R-
factor is as low as possible. A similar quality criterion is Rfree, which is calculated from a subset 
(~5-10%) of reflections that were not included in the structure refinement. 
For manual rebuilding of the initial  model a difference density map (|Fo|-|Fc|)  is used,  which 
shows the difference between the true and the currently modeled structure. With this map, parts 
that exist in the structure, but are not yet included in the model, as well as wrong parts of the 
model can be identified. In addition to manually improving the model, refinement programs are 
applied that refine the position and B-factors of every atom. These computational refinement 
programs imply restraints for e.g. bond lengths, bond angles, torsion angles and chiral volumes. 
After some rounds of manual and computational refinement, better phases and a decrease of the 
R-factor are achieved.
1.2.2 SAXS
1.2.2.1 Preface
Only  rigid  parts  of  a  protein  structure  can  be  determined  at  atomic  resolution  via  X-ray 
crystallography, but also structural information about the flexible parts of a macromolecule are of 
great  interest.  Therefore,  a  second  method  besides  crystallography should  be  carried  out  in 
solution to gain information about flexible regions of the sample. In this thesis SAXS was the 
method of choice to address these questions. SAXS is a technique that is carried out in solution 
and it offers the potential for obtaining structural information relatively easy, it does not require 
crystals and is therefore perfect for analyzing systems possessing substantial flexibility. SAXS as 
a method for biological macromolecules lagged many decades behind crystallography because 
the application of SAXS to macromolecules is a surprisingly complex problem. Even with good 
X-ray quality from new generation high energy synchrotrons and suitable computational power 
from advanced  computer  clusters,  SAXS  is  still  limited  by  the  relatively  small  number  of 
effective observations in a given solution scattering curve.
At the first glance it seems that SAXS provides even less information than EM. Yet, there are 
several advantages: SAXS experiments can be performed in a very short timescale and relatively 
small amounts of sample are needed. Moreover, as the samples are measured in solution many 
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different  and  preferably  physiologic  buffer  conditions  can  be  screened.  And  as  already 
mentioned, in contrast to EM SAXS can provide information about flexible parts of the sample. 
Especially by combining SAXS with crystallography and computational methods, a powerful 
tool is formed. The scattering observations from SAXS data combined with crystal structures can 
provide  more  accurate  and complete  models  of  protein  and  RNA structures,  conformations, 
interactions and assemblies in solution.
An example for the combination of SAXS with protein crystallography is shown in figure 1 
(from Putnam et al., 2008). 
A   B   C
Figure 1: SAXS model of the complexed cellulase (from Putnam et al., 2008).
A:  ab  initio model  representing  residues  as  beads  calculated  with  the  program 
GASBORp  (blue).  B:  Reconstitution  of  one  missing  module  represented  by  an 
ensemble  of  dummy  residues  (green).  The  secondary  structural  elements  of  the 
known atomic structure is shown in gray.  C:  Rigid body modeling applied on the 
known atomic structures (gray) in combination with ab initio modeling of the linker 
region (cyan) using the program BUNCH.
The full-length cellulase protein is composed of two domains and could not be crystallized due 
to  a  flexible  linker  between the two domains.  Still  is  was  possible  to  determine  the atomic 
structure  of  the  two domains  separately.  The  SAXS structure  of  the  full-length  protein  was 
calculated and the two crystal structures were modeled into the SAXS density. Using ab initio 
calculations, the connecting flexible linker could be positioned between the two domains. To 
further  optimize  the  model,  the  best-fit  conformation  could  be  searched  for  by  applying 
molecular dynamics on the linker region.
1.2.2.2 Structure Determination by Small Angle X-ray Scattering
In a SAXS experiment – similar to X-ray diffraction – the X-ray wave is scattered mainly by the 
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electrons surrounding the atoms of the protein. As SAXS is performed in solution, the proteins 
are spatially averaged and the wave does not encounter any regularly repeated elements like it 
does in a crystal. Therefore no interference can occur and no diffraction pattern can be observed. 
But  still  the  scattering  can  be  recorded  as  a  function  of  the  scattering  angle  and structural 
information can be extracted.
SAXS is  a  contrast  method were the scattering signal  is  derived from the difference  in  the 
average electron density of solvent and the electron density due to the molecule in the solution. 
As higher density differences give higher scattering intensities, nucleic acids give much stronger 
signals compared to proteins. 
To describe the scattering from assemblies of atoms it is convenient to introduce the scattering 
length density distribution ρ(r), which is equal to the total scattering length of the atoms per unit 
volume. SAXS experiments on biomolecules in solution require separate measurements of the 
scattering from sample and solvent,  as  the contribution of  the solvent  scattering to  the total 
scattering is relatively high. The scattering from the biomolecule is thus often referred to as 
excess scattering over  the solvent  scattering.  Assuming the solvent  has a  constant  scattering 
density ρs, the scattering amplitude from a single particle relative to that of an equivalent volume 
of solvent is given by the Fourier transform of the difference in scattering density Δσ(r) = σ(r) – 
σs:
A s =∫
V
r ei s r dr (6)
with A being the scattering amplitude and s the momentum transfer s = 4πλ-1 sin(θ), where 2θ is 
the total scattering angle relative to the forward direction. The integration is performed over the 
particle volume. 
In a scattering experiment the intensity I(s) (not the amplitude) is detected, which is proportional 
to the number of scattered photons. As the molecules are randomly distributed the intensity of the 
ensemble  is  a  function  proportional  to  scattering  of  a  single  particle  averaged  over  all 
orientations.  For  the  analysis  of  SAXS data  from biological  macromolecules  two  important 
restrictions are introduced, which greatly simplify the problem: first the system is postulated to 
be monodisperse and second no correlation between the molecules should exist.
Using equation 6 the spherically averaged single  particle  intensity can be calculated and by 
integrating in spherical coordinates one gets
I  s=4 ∫
0
D max
r 2r  sin sr
s r
dr (7)
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where  γ(r)  is the spherically averaged autocorrelation function of the excess scattering density, 
which is equal to zero for distances exceeding the maximum particle diameter Dmax. In practice 
the function p(r) = r2 γ(r) is called pair or distance distribution function and corresponds to the 
distribution of distances between elements inside the molecule, weighted by the excess density 
distribution. This pair distribution function is commonly used to analyze scattering data from 
biomolecules and is computed by the inverse transformation
p r = r
2
22
∫
0
∞
s2 I  s  sin sr
sr
dr (8)
1.2.2.3 The Guinier Approximation and Porod's Law
Besides  the  pair  distribution  function  an  approximation  is  important  that  is  only  valid  for 
scattering  at  very  small  values  of  momentum transfer  (s  → 0).  It  was  derived  by  Guinier 
(Guinier, 1939) and has long been the most important tool in the analysis of scattering from 
isotropic systems, the so called Guinier equation is:
I s ≃I 0e
− 13 R g
2 s 2
(9)
where I0 is the intensity at s = 0 and Rg is the radius of gyration of the molecule. It is clear that 
the radius of gyration can be calculated directly from the scattering data when using only very 
small angle data. A Guinier plot, where ln(I(s)) is plotted versus s2 should give a linear function 
with I0 as intercept and a slope that can be used to calculate Rg. Only very homogeneous samples 
with  no  attractive  or  repulsive  forces  between  molecules  will  give  a  linear  Guinier  plot. 
Therefore it is also a method do test the quality of the sample, but one has to keep in mind that it 
is still an approximation and only valid in the range of s ∙ Rg < 1.3. 
The radius of gyration characterizes the size of a particle and is defined as the square root of the 
average squared distance of each scatterer from the particle center. The advantage of the radius 
of gyration is the fact that it can be calculated by numerical integration from any structure, for 
example a crystal structure, and compared to the value obtained from the measurement. 
Besides Rg, the forward scattering intensity I0 can be determined. I0 is related to the molecular 
mass of the sample and independent from the shape. It is only dependent on the squared contrast 
of the particle, the concentration of the sample and the intensity of the transmitted beam. With 
known sample concentration and with a reference sample like BSA (bovine serum albumin) for 
proteins, the molecular mass can be calculated. 
Analysis  of  high  s-values  gives  information  regarding  molecular  shape.  For  a  folded 
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macromolecule the intensity of the scattering falls off by Porod's law (Kratky and Porod, 1949):
I  s∝s−4 (10)
This correlation is only true for a uniform density of the scatterer, which breaks down at high s 
values when atomic resolution information begins to contribute more and more to the scattering 
profile.  Therefore Porod's  law is  -  like the Guinier  approximation -  only valid  for a  certain 
position of the scattering curve. When the Porod plot (s4  · I(s) versus s4) at high angles is not 
linear, the samples shows internal inhomogeneities.
1.2.2.4 The Pair Distribution Function
The pair distribution function (equation 8) is the Fourier transform of the scattering profile I(s) 
and in principle both contain the same information. It can be explained like a two-dimensional 
Patterson  function  (see  1.2.1.4)  that  shows  the  frequency with  which  vectors  of  a  length  r 
connect  two volume elements within the molecule.  It  is  the real  space representation and is 
therefore much more intuitive that the raw data.  As shown in figure 2 the shape of the pair 
distribution function provides information about the shape of the molecule. 
Figure  2:  p(r)  distribution  and  bead  model  of  three  proteins  with  different 
overall  shape.  The  following  proteins  are  shown:  in  dark  green  the  small  and 
globular hinge domain of the SMC protein from Pyrococcus furiosus, in yellow the 
barrel-like structure of the  Archaeoglobus fulgidus Rrp4 exosome complex and in 
orange the elongated Rad50/Mre11 complex from Thermotoga maritima.
SAXS structures and the corresponding p(r) distribution of three different structure are shown: 
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the Rad50/Mre11 complex from  Thermotoga maritima (Bemeleit, 2008), the hinge domain of 
Pyrococcus furiosus SMC protein (Griese, unpublished) and the Rrp4 exosome complex from 
the  Archaeoglobus  fulgidus.  A globular  protein  like  the  SMC  hinge  domain  gives  a  fairly 
symmetric  shape  with  one  quite  narrow  peak.  An  elongated  protein  like  the  Rad50/Mre11 
complex gives a skewed p(r) distribution and a barrel-like protein like the exosome gives one 
peak that is broader than it would be for a sphere with the same Rg. 
Reliable  computation  of  p(r) is  essential  for  further  analysis  in  terms  of  three  dimensional 
models. Therefore one has to be very careful when extrapolating I(s) in both directions using the 
Guinier approximation and Porod's law not to produce artifacts. 
1.2.2.5 Ab initio Modeling
As described above some overall parameters can be computed directly from the scattering data 
without the calculation of any structural model: the radius of gyration (Rg), the molecular mass 
and  the  maximum  particle  diameter  (Dmax).  It  is  clear  that  the  reconstruction  of  a  three-
dimensional structure from a one-dimensional scattering curve is a more complicated problem. 
In 1998 Chacon et al. showed that the electron density map can be approximated in terms of an 
assembly of beads or dummy atoms. This bead model can be used to fit the scattering data. To 
achieve reasonable models it helps to add physical constraints, like imposing a uniform density 
on  the  interior  of  the  molecule.  Fitting  the  data  leads  to  a  multidimensional  minimization 
problem  that  can  be  numerically  solved.  The  program  DAMMIN  (Svergun,  1999)  uses  a 
simulated annealing procedure which imposes a compactness criterion. Improvement for protein 
solution structure calculations was achieved by the program GASBOR (Petoukhov and Svergun, 
2003) where the loose composition of beads (dummy atoms) is changed to a string of beads in 
the size  of  an average amino acid  (dummy residues).  GASBOR is  the method for  structure 
calculation used in this thesis. It compares thousands of configurations of a chain of dummy 
residues (as many as amino acids in the protein of interest) to the measured scattering curve. 
Like in DAMMIN, simulated annealing is used with additional penalties for non-protein-like 
density. GASBOR is always run at least 10 times and the results are aligned and averaged for a 
final shape. Through comparison of the different models in the context of compatibility one can 
evaluate the reliability of the final model. In a perfect monodisperse system all runs converge on 
a similar structure.
It is surprising that each existing three dimensional structure of a protein should be described by 
one unique scattering curve, but Sokolova et al. (2003) could show that all deposited structures 
1 Analysis of Large Protein Complexes and Their Ligands 13
in the protein data bank have distinguishable calculated SAXS profiles. However, current SAXS 
ab  initio shape  predictions  are  more  accurately  low  resolution  envelopes  (~15Å),  whose 
calculated scattering curves are consistent with the experimental  scattering curve.  Very basic 
protein properties are used to significantly reduce the number of acceptable three dimensional 
shapes.  The comparison of  ab initio SAXS structures of proteins with their  crystal  structure 
demonstrates the surprisingly high accuracy of the programs. 
However, the confidence level in shape reconstruction has to be improved. A more quantitative 
measure of the solution uniqueness is needed, especially when no structural information about 
the sample is available. But as soon as structural information is available, GASBOR is extremely 
useful to gain additional information about a system. Moreover, mixed populations have to be 
handled with care, as the ab initio prediction will then give averaged conformations and can be 
very misleading (Heller, 2005). Similar to the results from other single techniques, SAXS results 
have to be considered carefully for their reliability.
1.2.2.6 Computation of Scattering Patterns from Crystal Structures
For the comparison of SAXS data with atomic models from crystallography one can calculate ab 
initio solution structure models and superimpose them with the crystal structure. This may take 
some time, as the calculation of ab initio models needs a lot of computational power. However, 
the data of the two different  experiments can be compared on the level  of SAXS scattering 
curves: it is much faster to calculate the theoretical scattering curve of a known crystal structure 
and compare this with the solution scattering data. First, the  p(r) distribution is calculated by 
evaluating  all  interatomic  distances  in  the  structure.  The  commonly used program CRYSOL 
(Svergun et al., 1995) uses spherical harmonics envelopes that cover the entire model and then 
transforms the p(r) distribution to an intensity profile. 
The main problem in evaluating the solution scattering from atomic coordinates is the correct 
calculation of the influence of solvent scattering.  Thereby the hydration shell  that  surrounds 
macromolecules in solution has to be considered. The observed scattering of a protein is mainly 
given by the difference between the scattering of the protein with its ordered solvation layer and 
the excluded volume that takes into account the scattering of displaced solvent. The scattering of 
the excluded volume can be determined by defining the shape of the protein,  filling it  with 
electron density equivalent to bulk solvent and calculate the scattering (Fraser et al., 1978). 
For  computational  determination  of  the  solvation  layer  of  a  protein,  the  hydration  shell  is 
modeled  by explicitly placing  water  molecules  on the surface (Fujisawa et  al.,  1994)  or  by 
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surrounding the particle by a continuous envelope representing the solvation shell of 3Å with a 
density that can differ from both bulk density and the solute (Svergun et al., 1995).
1.3 Biochemical Activity Assays
Determination of protein structures is a major step to understand protein functions. However, 
structural data only gives snapshots of all the motion and reactions that take place in the cell. 
These pictures indeed help to make progress in understanding a particular problem. However, for 
a complete understanding it  is inevitable to identify and analyze the activity of a protein by 
biochemical activity assays. For some very common enzymatic activities, a functional assay is 
already established. Still the assay conditions have to be adapted to the present system. In this 
thesis, a protein with an enzymatic activity that was not yet described was analyzed. In this case 
an activity assay had to be developed. 
When the substrate of a protein is a mono- or polynucleotide, it is often very useful to work with 
radioactively labeled molecules. The isotope  32P, a  β-emitter  with a half-life of 14.3 days,  is 
routinely used in life-science laboratories, either directly incorporated in nucleoside mono-, di- 
or  triphosphates  or  to  produce  DNA and  RNA probes  with  a  radiolabeled  5'  phosphate. 
Radiolabeled  substrates  have  two  dominant  advantages  over  fluorescent  labels:  first  the 
sensitivity  is  extremely  high  –  only  very  low  concentrations  can  be  detected  via  phospho-
imaging.  Second, the incorporated radiolabel does not change the chemical properties of the 
substrate. Fluorophores are mostly very hydrophobic and therefore can influence the binding 
behavior of the nucleotide. 
To  verify  the  correct  functionality  of  an  assay  it  is  essential  to  perform negative  controls. 
Analysis of the atomic structure of the active site of an enzyme allows to conclude which amino 
acid side chains are essential for catalyzing the reaction or for substrate binding. The contacts 
can be via for example hydrogen bonds or ionic interactions. By introducing a point mutation 
into the protein sequence,  the chemical properties of the side chain can be changed and the 
enzyme may not be able to perform the reaction any more. For example, structural analysis of 
AAA-ATPases  showed  that  the  exchange  of  a  glutamate  to  a  glutamine  in  the  active  site 
completely abolishes activity in most cases (Lammens et al., 2004). Only if the wild type protein 
and the mutant version – purified in exactly the same way – show differing behavior in the 
activity assay one can be sure that the activity of the protein of interest is monitored.
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In  the  present  thesis  two  different  protein  complexes  were  analyzed  structurally  and 
biochemically:  the  DNA integrity  scanning  protein  A (DisA)  from  Bacillus  subtilis,  a  DNA 
damage  checkpoint  protein  with  a  novel  enzymatic  activity  and  the  archaeal  exosome,  a 
macromolecular complex involved in RNA degradation and surveillance. 
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2 Material and Methods
2.1 Material
Unless specified otherwise, all common chemicals were ordered by Merck (Darmstadt), Roth 
(Karlsruhe) or Sigma (Deisenhofen) in the highest available purity. The enzymes were obtained 
from  Invitrogen  (Karlsruhe),  MBI  Fermentas  (St.  Leon-Rot)  or  New  England  Biolabs 
(Frankfurt).  All  chromatographic  material  and  columns  was  obtained  from  GE  Healthcare 
(Munich).  Radioactive  material  (α-,  γ-32P-ATP  and  α-32P-GTP)  was  purchased  from  GE 
Healthcare  (Munich)  and  Hartmann  Analytik  (Braunschweig).  Crystallization  screens, 
crystallization grade reagents and crystallization tools were obtained from Hampton Research 
(Laguna Niguel, USA), Qiagen (Hilden) or Jena Bioscience (Jena). The DNA oligonucleotides 
for cloning were ordered from MWG (Martinsried) and RNA oligonucleotides for crystallization 
and RNAse assays were synthesized from Biomers (Ulm). All used oligonucleotides were HPLC 
purified. Thin layer chromatography plates for diadenylate cyclase assays were PEI-Cellulose F 
plates from Merck (Darmstadt). 
Bacterial  strains  used  in  this  theses  are  XL-1  blue  (recA1  endA1  gyrA96  thi-1  hsdR17 
supE44relA1  lac[F´proAB  lacIqZΔdM15Tn10(Tetr)])  from  Stratagene  (La  Jolla,  USA)  and 
Rosetta (DE3) (F- ompT hsdSB (rB- mB-) gal dcm lacY1 (DE3) pRARE (CmR)) from Novagen 
(Schwalbach/Ts). The cells were grown in LB media containing 1% (w/v) tryptone, 0.5% (w/v) 
yeast extract, 0.5% (w/v) NaCl (+ 1.5% (w/v) agar for selective media plates) (Miller, 1972).
2.2 Software
For primary analysis of SAXS data different programs from the ATSAS 2.1 software package 
were  used  (Konarev  et  al.,  2006).  All  ab  initio modeling  was  performed  using  GASBOR 
(Svergun et  al.,  2001) and multiple model  alignment,  averaging and superposition of crystal 
structures with SAXS structures was performed with SUPCOMB and DAMAVER (Volkov and 
Svergun, 2003).
Data processing of crystallographic data was performed with XDS (Kabsch, 1993), for many 
other applications suitable programs from the CCP4 program suite were used (CCP4, 1994). 
Manual building in electron density maps was done with COOT (Emsley and Cowtan, 2004). 
Refinement of models was performed with CNS (Brunger et al., 1998) and PHENIX (Afonine et 
al., 2005).
All  figures  of  protein  or  nucleic  acid  structures  were  created  with  PyMOL from  DeLano 
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Scientific (Palo Alto, USA). 
For  analysis  and  quantification  of  diadenylate  cyclase,  RNAse  assays  and  EMSAs  the 
ImageQuant Software from GE Healthcare (Munich) was used. 
Simulation  and  curve  fitting  of  the  RNase  assays  was  performed  with  MATLAB  from 
MathWorks (Munich). 
2.3 Methods
2.3.1 Cloning, Expression and Purification Methods 
2.3.1.1 Cloning
Standard methods for molecular biology were performed according to standard protocols. This 
includes  polymerase chain reaction, restriction enzyme digestion, ligation of DNA fragments, 
preparation of competent cells, transformation, amplification of plasmid DNA and analysis by 
agarose gel electrophoresis. Plasmid DNA preparation and purification of DNA fragments was 
performed  with  the  NucleoSpin®-Plasmid  Quick  Pure  Kit  and  NucleoSpin®  Extract  II 
(Macherey-Nagel, Düren), respectively. 
Point mutations were introduced by PCR-based site-directed mutagenesis (Ho et al., 1989). Two 
complementary oligonucleotides encoding the desired mutation are used to generate two DNA 
fragments with overlapping ends in the first amplification reaction (see table 1 for a list of all 
oligonucleotides).  In  a  second  amplification  reaction,  these  two  DNA fragments  serve  as 
template to amplify the full-length gene with the incorporated nucleotide exchange. Primers for 
site-directed  mutagenesis  were designed with primerX (http://bioinformatics.org/primerx).  In 
the  case of  bicistronic  vectors  the  whole  cassette  with  both  genes  was  amplified.  Further 
employed standard methods for working with and analysis of proteins like for example SDS-
PAGE, determination of protein concentration and protein concentrating were used as described 
in Sambrook and Russell 2001. 
Table 1: Oligonucleotides used for cloning
  Oligonucleotide Sequence (5' → 3' direction)
exosome forward and reverse primer
afRrp41 for NdeI AAAAAA CATATG TCGGAATTCAATGAAAAACCAGAA
afRrp41 rev Hind III AAAAAA  AAGCTT TCAGGCATCTTCACCACCCTCTG
afRrp42 for Nco I AAAAAAA CCATGG GCCCTGAAGACATCCTTGTGGACATT
afRrp42 rev Not I AAAA GCGGCCGC TTAAATTTCCTTAAATTTCTCCCTCAG
afRrp4 for Nco I AAAAAAA CCATGG GCAGGAAGATAGTACTGCCAGGAGAT
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Table 1: continued
  Oligonucleotide Sequence (5' → 3' direction)
afRrp4_cHis rev Not I AAAAAAA GCGGCCGC TTGAATTCCGACATCTGCCTTCCT
afCsl4 for Nde I AAAAAA CATATG AGATTCGTAATGCCGGGAGAT
afCsl4 for S1 Nde I AAAAAA  CATATG ATGGGAGATGTTGTCCTCGGCA GA
afCsl4 rev Hind III AAAAAA  AAGCTT CTACCACTCTCCCTTGCCGTAAT
primer for mutagenesis
afRrp42_Y70A_for CCGGGCGAGCCC GCT CCGGACACCC
afRrp42_Y70A_rev GGGTGTCCGG AGC GGGCTCGCCCGG
afRrp41_C43A_for CTGACGGGTCT GCG TACCTTGAAATG
afRrp41_C43A_rev CATTTCAAGGTA CGC AGACCCGTCAG
afRrp41_C140S_for GCAGGACAGCC AGT CTGAATGCTGC
afRrp41_C140S_rev GCAGCATTCAG ACT GGCTGTCCTGC
afRrp42_C248A_for GATGTGAGCATAAAC GCC GCGAGGAAGCTGAG
afRrp42_C248A_rev CTCAGCTTCCTCGC GGC GTTTATGCTCACATC
afRrp41_Cys_STOP_Hind_rev TTTTT AAGCTT TCA GCA GGCATCTTCACC
afRrp41_K51E_for CCTTGAAATGGGGAAGAAC GAA GTAATTGCAGCGGTTTTC
afRrp41_K51E_rev GAAAACCGCTGCAATTAC TTC GTTCTTCCCCATTTCAAGG
afRrp41_K37C_for GCAAGCGTTTTA TGT AGGGCTGACGGG
afRrp41_K37C_rev CCCGTCAGCCCT ACA TAAAACGCTTGC
afRrp42_D143C_for ATCCACGCTCTT TGT GATGACGGAAAC
afRrp42_D143C_rev GTTTCCGTCATC ACA AAGAGCGTGGAT
2.3.1.2 Protein Expression
A list of all used expression plasmids is given in table 2. 
Table 2: Expression plasmids
# insert vector restriction sites tag comments
1 afRrp41-afRrp42 pET-21 Nde I, Not I - bicistronic
2 afRrp41-afRrp42 pET-29 Nde I, Not I C-6xHis bicistronic
3 afRrp4 pET-29 Nco I, Not I C-6xHis -
4 afCsl4 pET-21 Nde I, Hind III - -
5 afCsl4 pET-28 Nde I, Hind III C-6xHis -
6 afCsl4_S1+ZnR pET-28 Nde I, Hind III C-6xHis Csl4 missing the N-terminal domain
7 afRrp41 (R65E)-afRrp42 pET-21 Nde I, Not I - bicistronic – neck mutation
8 afRrp41 (D180A)-afRrp42 pET-21 Nde I, Not I - bicistronic – active site mutation
9 afRrp41 (R65E+D180A)-afRrp42 pET-21 Nde I, Not I - bicistronic – active site and neck mutation
10 afRrp41-afRrp42 (Y70A) pET-21 Nde I, Not I - bicistronic – tyrosine mutation
11 afRrp42 (C248A) pET-28 Nco I, Not I - Rrp42 for fluorescent labeling
12 afRrp41 (C43A+C140S) pET-21 Nde I, Hind III N-6xHis / C-Cys Rrp41 for fluorescent labeling
13 afRrp41 (K51E)-afRrp42 pET-29 Nde I, Not I C-6xHis bicistronic – interface mutation
14 afRrp41 (K37C) pET-21 Nde I, Hind III - cysteine mutations for crosslink 
experiment15 afRrp42 (D143C) pET-28 Nco I, Not I C-6xHis
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For overexpression of recombinant proteins, competent  E. coli  Rosetta (DE3) cells (Novagen, 
Schwalbach/Ts)  were  always  freshly  transformed  with  plasmid  DNA carrying  the  gene  of 
interest.  In  case of  coexpression  of  two subunits,  plasmids  with resistance  for  two different 
antibiotics  were  chosen.  Cells  were  grown  at  37°C  in  LB  medium in  the  presence  of  the 
appropriate  antibiotics  to  an  optical  density at  600 nm of  0.8  -  1.0.  Protein expression was 
induced with 0.17 mM IPTG (Roth, Karlsruhe) and temperature was cooled down to 18°C. After 
shaking for  approximately 15 h at  18°C cells  were harvested by centrifugation at  4°C.  Cell 
pellets were flash frozen in liquid nitrogen and stored at -80°C.
DisA proteins were cloned and purified by Gregor Witte as described in Witte et al., 2008.
2.3.1.3 Purification of Exosome Proteins and Complexes
Clones of wild-type exosome constructs were obtained from Katharina Büttner (Büttner, 2005). 
For purification, cells were resuspended in lysis buffer (for all buffers, see table 3) and disrupted 
by sonication. Cell debris was removed by centrifugation. During a heat step of 80°C for 15 
minutes most E. coli protein impurities were heat denatured and removed by centrifugation. His-
tagged constructs were first purified using 3ml Ni2+-NTA material (Qiagen, Hilden) using a batch 
method. The resin was subsequently washed with wash buffer I and for nucleic acid removal 
with  high  salt  wash  buffer  II.  Protein  was  then  eluted  with  elution  buffer.  Fractions  were 
analyzed quantitatively for  protein content  using Bradford protein  assay (Bio-Rad,  Munich). 
Protein containing fractions were pooled, diluted 1:4 with dilution buffer, and further purified by 
anion exchange chromatography (HiTrap Q, GE healthcare, Munich), only in the case of the 
Rrp41-Rrp42-Rrp4 complex  with cation exchange chromatography (HiTrap SP, GE healthcare, 
Munich) using the Äkta System (GE Healthcare,  Munich).  Prior to the experiments,  the ion 
exchange columns were equilibrated with buffer A and protein was eluted with a gradient of 20 
column volumes  from buffer  A to  buffer  B.  Peak fractions  were  pooled,  concentrated  with 
centrifugal  devices  (Amicon® Ultra,  Millipore,  Billerica,  USA) and loaded onto a  Superdex 
S200 26/60 size exclusion chromatography column equilibrated with gelfiltration buffer). Peak 
fractions were concentrated to different concentrations according to the following experiments, 
flash frozen in liquid nitrogen and stored at -80°C. Cysteine mutants for labeling with fluorescent 
dyes were purified in the constant presence of 2mM β-mercaptoethanol or 5mM DTT to avoid 
misfolding. 
2.3.1.4 Purification of Exosome Complexes with Bound RNA
For structural  studies the Rrp41-Rrp42 and the Rrp41-Rrp42-Rrp4 complex were purified in 
complex with endogenously bound Escherichia coli RNA. To achieve a stable and homogeneous 
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protein-RNA complex,  some  changes  in  the  purification  strategy  were  performed:  the  Ni-
material was not washed with high salt when the complex was bound. In all buffers the salt 
concentration was never higher than 250mM. After the Ni-column the complex was loaded on an 
anion exchange column to remove as much unbound nucleic acids as possible. More than one 
size exclusion chromatography column was run, to assure the total removal of free RNA. Only 
when only one distinct peak was eluted, the fractions were pooled, concentrated and flash frozen.
Table 3: Buffers used for protein purification and biochemical assays
Buffer Composition
protein purification
lysis buffer 50mM Tris pH 7.4 (25°C), 250mM NaCl
wash buffer I 50mM Tris pH 7.4 (25°C), 250mM NaCl, 10mM imidazole
wash buffer II 50mM Tris pH 7.4 (25°C), 1.5M NaCl, 10mM imidazole
elution buffer 50mM Tris pH 7.4 (25°C), 250mM NaCl, 250mM imidazole
dilution buffer 50mM Tris pH 7.4 (25°C)
buffer A 50mM Tris pH 7.4 (25°C), 100mM NaCl
buffer B 50mM Tris pH 7.4 (25°C), 1M NaCl
gelfiltration buffer 20mM Tris pH 7.4 (25°C), 200mM NaCl
biochemical assays
diadenylate cyclase buffer 40mM Tris pH 7.5 (25°C), 100mM NaCl, 10mM MgCl2
TLC running buffer 1M NH4SO4, 1.5M KH2PO4, pH 3.6
RNAse buffer 20mM Tris pH 7.6 (25°C), 60mM KCl, 10% glycerol, 2mM DTT, 0.1% PEG 8000
stopping buffer
0.75 g/l bromphenol blue, 0.75 g/l xylene cyanol, 25% (v/v) glycerol, 50% 
formamide
20x TBE buffer 1.8M Tris, 1.8M boric acid, 40mM EDTA
labeling buffer 50mM Tris (pH 7.5), 150mM NaCl and 25% glycerol
2.3.2 Biochemical Assays
2.3.2.1 Diadenylate Cyclase Assays
For diadenylate cyclase assays 3.5 µM DisA (monomer concentration) was incubated with or 
without different amount of varying DNA molecules in 40 mM Tris (pH 7.5), 100 mM NaCl and 
10 mM MgCl2.  The reaction was started with the addition of 100 µM ATP containing 1:600 
radioactively  labeled  α-32P-ATP (3000Ci/mmol,  GE  Healthcare)  and  incubated  at  50°C  for 
TmaDisA and at 30°C for BsuDisA. As negative control the same assay was performed with GTP 
and α-32P-GTP instead of ATP. At different time points 0.5 µl of the reaction mix was applied on 
a PEI-Cellulose F thin-layer chromatography (TLC) plate (Merck, Darmstadt) and left to dry. 
The application of the protein on to the TLC plate and the drying stops the reaction and makes it 
possible to follow the cyclase activity through time. 
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For analysis the TCL plates were developed in 1 M NH4SO4 and 1.5 M KH2PO4, pH 3.6, dried 
and  exposed  on  a  Storage  Phosphor  Screen  (GE  Healthcare,  Munich)  and  scanned  with  a 
StormScanner (GE Healthcare, Munich). The intensity of the various radioactive species was 
calculated by quantifying the intensities of the relevant spots using the  ImageQuant software. 
2.3.2.2 RNAse Assays
2.3.2.2.1 Radioactive labeling of oligonucleotides
To visualize the different oligonucleotides used in RNase assays, they were radioactively labeled. 
The  radioactive  labeling  of  RNA was  carried  out  by  mixing  100  pmol  of  the  relevant 
oligonucleotide with 30 μCi  γ-32P-ATP,  and 10 U T4 Polynucleotide Kinase (Fermentas, St. 
Leon-Rot) and the supplied buffer in a 20 μl reaction for 1 h at 37°C following the provided 
instructions. The reaction contained additionally 0.8 U/μl RNasin (Promega, Mannheim). Free 
ATP was removed from the oligonucleotides using MicroSpin G-25 columns (GE Healthcare, 
Munich).
2.3.2.2.2 Assay Conditions
To analyze the RNase and polymerization activity of exosome complexes from Archaeoglobus 
fulgidus, the proteins were incubated in 20 mM Tris (pH 7.6), 60 mM KCl, 10 % glycerol, 2 mM 
DTT, 0.1 % PEG 8000. In addition different amounts of varying divalent ions like Mg2+ or Mn2+ 
were used. The reaction was started by adding radioactively labeled RNA molecules of different 
lengths in changing concentrations and incubated at 50°C. At different time points 2µl of the 
sample were mixed with 2 µl stopping buffer (0.75 g/l bromphenol blue, 0.75 g/l xylene cyanol, 
25 % (v/v) glycerol, 50 % formamide) and analyzed by gel electrophoresis.
2.3.2.2.3 Urea Gel Electrophoresis
Gels for analysis of oligonucleotide products was performed in a Sequi-Gen GT sequencing cell 
(BioRad,  Munich)  for  21  cm x 40  cm x 0.4  mm gels.  Sinalization  of  the  glass  plates  was 
performed to avoid sticking of the gel to the walls. 40 ml gel solution containing 8 M urea, 20 % 
polyacrylamide and TBE buffer (table 3) was prepared and the polymerizing reaction of the gel 
was started by addition of 18 µM TEMED and 180 µl 10% APS (ammonium peroxodisulfate). 
Gels were poured horizontally and run in TBE buffer. Gels were pre-run at 40 Watt, until the gel 
temperature reached 45 – 50°C. After thorough washing of the gel wells, 3 µl of sample were 
loaded and the gel was run for 2 h at 40 Watt. 
For  analysis  of  RNA bands  the  gel  was  removed  from the  cell  and  exposed  on  a  Storage 
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Phosphor  Screen  (GE Healthcare,  Munich)  for  1  h  and  scanned  with  a  StormScanner  (GE 
Healthcare,  Munich).  The  intensity  of  the  various  radioactive  species  was  calculated  by 
quantifying the intensities of the relevant bands using the ImageQuant software. 
2.3.2.3 EMSA (electrophoretic mobility shift assay)
To test binding of exosome complexes and single exosome subunits to RNA,  binding assays 
were  performed  with  different  radioactively  labeled  oligoribonucleotides  as  substrate  (see 
2.3.2.2.1). For each reaction, different concentrations of protein were incubated with 50 fmol 
RNA substrate in the same buffer that was used for the activity assays in a 20 μl reaction for 10 
minutes  at  room  temperature.  Reactions  contained  additionally  0.8  U/μl  RNasin  (Promega, 
Mannheim). The samples were mixed 5:1 with loading buffer (1.5 g/l bromophenol blue, 1.5 g/l 
xylene cyanol, 50% (v/v) glycerol), and RNA:protein complexes were resolved on a native 6% 
polyacrylamide gel. Gels were run in 0.5x TB-Buffer for 2 hours at 80 V. The gels were exposed 
on a  Storage  Phosphor  Screen  (GE Healthcare,  Munich)  for  1  h  and scanned with a  Storm 
Scanner  (GE  Healthcare,  Munich).  The  intensity  of  the  various  radioactive  species  was 
calculated by quantifying the intensities of the relevant bands using the ImageQuant software.
2.3.2.4 Fluorescent Labeling of the Exosome for Single-Molecule Experiments
In collaboration with the group of Taekjip Ha at the University of Illinois, USA single-molecule 
FRET  (fluorescence  resonance  energy  transfer)  experiments  were  performed.  For  these 
experiments fluorescently labeled exosome complexes had to be produced. Labeling was done 
with a Cy3 mono-functional maleimide which is particularly suitable for the selective labeling of 
molecules  containing  free  sulfhydryl  groups,  such  as  cysteine  residues.  Therefore  a  single 
cysteine mutant  of  the exosome had to  be produces  to  ensure specific  labeling.  All  existing 
cysteines  in  the  Rrp41 protein  (C43 and C140) were mutated  to  alanines  and an  additional 
cysteine was introduced at  the C-terminus.  The protein was purified together  with Rrp42 in 
presence of reducing agents. 
Labeling of the complex with Cy3 was performed using the Cy3 Maleimide mono-Reactive Dye 
pack from GE Healthcare (Munich) in labeling buffer (50 mM Tris (pH 7.5), 150 mM NaCl and 
25% glycerol) according to the supplied protocol. To optimize the labeling efficiency the reaction 
was carried out under oxygen free atmosphere in a glove box. After incubation over night the 
labeled protein had to be separated from remaining free dye. Therefore the complex was applied 
to a HiTrap Desalting column (GE Healthcare, Munich), followed by an anion exchange column. 
As the Cy3 dye is extremely hydrophobic it does not bind to the column and can so be efficiently 
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removed from the  protein complex. The labeling efficiency was determined by measuring an 
absorption spectrum and using the molar extinction coefficients of Dye and protein: Cy3: ε552nm = 
150 000 M-1 cm-1 and Rrp41-Rrp42 hexamer: ε280nm = 61 200 M-1 cm-1, the calculation has to be 
corrected for the absorbance of the dye at 280 nm (approximately 8% of the absorbance at 552 
nm).
2.3.3 Crystallization and Structure Determination
2.3.3.1 Exosome in Complex With Small RNA Molecules
120 µM Csl4-exosome wt and Y70ARrp42 (=27 g/l) in gel filtration buffer was incubated with 
400 µM RNA (3.3fold  excess)  for  10  minutes  on  ice.  Different  RNA molecules  were  used: 
10mer polyA, 8mer polyU, 6mer CCUCCU and 6mer CCACCA. The protein:RNA complex was 
crystallized  by sitting  drop  vapour  diffusion  technique  by mixing  1  μl  protein  and  1  μl  of 
reservoir solution (0.1 M NaAcetate, pH 4.6, 30% MPD, 100 mM NaCl) at 20°C.
In addition the Csl4-exosome was crystallized without RNA and the crystals were soaked with 
the  four  different  RNA molecules.  For  the  soaking  experiment  Csl4  exosome  alone  was 
crystallized in the same condition and 1 µl 0.5 mM RNA in the crystallization solution was 
pipetted to the drop. After 2 h crystals were washed for 10 min in reservoir solution.
Prior to data collection, crystals were directly mounted in nylon loops and flash frozen in liquid 
nitrogen. Datasets was recorded at the ID-14-2 beamline (ESRF, Grenoble, France) to 2.6 Å. 
Data from 180 images (0.5° rotation) were integrated and scaled with XDS (Kabsch 1993). A 
model of the apo-Csl4-exosome complex (Büttner et al., 2005) was used as a search model for 
molecular replacement using PHASER (CCP4, 1994). Refinement to 2.6 Å was performed with 
CNS (Brunger et al., 1998) and PHENIX (Afonine et al., 2005). In the additional electron density 
a 6mer RNA molecular was positioned using COOT (Emsley and Cowtan, 2004). Refinement of 
the  complete  complex  at  2.6  Å followed iterative  cycles  of  manual  model  completion  with 
COOT and refinement with CNS.
2.3.3.2 Csl4 S1-ZnR Domain
The truncated version of Csl4 (lacking the N-terminal domain) was concentrated to 5.5 mg/ml 
and screened for crystallization conditions. The protein was crystallized by sitting drop vapour 
diffusion technique  by mixing 1 μl  protein and 1 μl  of  reservoir  solution.  Crystals  grew in 
100 mM HEPES, pH 7.5, 20% PEG 4000 and 10% isopropanol. The condition was refined to 
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100 mM HEPES pH 7.8; 18% PEG 4000, 10% isopropanol and 10% glycerol and crystals were 
directly  flash  frozen  in  liquid  nitrogen.  A dataset  was  recorded  at  the  PX  beamline  (SLS, 
Villigen, CH) to 1.9 Å. Data from 360 images (0.5° rotation) were integrated and scaled with 
XDS (Kabsch 1993). Refinement to 1.9 Å was performed with CNS (Brunger et al., 1998) and 
PHENIX (Afonine et al., 2005). 
2.3.3.3 Exosome core with copurified RNA
Approximately  10  g/l  exosome  complex  with  copurified  RNA in  gel  filtration  buffer  was 
crystallized  by sitting  drop  vapour  diffusion  technique  by mixing  1  μl  protein  and  1  μl  of 
reservoir solution (0.1 M HEPES, pH 7.5, 5% MPD, 10% PEG 6000) at 20°C. Crystals grew 
after some days and were mounted in nylon loops and flash frozen in liquid nitrogen. A dataset 
was recoded to 3 Å  at the PX beamline (SLS, Villigen, Switzerland). Data from 360 images (1° 
rotation) were integrated and scaled with XDS (Kabsch 1993). A model of the exosome core 
(Büttner et al.,  2005) was used as a search model for molecular replacement using PHASER 
(CCP4,  1994).  Refinement  to  3.0  Å  was  performed  with  CNS  (Brunger  et  al.,  1998)  and 
PHENIX (Afonine et al., 2005).
2.3.4 SAXS Experiments and Data Processing
Results from all SAXS measurements are summarized in table A1 in the appendix.
2.3.4.1 DisA
T. maritima DisA protein for SAXS experiments was supplied by Gregor Witte in gel filtration 
buffer. Samples were measured at the SIBYLS beamline (Advanced Light Source, Berkeley, CA, 
USA) with a concentration of 2, 4, 6 and 8 mg/ml. PRIMUS (Konarev et al., 2003) was used to 
primary analyze  the  data  and  exclude  the  possibility  of  protein  aggregation.  In  the  case  of 
concentration  dependent  aggregation  or  attractive  forces  between  molecules  the  normalized 
scattering curves would diverge at small s-values. To exclude the possibility of radiation damage 
three different measurements with the same sample were performed: one short (6 seconds) one 
long (60 seconds) and a final  short (6 seconds) experiment. In the case of radiation damage 
during the long experiment, the first and the third scattering curve would differ. Good agreement 
between the two is a clear indicator of a protein structure that is insensitive to X-rays. The radius 
of gyration was calculated using the Guinier plot in the linear region (constraint: s · Rg < 1.3) and 
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the calculation of the pair distribution function was done with GNOM within PRIMUS. Thereby 
the  correct  maximum  particle  diameter  Dmax was  iteratively  determined  by  evaluating  the 
resulting Rg value, the I(s)-fit and the shape of the p(r)-distribution. Theoretical SAXS curves of 
the crystal structure were calculated using CRYSOL (Svergun et al., 1995). Ab initio modeling of 
the DisA solution structure was done with GASBORp (Svergun et al., 2001). Thereby different 
particle symmetries were assumed and more than 10 identically calculated models were aligned 
and averaged using DAMAVER and SUPCOMB (Volkov and Svergun, 2003).
2.3.4.2 Exosome
The different exosome complexes were measured in at least three concentrations in gel filtration 
buffer at the SIBYLS beamline (Advanced Light Source,  Berkeley,  CA, USA) and the X-33 
beamline (EMBL/DESY, Hamburg). Primary data analysis was performed like with the DisA 
protein (see 2.3.4.1). Pair distribution functions were calculated with GNOM (Svergun, 1992) 
and  ab initio models were calculated with GASBORp and GASBORi (Svergun et al., 2001), 
were GASBORp uses the pair  distribution function for  ab initio modeling and GASBORi the 
non-transformed scattering intensity. For apo-exosome complexes a P3 symmetry was assumed. 
Alignment of at least 15  ab initio models and averaging was performed with DAMAVER and 
SUPCOMB.
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3 The DNA Integrity Scanning Protein A (DisA)
3.1 The DisA Protein and its Influence on Sporulation
During cell division all organisms have to promote correct replication of chromosomes and their 
distribution to the two daughter cells. Both processes are very complex and require as intact 
chromosomes  as  possible.  To  avoid  loss  or  change  of  genetic  information,  cells  developed 
mechanisms  to  inhibit  the  progression  of  cell  multiplication  when  the  chromosomes  are 
damaged. These so-called  checkpoints (Hartwell and Weinert, 1989) seem to be universal to all 
cell  types.  In  2006  the  DNA integrity  scanning  protein  A (DisA)  of  the  gram-positive  soil 
bacterium Bacillus subtilis has been identified as a new and noteworthy checkpoint protein by 
Bejerano-Sagie and coworkers.
Bejerano-Sagie et al. identified the disA gene as the last gene in an operon that consists of six 
different genes involved in protein degradation, competence and DNA repair. They could show 
that the deletion of the  disA gene has no effect on cell division, sporulation or competence of 
DNA damage response in vegetative cells. Interestingly, they could show that in the presence of 
DNA damages, sporulation is inhibited by DisA. On the basis of this finding they examined the 
expression of early sporulation genes via their transcription factor Spo0A and concluded that 
DisA is at least partly required to inhibit Spo0A activity in case of occurring damaged DNA . 
The authors propose that DisA scans the genome of B. subtilis for damage and reports possible 
abnormalities to the cell-cycle machinery before starting the sporulation process. Using a time-
resolved fluorescence microscopy approach with fluorescently labeled DisA in living B. subtilis 
cells, they were able to visualize the movement of DisA foci in the living cell (figure 3). 
Figure 3: Visualization of moving DisA foci in B. subtilis cells (Bejerano-Sagie et 
al. 2006). The dynamic localization of DisA-GFP foci is demonstrated by time-lapse 
microscopy  from  individual  cells  before  polar  division.  Cells  are  stained  with 
FM4-64 (red) and DAPI (blue) and photographed at ~ 300 msec intervals. The scale 
bar corresponds to 1 µm.
When introducing DNA lesions in the cell they observed that the majority of DisA-GFP (green 
fluorescent protein) loci were no longer moving but seem to be stalled at various positions within 
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the cell. By introducing a double strand break at a known position they could even presume that 
the DisA-GFP locus is stopping at the approximate position of the lesion.
As a consequence of their data Bejerano-Sagie et al. proposed the following model: the DisA 
expression increases when sporulation condition are  sensed.  At a  certain  protein level,  DisA 
forms globular structures that  move rapidly within the cell and scan for DNA lesions.  Upon 
detection of  a lesion the DisA complex looses  its  mobility and stalls  – thereby triggering a 
cellular response that leads to a temporary block to initiation of sporulation. After repair of the 
lesion the arrest is abolished and the sporulation processes can be initiated or continued.
The results presented by Bejerano-Sagie et al. give remarkable new insights into the processes in 
which DisA seems to be involved and in the downstream effects of this checkpoint protein. As 
the  authors  focused  in  their  work  mainly on  in  vivo data,  further  detailed  biochemical  and 
biophysical analysis of the DisA-protein can provide answers to open questions, such as the size 
of a DisA focus and its composition. The exact mechanisms of DisA DNA lesion recognition is 
not at all understood and the question remains, if DisA directly recognizes DNA abnormalities or 
if  one  or  more  interacting  proteins  are  additionally  involved.  Furthermore,  the  downstream 
events triggered by DisA, which can induce sporulation arrest by an unknown signaling pathway, 
remain to be investigated.
3.2 The Crystal Structure of T. maritima DisA
As already mentioned above, a very powerful method to understand protein complexes, their 
function and their  duty in  the living cell  is  the determination of the atomic structure of the 
complex. To shed more light on the properties of the DisA protein, the crystal structure of the 
Thermotoga  maritima homolog  of  DisA was  solved  (Witte  et  al.  2008),  which  shows  high 
sequence homology to the Bacillus variant of DisA (more than 55 %).
After purification of both B. subtilis (Bsu) and T. maritima (Tma) DisA proteins, analytical size 
exclusion  chromatography  and  analytical  ultracentrifugation  experiments  showed  that  DisA 
forms an asymmetric-shaped octameric complex in solution under the present conditions. 
The obtained crystal structure of TmaDisA is shown in figure 4. DisA forms a dumbbell-shaped 
structure with dimensions  of 80 x 55 x 30  Å and consists  of three structural  domains.  Two 
different globular domains at  the N- and C-terminus of the protein are connected by a third 
domain that contains an elongated bundle of three α-helices. No reasonable structural homologue 
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of this middle domain could be found by database searches, but relatives of the two globular 
domains could be found:
The C-terminal domain is with only 62 residues relatively small and possesses a typical helix-
hairpin-helix (HhH) fold. This motif is known to be associated with DNA phosphate backbone 
binding in numerous DNA-interacting proteins. Therefore the C-terminal part of DisA is very 
likely the DNA-binding site. 
On the opposite side of the protein, at the N-terminus, a larger globular domain with 145 amino 
acids is  located.  Comparison of this  domain with structurally similar proteins gave only one 
structural  neighbor  in  the  DALI  database  (Holm  and  Sander,  1996).  This  uncharacterized 
prokaryotic domain of unknown function has not been further characterized, yet. 
Figure 4: Crystal structure of the DisA monomer from  Thermotoga maritima. 
Shown are the three domains of DisA in ribbon representation and the bound ligand 
as  sticks.  The  smaller  C-terminal  DNA binding  domain  is  shown in  orange,  the 
nucleotide binding domain in green and the connecting helical domain in blue. The 
N-terminal domain of the second interacting DisA molecule is only partly shown. 
The ligand is  bound by the two opposing DisA N-termini.
Especially worth mentioning is  a  finding  in  the structure  of  DisA that  at  first  could  not  be 
explained:
In the electron density a non-protein ligand could be seen, which was clearly coordinated by the 
N-terminus of DisA (figure 4). This ligand was located at the interface between two opposing 
DisA molecules and on a symmetry axis. The electron density at this position resembled a cyclic 
purine nucleoside, but none of the commonly known small biological molecules could be fitted 
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into the density. During crystallization no additive that could explain this density was added so 
this molecule must have been picked up endogenously or even been synthesized by DisA itself 
during recombinant expression in the  Escherichia coli cells. The shape and dimension of the 
density as  well  as  the chemical  nature of  the  corresponding protein-binding  pocket  strongly 
argues for the presence of a bis-(3'-5')-cyclic dimeric adenosine monophosphate (c-di-AMP). By 
the use of  MALDI-TOF mass spectrometry of the whole protein complex, this assumption could 
be verified.
However, the occurrence of the so far unknown c-di-AMP molecule that is well-coordinated by 
DisA residues is puzzling. Neither the existence nor the origin and function of this molecule have 
been described so far. In addition to this, it still has to be proved that c-di-AMP is the natural 
ligand of DisA, how it was produced and that it was not by accident copurified as an artifact 
from recombinant expression in E. coli. 
3.3 Cyclic Purine Nucleotides As Second Messengers
Second messengers are elements of the signal transduction cascade. In the second messenger 
system a small and thus fast diffusing signaling molecule is rapidly generated and/or released, 
which then activates effector proteins within the cell to exert a cellular response. 
Secondary messenger systems can be activated by diverse means. In the case of small cyclic 
molecules the increase of the second messenger in the cell  is regulated via the activation of 
cyclases, which synthesize cyclic nucleotides. These small molecules may then go on to exert 
their effect by binding to and thereby (in)activating effector molecules such as protein kinases, 
ion  channels  and  a  variety  of  other  proteins,  continuing  and  down-streaming  the  signaling 
cascade.
3.3.1 cAMP and cGMP
The discovery of the second messenger adenosine 3',5' cyclic monophosphate (cAMP) and the 
molecular  analysis  of  its  role  in  hormone  action  (Sutherland,  1972)  opened  a  new  era  in 
biological research. Only shortly later guanosine 3',5' cyclic monophosphate (cGMP) was found 
to be an important player in eukaryotic signal transduction (Fedorov, 1976). cAMP is synthesized 
by an adenylyl  cyclase (AC) from ATP, whereas cGMP is  synthesized by the corresponding 
guanylyl cyclase (GC) from GTP (for chemical structures see figure 5).
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Figure  5:  cGMP and  cAMP:  Cyclic  adenosine  monophosphate  and  guanosine 
monophosphate are formed through introduction of a chemical bond between the 5'-
phosphate and the oxygen of the 3'-OH-group.
Both  are  degraded  to  nucleoside  monophosphates  by  cyclic  nucleotide  phosphodiesterases 
(PDEs). The levels of cAMP and cGMP in the cell are tightly balanced by the opposing actions 
of purine nucleotide cyclases and PDEs, both of which can occur in multiple isoforms, often with 
distinct subcellular locations. This arrangement facilitates fine tuning of cellular responses. In 
their roles as eukaryotic second messengers, cAMP and cGMP can bind to and activate a number 
of  intracellular  receptors;  these  include  cyclic  nucleotide-dependent  protein  kinases,  cyclic 
nucleotide-gated ion  channels,  PDEs,  a  Rap1 guanine  nucleotide-exchange factor  (Epac)  (de 
Rooij et al., 1998) and GAF domains. The protein kinases are key regulators of these signaling 
pathways and their activation triggers a cascade of downstream events that leads to a cellular 
response. In many prokaryotes, the biological activity of cAMP is mediated through its role in 
transcriptional activation (Baker and Kelly, 2004; Lucas et al. 2000; Kaupp and Seifert, 2002).
Whereas cAMP signaling is common to both prokayotes and eukaryotes, cGMP does not seem to 
be present  in  bacterial  cells.  However,  there  is  increasing  evidence that  the  cyclic  dimer of 
cGMP, c-di-GMP plays a critical role in bacterial signaling (D'Argenio and Miller, 2004; Jenal, 
2004).
3.3.2 C-di-GMP and Associated Enzymes
Although the cyclic nucleotide bis-(3'-5')-cyclic-di-guanosine monophosphate (c-di-GMP, figure 
6) was already discovered in the 1980s, its global role in bacterial signaling has become apparent 
only recently in the view of the growing bacterial genome sequence information available. C-di-
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GMP affects  various cellular  functions  principally related to the transition between a motile, 
single-cell  state  and an adhesive,  surface-attached,  multicellular  state  called “biofilm” (Hall-
Stoodley  and  Stoodley,  2005).  C-di-GMP  is  synthesized  out  of  two  GTP  molecules  by 
diguanylate cyclases and hydrolyzed again by c-di-GMP specific phosphodiesterases, both of 
which occur  in  soluble  and membrane-bound variants.  Homologs  of  these proteins  are  only 
found in eubacteria, which implies that c-di-GMP signaling is specific to this domain of life. The 
domain responsible for cyclase activity is named GGDEF domain and the diesterase activity is 
associated with the EAL domain. Recently, the predicted enzymatic activities of these domains 
that are named for their most obvious conserved amino acids, was experimentally verified (Paul 
et al. 2004, Chan et al. 2004, Chang et al. 2001). 
Figure 6: C-di-GMP signaling molecule: One c-di-GMP molecule is synthesized by 
a  diguanylate  cyclase  from  two  GTP  molecules  through  release  of  two 
pyrophosphates.
3.3.2.1 Diguanylate Cyclase Activity and GGDEF Domains
Proteins with GGDEF domain are very specific for GTP as a substrate and the only detectable 
product is c-di-GMP. Like the well-characterized adenylyl and guanylyl cyclases (Baker et al, 
2004),  diguanylate  cyclases  (DGCs)  seem  to  function  as  dimers  of  trimers,  whereby 
oligomerization is an intrinsic property of the GGDEF domains (Ryjenkov et  al.,  2005). The 
activity of the GGDEF domains is stimulated by phosphorylation-induced dimerization, which is 
thought to be mediated by an N-terminal receiver domain. One of the best characterized proteins 
with  GGDEF domain  is  PleD -  named like  this,  because  mutations  in  the  pleD gene  cause 
pleiotropic effects (Sommer and Newton, 1989; Aldridge et al., 2003; Paul et al., 2007). PleD is a 
member  of  the  response  regulator  family  required  for  pole  development  in  Caulobacter  
crescentus (Aldridge et al., 2003). Biochemical analysis of purified PleD, which consists of two 
N-terminal  receiver  domains  arranged  in  tandem and  a  C-terminal  GGDEF output  domain, 
showed  that  this  protein  is  a  diguanylate  cyclase.  An  important  progress  in  understanding 
GGDEF domains was the atomic structure of PleD in complex with c-di-GMP solved by Chan et 
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al. in 2004 (figure 7). 
Figure 7: Crystal structure of PleD from Caulobacter vibiroides with bound c-di-
GMP: The two receiver domains are shown in blue and the catalytic GGDEF domain 
in green. The c-di-GMP molecules are shown as sticks, the one in the active site is 
shown in orange and the two c-di-GMP molecules bound to the regulatory site are 
shown in brown and light yellow.
The diguanylate cyclase domain shows a tertiary structure closely similar to that of the catalytic 
core of adenylyl cyclases and to the “palm” domain of DNA polymerases. These domains are 
functionally related and are catalyzing 3'-5' phosphodiester bond formation. Nucleotide/protein 
interactions in the active side of the GGDEF domain clearly explain the preference of these 
cyclases for GTP in contrast  to ATP. The insights gained from the atomic structure allow to 
propose a binding mode for GTP and a model for the catalytic mechanism. The PleD crystal 
structure revealed an additional binding site for c-di-GMP nested in the interface between the 
GGDEF domain and the central receiver-like domain (figure 7). High-affinity binding of c-di-
GMP to this site is responsible for the observed strong non-competitive product inhibition of the 
cyclase activity and leads to the conclusion that allosteric feedback inhibition in diguanylate 
cyclases is a general regulatory principle of c-di-GMP signaling. 
3.3.2.2 Phosphodiesterase Activity and EAL Domains
Shortly after identifying GGDEF domains as the responsible proteins for diguanylate cyclase 
activity, the phosphodiesterase activity was unambiguously assigned to EAL domains (Christen 
at al., 2005). For several EAL proteins it could be shown that c-di-GMP is rapidly hydrolyzed to 
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pGpG, whereas the further hydrolysis to two GMP molecules is much slower and does not seem 
to be a physiologically relevant activity of this domain. Observations made with isolated EAL 
domains showed very effective hydrolysis of c-di-GMP, therefore these proteins were proposed 
to be active as monomers.
Besides, catalytically non-active EAL domains could be found (Schmidt et al., 2005), which led 
to the conclusion that they might have adopted alternative regulatory functions. Furthermore, the 
significance and catalytic function of proteins containing both GGDEF and EAL domains is still 
unclear. All biochemically analyzed enzymes possessed either cyclase or diesterase activity. The 
existence of bifunctional enzymes is quite likely, because there are bacterial genomes that encode 
only  one  GGDEF+EAL  protein,  but  have  no  separate  genes  for  either  a  cyclase  or  a 
phosphodiesterase. 
3.3.2.3 PilZ as First Proposed c-di-GMP Binding Domain
Recently the 118 amino acid PilZ domain was identified as a candidate for c-di-GMP binding 
(Amikam and  Galperin,  2006).  It  had  already  been  discussed  as  a  candidate,  because  PilZ 
domain proteins are part of biosynthesis pathways that are regulated by c-di-GMP. The knockout 
of the name-giving protein PilZ, which is a stand alone protein in the type IV pili biosynthesis 
pathway without assigned function, shows the same phenotype as cells lacking the FimX protein, 
a multi domain GGDEF-EAL protein (Huang et al., 2003). This observation indicates that PilZ is 
part of a c-di-GMP signaling pathway or even the protein, which is located directly downstream 
of c-di-GMP. 
3.4 The Role of Holliday Junctions and Fork Structures in DNA Repair
The integrity of the genetic  information is  essential  for the sustainment  of life.  However,  it 
cannot  be prevented  that  damage from various  threads  (e.g.  radiation)  occurs  to  the  genetic 
blueprint. To overcome this problem and to keep the genomic integrity, organisms developed 
sophisticated repair mechanisms to limit corruption to their DNA. Failure of these systems can 
be fatal or have severe consequences such as cancers and other heritable or sporadic disorders. 
Different signals and recognition mechanisms can lead to the activation of the respective repair 
pathway. 
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3.4.1 Double Strand Breaks
Different kinds of damage can change the DNA structure.  Probably the most severe kind of 
damages are double strand breaks, in which both strands of the DNA are broken, because this can 
lead  to  genome  rearrangements.  Cells  developed  two  different  methods  of  repairing  double 
strand breaks: non-homologous end joining and recombinational repair (also known as template-
assisted repair) (Siede et al., 2006). Recombinational repair requires the presence of a (nearly) 
identical sequence to be used as a template for repair of the break. The enzymatic machinery 
responsible for this repair process is closely related to the machinery responsible for homologous 
recombination  during meiosis. Like during homologous recombination, a special DNA tertiary 
structure called Holliday junction occurs. A Holliday junction is a mobile junction between four 
strands of DNA (figure 8).
The structure is named after Robin Holliday, who proposed it in 1964 (Holliday, 1964). Because 
of the fact that these junctions are formed between highly homologous sequences, they can slide 
up  and  down the  DNA.  In  bacteria,  this  sliding  (or  branch  migration)  is  facilitated  by  the 
RuvABC  complex  (Kowalczykowski,  2000).  An  important  progress  in  understanding  the 
recognition and binding process was the solution of the atomic structure of RuvA bound to a 
Holliday junction (figure 8, Ariyoshi et al., 2000). The arrangement of four HhH-motifs in the 
tetrameric structure of the RuvA protein is obviously essential  for the binding to this highly 
symmetric DNA element. 
Figure 8: Crystal structure of RuvA from Escherichia coli bound to a Holliday 
junction:  The four copies of RuvA are shown in ribbon representation in different 
colours.  The bound Holliday junction is  shown in gray.  In the crystal  a four-fold 
symmetry  axis  is  located  in  the  middle  of  the  RuvA tetramer  and  the  Holliday 
junction. 
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3.4.2 Stalled Replication Forks
During  DNA replication  three  DNA double  strands  meet  together  forming  the  so  called 
replication fork. Normally this replication fork is moving along the DNA sequence together with 
all involved proteins (Kornberg and Baker, 2005). The replication process is highly processive 
and accurate, but any obstacles can be a potential thread in this dynamic fork progression. If for 
example  the  replisome runs  into  a  site  with  DNA lesions  caused  by UV-light,  for  example 
thymidine-dimers, this can lead to a complete stop of movement of the replication fork (stalling). 
The stalled replication fork can then be recognized by the corresponding repair  factor and a 
damage response system is activated. 
3.4.3 DNA Damage Checkpoints
The  DNA repair  mechanisms  need  some  time  to  recover  the  correct  situation  in  the  cell. 
Therefore it has to be assured that the cell does not continue cell division as long as the repair 
enzymes are not yet finished with their work. Therefore, so called cell-cycle checkpoints are 
activated after the detection of DNA damage. DNA damage checkpoints occur at the G1/S and 
G2/M boundaries of the cell cycle. Some checkpoint proteins respond to DNA double-strand 
breaks,  disruptions in  chromatin structure or to stalled replication forks (Siede et  al.,  2003). 
Normally kinases are involved, which phosphorylate downstream targets in a signal transduction 
cascade, eventually leading to cell cycle arrest.
3.5 Aim Of The Project
The main objective of this project was the understanding of the biochemical function of DisA 
from T. maritima and its B. subtilis homolog. Surprisingly, in the crystal structure of T. maritima 
DisA, electron density for a c-di-AMP molecule was identified which could also be proved by 
mass spectrometry. The existence of c-di-AMP as biological molecule was not described in the 
literature,  yet.  As  the  structure  of  DisA in  complex  with  c-di-AMP is  not  a  proof  for  a 
physiological role of the newly identified molecule, further biochemical studies are needed. It 
has to be clarified, whether DisA picked up the c-di-AMP molecule from the E. coli cells during 
expression  or  if  it  synthesized  it  de  novo from ATP.  Furthermore,  the  possibility  that  DisA 
actually prefers binding to the thoroughly investigated second messenger c-di-GMP, or even can 
synthesize  c-di-GMP from GTP,  has  to  be  ruled  out.  Using  in  vitro biochemical  assays  the 
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cellular function of DisA will be analyzed.  
Additionally,  the  correct  octameric  organization  of  T.  maritima DisA is  still  not  clear.  Even 
though size exclusion chromatography and analytical ultracentrifugation could show that DisA is 
a  homo-octamer,  the  crystal  packing  of  DisA in  the  TmaDisA crystals  allow  two  different 
octameric assemblies. To get answers to this problem a Small Angle X-ray Scattering (SAXS) 
approach will be used to identify the correct DisA octamer.
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4.1 Identification of the Correct Quaternary Structure of DisA
To understand the function of the DNA integrity scanning protein A (DisA) better, DisA from the 
thermophile bacterium Thermotoga maritima (TmaDisA) was crystallized by Gregor Witte and 
the atomic structure was solved (PDB entry 3C1Y). As shown in figure 9, TmaDisA crystallized 
in  a  long  fiber-like  chain  of  interconnected  tetramers.  The  interface  within  the  tetramer  is 
especially mediated by the helical domain in the middle of the protein (shown in blue) and is 
with approximately 4400Å2 quite large and very likely a stable physiological interface. From size 
exclusion chromatography and analytical  ultracentrifugation studies,  it  was already clear that 
DisA forms a complex in solution that is definitely larger than a tetramer. The results strongly 
support the existence of an octameric complex in solution.
MODEL 1    MODEL 2
Figure  9:  Organization  of  DisA tetramers  in  the  crystal.  The  two  possible 
octameric DisA complexes are indicated. In model 1 (blue) two tetramers interact via 
the N-terminal nucleotide binding domains and in model 2 (orange) the interaction is 
mediated via the C-terminal DNA binding domains.
Figure 9 depicts the two different possible octameric assemblies,  which can be found in the 
crystal structure: in model 1 the two tetramers interact via the N-terminal nucleotide binding 
domain  (green)  and in  model  2  the interaction is  mediated via  the postulated DNA binding 
domain (orange) at the C-terminus. In model 1 the bound c-di-AMP ligand would be buried in 
the interface, whereas in model 2 it would be accessible to the solvent. 
To  identify  which  of  the  two  octameric  forms  is  existent  in  solution,  SAXS  studies  were 
performed. SAXS curves were measured at different protein concentrations and no concentration 
dependent  aggregation or  the  existence of  attractive  forces  between the complexes  could  be 
observed.  In  addition,  the  sensitivity  of  the  protein  to  radiation  was  analyzed  by  replicate 
exposures of the sample to X-rays and the complex seemed to be structurally very stable even 
after long exposure. The measured scattering curve of DisA is shown in figure 10A. 
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To determine the radius of gyration the ln(s) vs. s² - Guinier plot (Guinier, 1939) was used by 
analyzing the region of small s-values (see figure 10B). The Rg was determined from the slope of 
the linear regression curve extrapolated to s² = 0 to be 52.8  Å for all protein concentrations 
(considering s · Rg < 1.3 to fulfill the constraints for the Guinier approximation).
For  transformation  of  the  scattering  data  into  the  pair-distribution  function,  the  maximum 
particle diameter Dmax was determined to be 176 Å, which fits very well to the longest distance of 
slightly less than 175 Å in the crystal  structure.  The calculated p(r)-distribution is shown in 
figure 10C and shows the typical shape of an elongated, cylindrical molecule.
A B
C
Figure 10: SAXS studies with DisA 
from T. maritima. A: Scattering curve 
of  DisA.  The  buffer  is  already sub-
tracted  and  the  intensity  is  plotted  
logarithmically.  B:  Linear  region of  
the Guinier plot, from which Rg and I0 
can be derived.  C:  Pair  distribution  
function of DisA, which was used for 
ab inito modeling with GASBORp. 
The  solution  structure  was  determined  using  the  p(r)  distribution  and  the  dummy  residue 
approach (Svergun et al., 2001) with different symmetry constraints for modeling. As the DisA 
structure shows a 4-fold symmetry and a 2-fold symmetry with perpendicular symmetry axes, 
four different solution structures were calculated: implicating no symmetry (P1), one forced 2-
fold  symmetry  axis  (P2),  one  forced  4-fold  symmetry  axis  (P4)  and  forced  2-  and  4-fold 
symmetry axis (P42). For all four structures the ab initio structure calculation was repeated 10 
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times using identical input parameters and the structures were then aligned and averaged. The 
obtained structures are shown in figure 11 as bead models.
Figure  11:  DisA  solution  structures  calculated  with  different  implicated 
symmetries. The depicted bead models of SAXS solution structures were calculated 
with GASBORp using the pair distribution function of DisA shown in figure 9C. 10 
structures  were aligned and averaged.  For  ab initio modeling  different  symmetry 
constraints were used: no symmetry (orange), 2-fold (green) and 4-fold (blue) and 
both 2- and 4-fold symmetry (yellow). 
The final bead model calculated with forced single 4-fold symmetry did not give a reasonable 
result, because the program has located the symmetry axis in a wrong orientation. All other three 
structures show a similar overall shape. 
To determine which of the two possible crystallographic octamers is present in solution,  the 
crystal  structures  were  overlaid  with  the  ab  initio solution  structure  using  the  SUPCOMB 
program (Kozin and Svergun, 2000). The superposition of the bead model obtained with the 2-
fold symmetry with both octamer models is shown in figure 12. Model 1 with facing N-termini 
of DisA fits very well to the solution structure, whereas for model 2 some structural elements 
clearly stick out of the envelope and are missing at other positions. 
In addition to comparison at structural level, the two models were compared with the SAXS data 
at the level of the scattering curves.
The  theoretical  scattering  curves  of  both  possible  octameric  models  were  calculated  using 
CRYSOL and overlaid with the measured scattering curve of the DisA complex. Figure 13 shows 
the  comparison  between  calculated  and  measured  scattering  data.  Whereas  the  calculated 
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scattering curve for  model  1  only shows small  deviations  from the measured data,  model  2 
clearly does not fit the experimental scattering curve. Thus, model 1 is existent in solution and 
the crystal structure of DisA resembles its solution structure very much.
Figure 12: Superposition of the two possible octamer models with the SAXS 
structure. Clearly model 1 (top) fits better to the solution structure than model 2.
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Figure 13: Experimental scattering curve in comparison to theoretical scattering 
curves calculated from the two possible DisA assemblies: The calculated scattering 
curve for model  1 (solid blue line)  agrees very well  with the experimental  curve 
(black  crosses),  while  the  calculated  curve  for  model  2  (dashed  orange  line) 
substantially disagrees. 
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4.2 Identification of the Enzymatic Activity of DisA
4.2.1 DisA is a Specific Diadenylate Cyclase
During model building of the DisA structure, additional electron density for a ligand bound to 
the N-terminal domain of DisA could be observed.  Using mass spectrometry the ligand was 
proved  to  be  a  bis-(3'-5')-cyclic  dimeric  adenosine  monophosphate  (c-di-AMP).  As  no  such 
molecule  was  added  during  purification  or  crystallization  it  must  have  been  co-purified. 
However, this ligand has not been described as a biological molecule in literature, yet. Thus, it 
remained to be analyzed whether DisA bound endogenous c-di-AMP during expression in E. coli 
cells (assuming that c-di-AMP exists in E. coli) or synthesized it from substrates available in the 
cells. 
Even  though  c-di-AMP is  unknown  so  far,  a  similar  molecule,  c-di-GMP,  is  already  well 
characterized as widespread second messenger in prokaryotes (Camilli and Bassler, 2006; Jenal 
and Malone, 2006; Römling and Amikam, 2006) and a biochemical assay for its synthetase was 
already established (Christen et al., 2005). To test whether DisA may be the synthetase for c-di-
AMP a diadenylate cyclase assay was developed by adaptation from the diguanylate cyclase 
activity assay described by Christen et al. (2005). DisA was incubated with radioactively labeled 
α32P-ATP as a substrate and the formation of c-di-AMP was monitored over time. Separation of 
the  substrate  ATP  and  the  reaction  product  c-di-AMP  was  achieved  with  thin  layer 
chromatography in a suitable running buffer as described in Christen et al. (2005). 
Thermotoga maritima DisA Bacillus subtilis DisA
substrate: ATP GTP ATP GTP
phosphate
ATP
   
c-di-AMP
time [min]            0    5   10   20  30  45      0    5   10  20   30  45       0    5   10  20  30  45      0   5   10   20  30  45
Figure 14: Dinucleotide cyclase activity of DisA is specific for ATP.  Thin-layer 
chromatography of assay products for TmaDisA and BsuDisA carried out at 50°C and 
30°C respectively. With both DisA proteins the amount of c-di-AMP is increasing 
while ATP concentration is decreasing. Activity can only be observed with 100 µM 
ATP and not with equal amount of GTP. 
4 Results – DisA 42
The experiment was able to prove the existence of a reaction product behaving similar to c-di-
GMP (Christen et al., 2005) on a TLC plate. However, the activity seems to be low as shown in 
figure 14. Due to the fact that all earlier published  in vivo  experiments with DisA (Bejerano-
Sagie et al., 2006) were carried out with the homologue from  Bacillus subtilis, both proteins 
BsuDisA and TmaDisA were tested for activity (figure 14). 
The assays with Thermotoga maritima DisA had to be performed at 50°C as the source organism 
is a thermophile and the TmaDisA activity increased strongly with temperature (figure 15A-C)). 
Assays with BsuDisA were carried out at 30°C. It could be shown that both proteins are equally 
active. For reasons of comparison and due to the fact that ATP gets more easily hydrolyzed at 
higher temperatures, all further studies were carried out with BsuDisA protein at 30°C.
Figure 15 A-C: The cyclase activity of TmaDisA is temperature dependent. The 
cyclase assay was carried out at 30°C, 40°C and 50°C and an increase in activity can 
be  observed  for  higher  temperatures.  D:  Mg2+  ions  are  necessary  for  enzymatic 
activity of DisA.  E: Using cordycepin triphosphate, which is missing the 3'-OH at 
the ribose, no reaction product can be observed. F: Sodium azide does not affect the 
enzymatic activity of DisA. Time points were taken as shown in figure 14. 
To proof that the in vitro synthesized product of the reaction is in fact a c-di-AMP molecule, two 
independent  reactions were performed in  parallel:  one with radioactively labeled ATP and a 
second one with non radioactive ATP and both were incubated for 1 h. Using the radioactively 
labeled sample, the position of the spot was identified and the equivalent part on the second 
TLC-plate was scratched off the plate and incubated in water for 30min at 50°C. This sample 
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was  analyzed  by negative  mode  MALDI-TOF mass  spectrometry  using  sinapinic  acid  as  a 
matrix.  In comparison to  the reference (matrix alone)  the spectrum of the sample showed a 
prominent  peak at  657 Da which  corresponds to  the mass  of  single-charged c-di-AMP (see 
appendix 9.3.2).
While c-di-AMP was not discovered as relevant biological molecule before, the closely related 
c-di-GMP is well characterized. To ensure that DisA did not use ATP as a substrate, because its 
cellular  level  is  much  higher  than  that  of  GTP,  the  assay  was  carried  out  under  the  same 
conditions only exchanging ATP with GTP as a substrate. No comparable diguanylate cyclase 
activity could be detected,  excluding the possibility that  DisA may be a diguanylate cyclase 
(figure 14).
In  a  bacterial  cell  more  variants  of  nucleotide  triphosphates  exist  that  could  possibly  be  a 
substrate for DisA. To ensure that DisA uses only ATP as substrate, competition assays were 
carried out in the presence of radioactive ATP and equal amounts of competing unlabeled ATP 
(control),  GTP,  ITP,  CTP  or  UTP.  Only  non  radioactive  ATP  was  able  to  compete  with 
radioactively labeled ATP. This result indicates that neither one of this triphosphates can compete 
in binding at the active site of DisA nor in being a substrate for transformation into a cyclic 
dinucleotide (figure 16).
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Figure  16:  Competition  assay  to  verify  the  specificity  of  DisA.  DisA was 
incubated with 100µM α-32P-ATP and 0 or 100 µM of the indicated cold NTPs. The 
relative  amount  of  synthesized  c-di-AMP is  shown  (mean  of  three  independent 
experiments ± standard deviation).  Only ATP is  able to  compete with α-32P-ATP, 
indicating that DisA is a specific diadenylate cyclase. 
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4.2.2 The Influence of Mg2+ and Active Site Mutants on the Activity
Comparison of the diadenylate cyclase active site with other enzymes that use ATP as substrate 
indicated that DisA may need Mg2+ for activity. Testing the activity of DisA without any divalent 
ions in the reaction buffer verified this assumption, as no c-di-AMP could be detected after 45 
min (see figure 15D).
  D75
R108
            R108
 D75  T107    T111
Figure 17: Detailed view of the active site of  TmaDisA.  Some amino acids that 
seem to be important for substrate binding or catalysis are shown in sticks. 
A closer look to the structure of DisA at the active site (figure 17) suggested some amino acids 
which may be important for either binding ATP or catalyzing the cyclase reaction. To test their 
importance in c-di-AMP formation mutants were supplied by Gregor Witte and tested in the 
cyclase  assay.  The  following  mutants  resulted  in  total  abolishment  of  diadenylate  cyclase 
activity:  D75A,  D75N,  R108A+H109A+R110A and T107V+T111V.  In  addition,  the  cyclase 
activity was tested with an ATP analogue as substrate that is missing the 3'-OH at the ribose 
(cordycepin  triphosphate).  A proposed nucleophilic  attack  from the  α-phosphate  of  one ATP 
molecule on the 3'-OH of the second ATP molecule should then be impossible and indeed no c-
di-AMP formation could be observed with this substrate under the used conditions (figure 15E).
4.3 The Influence of Different DNA Molecules on DisA Activity
DisA was postulated to be a DNA damage checkpoint protein (Bejerano-Sagie et al., 2006) that 
recognizes directly or indirectly DNA lesions and induces an arrest in cell cycle progression. The 
fact  that  biochemical  analysis  of DisA revealed specific  adenylate cyclase activity raises the 
4 Results – DisA 45
question, if the activity is influenced by (damaged) DNA. Therefore, the activity of DisA was 
tested  in  the  presence  of  different  synthetic  DNA substrates  that  are  equivalent  to  DNAs 
occurring in DNA damages and DNA repair (Figure 18).
 
single strand (ss) mismatch (mm)
double strand (ds) 3' overlap (3'ol)
3' overhang (3'oh) 5' overlap (5'ol)
5' overhang (5'oh) fork
plasmid DNA Holliday junction (hol)
Figure 18: DNA molecules used to test for their influence on DisA activity. DNA 
structures that showed an effect on DisA activity are colored. 
DisA was incubated with increasing amounts of all  DNA molecules shown in figure 18 and 
diadenylate  cyclase  activity  was  measured  as  described  before.  Single-stranded  and  double-
stranded  DNA of  different  lengths,  as  well  as  plasmid  DNA and  dsDNA with  3'-  and  5'-
overhangs had no detectable effect  on DisA activity.  Thus, DNA ends and therefore double-
strand breaks are unlikely to be the primary recognition site for DisA – which in consequence 
leads to the idea that DisA possibly does not bind to the damage itself but to DNA structures 
which are emerging from DNA-damages. 
During the recognition and repair of DNA damage different DNA secondary structures can arise 
like e.g. fork structures, Holliday junctions or DNA with single-stranded flap structures.
The effect of these DNA molecules on DisA activity is shown in figure 19. Whereas 3'- as well 
as 5'-single-strand flap structures only moderately affected DisA activity by slightly decreasing 
its ability to synthesize c-di-AMP, branched nucleic acids that resemble three-way and four-way 
DNA junctions  strongly modulated the activity.  In comparison to  branched nucleic  acid,  the 
presence  of  ssDNA and  dsDNA had  no  effect  on  the  activity  of  DisA within  error  range. 
Addition of 3'- or 5'-single stranded flap structures leads to a reduction of diadenylate cyclase 
activity  of  around  50  % for  a  concentration  of  two  DNA molecules  per  DisA octamer.  In 
presence of three- and four-way DNA junctions the effect is even stronger. Two fork-like DNA 
molecules or two Holliday junctions can reduce the activity to approximately 20 % compared to 
the activity in absence of DNA.
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Figure  19:  Effect  of  different  DNA molecules  on  DisA activity.  Diadenylate 
cyclase activity of 3.5 µM DisA is unaffected by increasing amounts of ssDNA or 
dsDNA(- = no DNA; triangles = increasing concentrations of 0.65, 1.3, 2.0, 2.4, 3.0 
and 6.5 µM DNA). 3' flaps and 5' flaps (3'ol and 5'ol) moderately reduce activity. 
Three-  and  four-way  junctions  substantially  inhibit  the  activity  of  DisA.  Data 
represent the mean of six independent experiments ± standard deviation.
Summarized, this data suggests that the catalytic activity of DisA is regulated by binding of the 
complex  to  branched  nucleic  acids,  well-known  structures  occurring  during  DNA  repair 
pathways.
4.4 The Influence of Azide
Using fluorescence microscopy Berjerano-Sagie et al.(2006) analyzed the movement of DisA-
GFP foci  in  vivo.  In  the  presence  of  the  ATPase  inhibitor  sodium  azide  they  detected  an 
immediate stalling of DisA. On the basis of this observation they concluded that mobility of 
DisA is energy dependent. As the diadenylate cyclase assays clearly shows that DisA uses ATP as 
a substrate, sodium azide might inhibit this activity similar to the inhibition of  ATPases. To test 
this hypothesis, DisA activity was analyzed in presence of up to 10 mM sodium azide in the 
assay buffer and no differences in enzymatic activity could be detected. Therefore, the effect of 
sodium azide on the movement of DisA does not seem to be due to direct  influence on the 
diadenylate cyclase activity (see figure 15F). 
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4.5 DisA and DNA Binding
The obvious effect of DNA on the activity of DisA can only be explained by binding of the 
complex to DNA, followed by a conformational change which then influences the activity of the 
protein. The C-terminal domain of DisA was identified as potential DNA binding domain by 
structural homology searches (Holm and Sander, 1997). It is highly homologous to helix-hairpin-
helix (HhH) domains that are common non-specific DNA binding domains. In electrophoretic 
mobility shift experiments DisA has a more than two times higher affinity to Holliday junction 
DNA compared to normal dsDNA.
Of special interest in this context is the HhH domain of the Holliday junction binding protein 
RuvA, as the structure of this protein was solved in complex with a Holliday junction (PDB 
entry 1C7Y, Ariyoshi et  al.,  2000). To get a principal idea about the possible mode of DNA 
binding of DisA, the HhH domain of RuvA and the bound DNA was superimposed with the C-
terminal domain of DisA using SSM superpose implemented in COOT (figure 20).
Figure 20: Superposition of the HhH domain from TmaDisA (orange) with the 
HhH domain of RuvA bound to DNA (grey, PDB code 1C7Y).  The prominent 
DNA binding loop (magenta, including side chain sticks for a conserved lysine) is 
highly  conserved  between  HhH  domains  from  DisA  and  RuvA,  indicating  a 
conserved mode of DNA backbone interaction.
Comparison of the sequence of the DisA HhH domain with other HhH domains gave a very 
conserved patch of amino acids within a DNA binding loop (figure 20, magenta). To prove that 
the HhH domain of DisA is in fact the DNA binding motif, one of the conserved residues that 
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shows backbone interactions with the DNA, glycine 334, was mutated to a glutamate and this 
protein  expressed  and purified  by Gregor  Witte.  In  electrophoretic  mobility  shift  assays  the 
G334E  mutant  shows  a  drastically  reduced  binding  to  the  DNA  substrates,  proving  the 
involvement of this domain in DNA binding. To analyze whether the HhH-motif is involved in 
regulation  of  the  diadenylate  cyclase  activity,  the  G334E mutant  was  also  used  for  cyclase 
assays.
The mutant protein was tested for influence of Holliday junctions on the activity (figure 21). 
Compared  to  wild-type  protein  the  inhibitory  effect  of  the  Holliday  junction  is  drastically 
diminished in  case  of  the  G334E mutant,  which  indicates  a  decrease  in  specific  binding  to 
branched nucleic acids. This result strengthens the proposed role of the HhH domain in being the 
binding site for Holliday junctions and also the fact that binding of DNA to these motifs leads to 
structural  changes  which  are  somehow  translated  to  the  N-terminal  domain  to  regulate  the 
activity. 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
no DNA dsDNA holliday
sy
nt
he
si
ze
d 
c-
di
-A
M
P 
[1
/m
in
]
wt
G334E
Figure 21: Influence of glycine 334 on Holliday junction binding. The inhibitory 
effect of the Holliday junction on DisA activity is much lower for the G334E mutant 
compared  to  the  wild-type.  This  indicates  that  glycine  334  is  important  for  the 
affinity of DisA to DNA and that DNA-binding to the HhH is the trigger for changes 
in activity of the N-terminal domain.
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5.1 SAXS as Complementary Method to X-ray Crystallography
The identification of the correct octameric assembly of the DisA complex perfectly shows the 
power of SAXS when structural information is already available. When using crystallography as 
a method in structural biology it is always difficult to proof that the determined atomic structure 
is not only a crystallographic artifact. It has to be shown that the proteins or complexes have the 
same fold  and assemble  to  the  same  overall  structure  in  solution  as  they do  in  the  crystal. 
Furthermore the conditions in which some proteins crystallize are far from physiological,  for 
example some crystals grow under extreme pH-values or very high salt concentrations. With 
SAXS  one  can  determine  a  structure  under  conditions  that  are  as  physiologic  as  possible. 
Summarized it can be said that SAXS is very important for protein crystallographers to proof the 
relevance of their structures for biological studies. 
In addition – as it  was shown for the  TmaDisA protein – it  is  often not easy to distinguish 
between real, physiological interfaces within a protein crystal and crystallographic contacts that 
do not exist  in solution.  The calculation of theoretical  scattering curves of atomic models is 
possible in only some minutes and a SAXS experiment does not require much time. This makes 
SAXS an easy method to determine or verify an oligomeric assembly that can be seen in a 
protein crystal.
5.2 The DisA Octamer
From the results of different experiments, the DisA protein was already proposed to form an 
octameric complex in solution. From the way the protein crystallized, no distinct octamer could 
be identified, but two possible models were found. The two tetramers could either be arranged in 
a head-to-head of in a foot-to-foot orientation. Looking at the two different interfaces already 
gives a first hint to the correct complex. In the first model the interaction is mediated via the N-
terminal nucleotide binding domain. This interface is substantially larger than the interface in the 
second model,  where two C-terminal HhH domains interact  with each other.  In addition,  the 
amino acids  mediating the  interaction  in  the  first  model  are  highly sequence  conserved and 
hydrophobic in nature. This already gives promising hints to a physiologic interface in contrast 
to the interface between the HhH domains, which has more hydrophilic residues and resembles 
more a crystal contact. 
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Still it had to be experimentally verified that one of the proposed octameric models matches the 
solution structure of DisA. The results of the SAXS studies proof without any doubt that model 1 
is present in solution and that the four nucleotide binding sites are located in the center of the 
complex. 
5.3 Reliability of SAXS Structures
When determining a solution structure with SAXS a three-dimensional model has to be created 
from a  two  dimensional  scattering  curve,  which  represents  averaged  data  from all  possible 
orientations of the molecule. Although it is possible to calculate an ab initio structure using only 
the scattering data, it is very helpful to have at least some additional structural information. In the 
case of DisA even before solving the crystal structure, it was already known that the protein 
forms  an  octamer  in  solution.  Using  this  information  it  was  possible  to  assume  different 
symmetries of the oligomer, use this information as an additional input parameter and improve 
the model.
However, like in most theoretical fitting algorithms one has to be very careful not to use false 
constraints and reasonable input parameters. A significant disadvantage of SAXS is the fact that 
no real parameter for quality control of the result exists. In X-ray crystallography the R-factor, 
(especially Rfree) enables the scientist to estimate the reliability of the achieved result. In SAXS 
every scattering curve will result in some three dimensional bead model and the biologist then 
has to decide to the best of his knowledge whether this structure is reliable or not. For example, a 
protein complex that has a special symmetry in a crystal is often less symmetric in solution. 
Therefore it is very important to proof that an implicated symmetry constraint is correct.
As shown for the DisA complex, it is important to try different symmetries in comparison to the 
no-symmetry approach. The four SAXS solution structures from the DisA protein show that the 
2-fold and 4-fold symmetry implicated in the calculations was correct, as the variation between 
the structures is negligible.
The shape of the structure obtained with one 4-fold symmetry axis is obviously different to the 
other three models. In this case the program located the symmetry axis in the wrong orientation 
and  then  the  iterative  minimization  method  resulted  in  the  wrong  structure.  However, 
comparison  of  all  obtained  structures  with  the  symmetry-free  structure  clearly proofs  which 
result is correct. 
In summary, SAXS is extremely powerful when structural information is already available and 
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provides supplemental information of the solution structure of the protein. It can also be used as 
an ab inito approach, but then one has to be very careful with the interpretation and reliability of 
the obtained structure to be certain not to look at artifacts. In principle, one scattering curve can 
be explained by two completely different structures. However, comparative database searches 
with theoretical scattering curves of proteins available in the PDB did not reveal overlaps of two 
different structures with the same theoretical scattering curve (Sokolova et al., 2003).
5.4 The Moving Foci of DisA
From their  in vivo observations using  B. subtilis cells, Bejerano-Sagie et al. (2006) concluded 
that  the  cells  increase  expression  of  DisA upon  sensing  sporulation  conditions,  the  protein 
assembles to a globular structure and moves rapidly along the chromosome searching for DNA 
lesions. These data are all based on observations made using GFP-labeled DisA. However, it is 
still not understood how this single, rapidly moving focus is composed and how is moves. The 
structural analysis in this work shows that DisA forms a stable octamer in solution. For DNA 
polymerases that are only loosely localized close to the replication fork 20-40 proteins where 
already detectable as fluorescent foci (Lemon and Grossman, 1998). In the case of DisA, the 
fluorescent GFP-fusion molecules are very tightly arranged. This raises the possibility that only a 
few DisA complexes  might  form part  if  not  all  of  the  detectable  in  vivo focus  as  the local 
concentration of GFP-fluorophors is very high due to the compact assembly. 
The mobility of DisA in wild type cells had a mean velocity of 0.22µm/s and was immobilized in 
cells  that  contained  a  double  strand  break  or  were  treated  with  azide.  Using  fluorescence 
correlation spectroscopy the diffusion constants for protein complexes similar or larger in size to 
octameric DisA could be measured to be in the range of 1-3 µm2/s (Wang et al., 2006). As these 
numbers are quite similar, DisA movement may at least be in part driven by brownian diffusion. 
This assumption would also explain the finding that chromosomal DNA is not needed for DisA 
mobility (Bejerano-Sagie et al., 2006).
The stalling of the foci in the presence of DNA double strand breaks can be explained by the fact 
that DisA has higher affinity to Holliday junctions than  to “normal” double stranded DNA. This 
suggests  that  the  immobilization  does  not  occur  at  the  double  strand itself,  but  at  branched 
nucleic acids like Holliday junctions of stalled replication forks. These types of branched nucleic 
acids are not present in a normally replicating cell but are formed during DNA double-strand 
break induced recombination, chromosome missegregation or as a consequence of replication 
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forks stalling at a lesions. These data lead to the conclusion that DisA might be a more general 
sensor for unsegregatable chromosomes and might fulfill  its role as a checkpoint protein via 
coupling the recognition of unfinished repair with the activity of c-di-AMP synthesis. 
5.5 c-di-AMP and Diadenylate Cyclase Activity
C-di-AMP is related to, but distinct from c-di-GMP. The molecule has not been described as a 
biological molecule that is existing in or synthesized by any pro- or eukaryotic organism, yet. In 
contrast to this the related c-di-GMP is widely studied and was identified as a bacterial signaling 
molecule. It serves as the focal point for several extracellular sensory inputs and plays a role in 
regulating complex cellular processes that are also regulated by quorum sensing. Similar to the 
important second messenger cAMP the level of c-di-GMP is regulated by the activity of enzymes 
that synthesize it from GTP and others that degrade it again to GMP. The cyclase activity is 
associated with GGDEF domains, while the phosphodiesterase activity is associated with EAL 
domains (the names stand for the conserved amino acid sequence motif in the active site). These 
domains as well as c-di-GMP as a second messenger are only found in eubacteria and are absent 
in archaea and eukaryotes (Galperin, 2005).
Although no structural or sequence homology between GGDEF domains and DisA can be found, 
it  is quite likely that c-di-AMP works as a second messenger in a similar way to c-di-GMP. 
Although  c-di-AMP synthesis  may  have  evolved  independently  of  c-di-GMP synthesis,  the 
general overall architecture of the DisA octamer, with central pairs of DAC (diadenylate cyclase) 
domains  and  peripheral  HhH domains  resembles  to  some extent  the  allosterically  regulated 
diguanylate cyclase PleD (figure 7, Chan et al., 2004). 
A structure similarity search for the DAC domain of DisA in the protein data bank using the 
DALI search tool (Holm and Sander, 1996) revealed only one structure that shows the same 
overall fold (figure 22). The identified protein, a structure contributed by a structural genomics 
consortium, belongs  to  the uncharacterized  cluster  of  orthologous  groups COG1624 and has 
outside the DAC domain no sequence homology to DisA. The superposition of the DAC domain 
of DisA with this “domain of unknown function” (DUF) from Bacillus cereus (PDB code 2FB5) 
shows that most of the side chains that are involved in c-di-AMP binding in DisA are conserved 
and also present  in the DUF (see appendix 9.3.1 for a sequence alignment).
Therefore, it is quite likely that this protein of unknown function possesses a DAC domain and 
functions  as  diadenylate  cyclase.  Although  DisA sequences  (including  the  DAC  and  HhH 
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domains) are limited to a subset of eubacterial genomes, the DAC alone is widespread among 
eubacterial  genomes and can be identified also in archaea.  In contrast,  the GGDEF domains 
correlated with c-di-GMP synthesis are restricted to eubacteria. 
Figure 22: Superposition of the N-terminal di-adenylate cyclase domain of DisA 
with the C-terminal domain of a protein with unknown function. The N-terminal 
domain  of  DisA is  shown in  green,  the  c-di-AMP molecule  in  magenta  and the 
structurally related protein found by DALI search is shown in brown (PDB code 
2fb5). Side chains involved in binding and possibly in synthesis of c-di-AMP are 
shown as sticks. These residues are conserved between both proteins, suggesting that 
the homologous protein also possesses di-adenylate cyclase activity.
Combining  all  results  published  by Bejerano-Sagie et  al.  2006 and the results  of  this  thesis 
allows the proposition of a model for the function of DisA and c-di-AMP in the cell:
C-di-AMP might  play  a  general  role  in  the  regulation  of  some  cellular  processes  that  are 
associated with DNA repair and damage signaling. Using DisA-null cells Bejerano-Sagie and 
coworkers could show that DNA damages induce premature timing of sporulation. However, 
present results do not explain whether c-di-AMP has a direct or indirect effect on sporulation. 
The  in vitro data suggests  that  a higher level of c-di-AMP could be present in healthy cells 
leading to normal cell division or sporulation. The presence of damaged DNA and the resulting 
abnormal branched nucleic acids would lead to a decrease in c-di-AMP level, signaling the cells 
the presence of an abnormal situation. This will possibly induce a signaling cascade that results 
in a stop of sporulation. Only after successful repair of the lesions the enzymatic activity of DisA 
is back at the normal level – because of the lack of binding targets – and so signals the cell to 
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resume dividing.
Sequence similarity searches for homologous proteins of DisA revealed that they are also found 
in non-sporulating eubacteria. As mentioned above, the DAC domains, which synthesize c-di-
AMP are  even  found  archaea,  allowing  the  conclusion  that  c-di-AMP is  possibly  not  only 
involved  in  sporulation  signaling,  but  has  a  more  general  role  in  the  regulation  of  the  cell 
division process via recognition of unsegregatable chromosomes. 
The relatively low affinity of DisA to DNA and the low c-di-AMP synthesis rate may indicate 
that other factors like interacting proteins, special DNA sequences or DNA structural specificities 
are important in vivo. 
5.6 The Effect of Holliday Junctions on the Activity
When looking at the structure of DisA octamers from the top, the HhH domains are arranged in a 
way that offers a plausible mechanism for the effect of DAC-regulation by binding to Holliday 
junctions (figure 23A). The four HhH domains are arranged at both sides of the DisA octamer in 
a geometry that strikingly resembles the four HhH domains in the Holliday junction binding 
protein RuvA. 
Based on the structural similarity between HhH motifs of DisA and RuvA, a similar geometry of 
HhH domains bound to  DNA is very likely.  In the case of RuvA each arm of the Holliday 
junction is bound by one HhH domain (Ariyoshi et al., 2000; Hargreaves et al., 1998; Rafferty et 
al., 1996; Roe et al., 1998). Superposition of the DNA bound RuvA with the HhH domain of 
DisA reveals a common fold and shows that some potential DNA-binding residues are present in 
both HhH domains (figure 20). Indeed it could be shown that the mutation of residue G334 to a 
glutamate strongly reduces the capability of the Holliday junction to inhibit diadenylate cyclase 
activity of DisA. These data support the model of a DNA-binding mode of DisA that is related to 
RuvA. However, in the available DisA structure the HhH-motifs are not all capable of binding 
DNA without  conformational  changes,  as  they  seem to  be  in  a  hinged  position.  Supposing 
similar geometries using RuvA as a template, the HhH motifs of DisA require slight rotation and 
tilt to reach the orientation to be well positioned to bind branched nucleic acids. This movement 
very  likely  involves  also  parts  of  the  helical  DisA middle  domain  which  then  might  affect 
activity by  changes in the N-terminal DAC-domains (figure 23C).
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Figure 23: HhH domains of DisA and RuvA in comparison. A: Top view of DisA 
(left)  and RuvA bound to a  holliday junction (PDB entry 1C7Y, Ariyoshi  et  al., 
2000),  HhH domains are shown in orange. B: Schematic view of the orientation of 
the HhH domains. In order to be orientated in the same way as the HhH domains of 
RuvA, the HhH domains of DisA would have to turn and tilt (C).
Considering all data, a mechanistic model for the role of DisA as a checkpoint protein can be 
proposed (figure 24): In a normal, healthy cell with no chromosomal damage, DisA synthesizes 
c-di-AMP which serves as a signal for normal cell division progress. In the presence of branched 
nucleic acids like recombination intermediates or stalled replication forks DisA binds to these 
targets, thereby losing the ability to synthesize c-di-AMP. This decrease in c-di-AMP level is a 
signal  for  the  presence  of  unsegregatable  chromosomes  and  leads  (possibly  through  further 
downstream signaling) to a halt in the cell cycle progression. Still some aspects of this model – 
like the mode of DNA binding – are speculative and need to be tested.
The determination of the atomic structure of DisA bound to a Holliday junction would help to 
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understand, how the DNA can affect the active site although it is positioned at the opposing end 
of the molecule. In addition, in vivo studies with c-di-AMP to proof and further analyze its role 
as second messenger could help to support the model that was proposed in this thesis. 
Figure  24:  Mechanistic  model  for  the  role  of  DisA. In  the  absence  of 
chromosomal damage DisA synthesizes c-di-AMP. Recognition of branched nucleic 
acids  leads  to  inhibition  of  c-di-AMP  synthesis,  signaling  the  presence  of 
unsegregatable chromosomes.
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6 The Exosome and RNA Metabolism
6.1 The Exosome and Quality Control
The variety and amount of RNA molecules that are produced in the cells of all organisms is 
remarkable. There are mRNAs from thousands of genes as well as many RNA molecules that are 
not translated into proteins and function directly as RNAs. These non-coding RNAs include 
tRNAs  (transfer  RNAs  involved  in  translation),  rRNAs  (ribosomal  RNAs),  snRNAs 
(spliceosomal small nuclear RNAs), snoRNAs (small nucleolar RNAs involved in processing of 
rRNAs)  and  a  diversity  of  other  RNAs  that  influence  processes  ranging  from chromosome 
replication to mRNA translation (Warner, 1999). In addition, RNA molecules can be combined 
with proteins and form a ribonucleoprotein (RNP). Similar to proteins, many RNAs are only 
functional when folded into a complex structure. Not only in the case of mRNAs, non-functional 
mutated  RNA can  arise  by  synthesis  from  mutant  genes,  transcriptional  errors,  premature 
termination, post-transcriptional editing events and mistakes in RNA processing. These errors 
may result in RNA misfolding and/or failure to assemble with proteins to form functional RNPs. 
When the cell recognizes defective or non-functional RNAs, rapid degradation of these RNAs is 
induced. Additionally, posttranscriptional degradation is an important method to regulate cellular 
mRNA  levels.  Efficient  surveillance  machineries  are  responsible  to  distinguish  between 
defective and non-defective RNAs and to monitor the process that converts the primary RNA 
transcript to a mature RNP. 
Two main pathways involved in RNA degradation have been identified in eukaryotes: the RNA 
is degraded from the 5'-end either by the 5' exonuclease Rat1 (Xrn2 in humans) or by Xrn1 
(Kastenmayer and Green, 2000). These enzymes are known to be involved in the degradation of 
decapped mRNAs. This thesis  concentrates on the second pathway,  which is  responsible  for 
degradation from the 3'-end by the so called exosome.
In archaea and eukaryotes the exosome is a key component of the RNA surveillance machinery 
(Mitchell et al., 1997). The exosome is a multiprotein complex with 3' → 5' exonuclease activity. 
It degrades many RNAs that are targeted by surveillance activities in the nucleus as well as in the 
cytoplasm. In addition, it is responsible for the precise trimming of 3'-ends of several nuclear 
RNA precursors (Allmang et al.,  1999; Allmang et al.,  2000; van Hoof et al.,  2000; Hilleren et 
al.,  2001;  Suzuki  et al.,  2001; Andrulis  et al.,  2002; Torchet  et al.,  2002; Orban and Izaurralde 
2005). 
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The yeast exosome was identified in 1997 as a 3' → 5' exonuclease that is responsible for the 3′ 
end maturation of 7S rRNA to mature 5.8S rRNA (Mitchell et al., 1996). Two years later the 
human homologs were identified as components of the known PM-Scl particle, a multi-subunit 
complex recognized by autoimmune sera of patients suffering from  polymyositis-scleroderma 
overlap syndrome (Allmang et al., 1999). 
6.2 Exosome-like Complexes in Bacteria, Archaea and Eukaryotes
Exosome complexes are found in archaea and eukaryotes and are homologous to the bacterial 
polynucleotide phosphorylase (PNPase). The PNPase, which was also found in mitochondria and 
chloroplasts,  is  therefore often referred to as an exosome-like complex.  From known crystal 
structures it is assumed that all exosomes and the PNPases are structurally highly conserved. 
The  eukaryotic  core  exosome  consists  of  six  polypeptides  with  sequence  similarity  to  the 
phosphate-dependent 3'→5' exoribonuclease RNase PH and three protein K homology (KH) and/
or S1-domain-containing RNA-binding proteins. In eukaryotes, additional subunits include the 
RNase R homolog Rrp44/Dis3 (identified in the yeast exosome) and the RNase D homolog Rrp6 
(only  present  in  the  nuclear  isoform).  The  archaeal  exosome  exhibits  a  simplified  subunit 
composition and is assembled from three copies each of two RNase PH-like proteins (Rrp41 and 
Rrp42),  Rrp4  (ribosomal  RNA  processing  proteins)  and/or  Csl4  (Cep1  synthetic  lethal  4) 
(Evguenieva-Hackenberg et al., 2003).
6.2.1 Bacterial PNPase and RNase PH
Remarkably, the Polynucleotide phosphorylase (PNPase) can catalyze both the processive 3' → 
5' degradation of RNA and the reverse reaction, meaning the addition of nucleotides to the 3'-end 
(Grunberg-Manago,  1999).  PNPase  was  the  first  identified  enzyme  that  can  catalyze  the 
formation  of  polynucleotides  from ribonucleotides  without  the  need  of  a  template.  When  a 
mixture of nucleotide diphosphates is available, the PNPase produces a random polymer. In E. 
coli it was thought to be mostly involved in degradation, but more and more often its activity in 
the polymerization of heteropolymeric tails has been reported (Mohanty and Kushner, 2000). In 
spinach chloroplasts, cyanobacteria and gram-positive bacteria PNPase is even suggested to be 
the major polyadenylating enzyme (Bollenbach et  al.,  2004). In  E. coli the PNPase is partly 
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associated with the endoribonuclease RNase E, an RNA helicase, enolase, and possibly other 
proteins in a high molecular weight complex called the degradosome (Regnier and Arraiano, 
2000). Figure 25 shows the atomic structure of PNPase in comparison with exosomes. 
RNase PH is the other member of phosphate dependent 3'→5' exoribonucleases in bacteria. It is 
a  relatively  small  single  domain  protein  that  is  known  to  be  involved  in  trimming  tRNA 
precursors at their 3' ends (Li and Deutscher, 1996). Homologs of RNase PH exist in all three 
kingdoms of life and form the core of the exosome complexes in archaea and eukaryotes. In 
bacteria, six RNase PH polypeptides form a hexameric ring that is similar to that of PNPase and 
the exosome (Ishii et al., 2003). 
6.2.2 Comparison of Exosome-like Complexes
All exosome-like complexes contain two subunits that  are related to the RNase PH enzyme. 
These subunits are therefore termed RNase PH-like (PH) domains. The other two subunits are 
homologous to the KH and S1 domains, which are characteristic for RNA binding proteins. 
The crystal structures of the bacterial PNPase, the archaeal exosome and the human exosome 
were determined by X-ray crystallography and are shown in figure 25 (Symmons et al., 2000; 
Büttner et al., 2005; Liu et al., 2006). 
All  structures  are  ring-shaped  with  the  PH domains  surrounding  a  central  channel  that  can 
accommodate a single-stranded RNA molecule (see figure 25). In bacteria the complex consists 
of a ring with six copies of one polypeptide chain. In archaea three different proteins form a 
hetero-trimeric complex. The eukaryotic exosome, which is active in the cytoplasm and nucleus, 
consists of 10 – 11 different proteins and is the most complex version of all. However, alignment 
of  the  proteins  points  to  a  high  structural  similarity  between  the  archaeal  and  eukaryotic 
exosomes and the PNPases: The core structure is in all cases a similar ring shaped complex 
consisting of six different PH-domains and three subunits with an RNA binding surface like KH 
or S1 domains. In addition to this highly conserved complex, a novel subunit was found in yeast: 
a hydrolytic 3' → 5' exonuclease (Rrp44 or Dis3), which belongs to the family of RNase R and 
RNase II in bacteria. 
In the archaeal exosome three active sites that catalyze the degradation and polymerization of 
RNA are located at the inner side of the processing chamber. In contrast, the nine-subunit core of 
the yeast and the human exosome have no phosphate dependent RNase activity (Dziembowski et 
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al,  2007; Liu et al,  2006). Instead, hydrolytic processive and distributive exonuclease activities 
could be observed for the ectopic components Rrp44 and Rrp6 (Mitchell et al., 1997; Briggs et 
al., 1998).
  bacterial PNPase      archaeal exosome   human exosome
Figure 25: Crystal structures of bacterial PNPase, archaeal exosome and human 
nine-subunit  exosome. The  exosome  clearly  is  evolutionary  conserved.  PH  like 
domains  are  shown in  green  (Rrp41 homolog:  light  green,  Rrp42  homolog:  dark 
green) and the KH and S1 domain containing cap proteins are shown in red. S1 and 
KH domains of PNPase are incompletely resolved and may be mobile. (PDB entries: 
PNPase: 1E3P; archaeal exosome with Rrp4 as cap protein: 2BA0; human exosome: 
2NN6)
6.3 Functions of the Exosome
6.3.1 The Exosome in Cytoplasm and Nucleus
Mitchell et al. (1997) identified nuclear and cytoplasmic forms of the exosome in eukaryotes, 
especially the yeast exosome is best studied and characterized. It could be shown that the nuclear 
and cytoplasmic exosome complexes share ten common components, but differ in the presence 
of the GTPase Ski7 in the cytoplasmic complex and the RNase Rrp6 and the putative nucleic 
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acid  binding  protein  protein  Rrp47  (also  known  as  Lrp1)  in  the  nuclear  complex.  Table  4 
summarizes  the  most  important  components  of  the  exosome  and  exosome-like  complexes 
(Allmang et al., 1999; Burkard and Butler, 2000; van Hoof et al., 2000; Araki et al., 2001; Peng 
et al., 2003; Mitchell et al., 2003). 
Table 4: Comparison of exosome complexes and description of their proteins
bacterial
homolog
archaeal 
exosome
yeast 
exosome description of subunits
PNPase
Rrp41
Rrp41 Part of the hexameric ring structure and homologous to 
archaeal Rrp41 – in archaea a phosphate dependent 
exonuclease, in eukaroytes catalytically inactive
Rrp46
Mtr3
Rrp42
Rrp42 Part of the hexameric ring structure and homologous to 
archaeal Rrp42 – in archaea and eukaryotes catalytically 
inactive
Rrp43
Rrp45
Rrp4
Rrp4
Cap proteins that have S1and KH RNA binding domains
Rrp40
Csl4 Csl4 Cap protein that has an S1 domain and a zinc-ribbon domain
RNase R - Rrp44 (Dis3) Member of the RNase II familiy
- - Rrp6 Similar to E.coli RNase T/D familiy – present only in the nuclear exosome
- - Rrp47 Possible RNA binding protein – present only in the nuclear exosome
- - Ski7 Putative GTPase – present only in the cytoplasmic exosome
Proteins for which in vitro exonuclease activity could be detected are highlighted in gray. 
6.3.1.1 The Exosome in the Cytoplasm
For the cytoplasmic exosome mRNAs are the only known substrates. RNA levels are not only 
determined by their  rate of synthesis,  but also by the rate of degradation.  Therefore,  mRNA 
turnover rates are an integral component of the control of gene expression. With the help of the 
Ski2 protein the exosome is responsible for the  3' → 5' degradation of mRNAs.
In addition, the exosome degrades mRNAs with structural defects in two different pathways: in 
the  non-stop  decay pathway the  exosome eliminates  transcripts  lacking  a  termination  codon 
(Frischmeyer et al., 2002). In the nonsense-mediated decay pathway it degrades mRNAs with 
nonsense mutations that were recognized by the exon-junction complex (Lejeune et al., 2003). 
The  human  exosome  is  additionally  involved  in  the  rapid  decay  of  mRNAs  with  AU-rich 
sequence elements in the 3'-untranslated region (Chen et al., 2001). Via AU-rich elements the 
expression of proteins like growth factors and proto-oncogenes is kept transient. 
6 The Exosome and RNA Metabolism 62
Finally the exosome is involved in cleavage of 5' fragments of mRNAs. These fragments can 
occur in the no-go decay pathway, which targets mRNAs on which translation has stalled (Doma 
and Parker, 2006).
6.3.1.2 The Exosome in the Nucleus
In the nucleus the exosome is involved both in the maturation of RNAs by trimming the RNA to 
a precisely defined end point and in the rapid and complete degradation of defective RNAs. 
More precisely it is responsible for the maturation of the 5.8S rRNA, snRNAs and snoRNAs and 
the degradation of aberrant nuclear precursors of mRNAs, tRNAs and rRNAs. This dual role of 
the exosome requires specific signals that are associated with the different substrates. Thereby 
the complex must be able to structurally distinguish between all types of RNA. This mechanisms 
remain unclear, but it is very likely that the tertiary structure of the substrates as well as specific 
associated proteins play an important role. 
6.3.2 RNA Degradation
For all exosome and exosome-like complexes a exoribonuclease activity was observed. However 
the position of active sites and the mode of degradation vary from archaea to yeast/human.
6.3.2.1 RNA Degradation by the Exosome in Archaea
The archaeal exosome as well as the bacterial PNPase possess phosphate dependent exonuclease 
activity. The active site is located at the inner side of the RNase PH ring, hence the RNA is 
degraded  inside  a  processing  chamber,  similar  to  protein  degradation  by  the  proteasome. 
Although both Rrp41 and Rrp42 from the archaeal exosome adopt the RNase PH fold which is 
characteristic  of  phosphorolytic  3'  → 5'  exoribonucleases,  only  Rrp41  has  catalytic  activity 
(Lorentzen et al., 2005). All three active sites within the complex are only accessible via the 
central  channel  and  the  cap  protein  Rrp4  strongly  influences  the  binding  affinity  to  RNA 
(Oddone et al.,  2007). From these results a model for RNA recognition and degradation was 
proposed and is shown in figure 26 (Büttner et al., 2005; Lorentzen et al., 2007). The model 
assumes that the 3' end of the RNA substrate is recruited by the S1-pore of the Rrp4/Csl4 cap and 
then threaded through the neck of the central channel to the processing chamber, where it binds 
to one of the active sites and is processively degraded. 
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6.3.2.2 RNA Degradation by the Exosome in Yeastb
In eukaryotes the equivalent active sites are not functional and no catalytic activity could be 
detected from the RNase PH ring (Liu et al., 2006). However, two additional factors that are only 
present  in  the  eukaryotic  exosome,  namely  Rrp6  and  Rrp44  (also  known  as  Dis3)  showed 
hydrolytic exonuclease activity  in vitro (Burkard and Butler, 2000; Dziembowski et al., 2007). 
Only Rrp44 is part of the core exosome and present in the nucleus and cytoplasm. From native 
mass spectrometry analysis (Hernandez et al., 2006) the position of the Rrp44 protein relative to 
the other 9-subunits could be detected: Rrp44 interacts with three adjoining proteins from the 
RNase  PH  ring,  namely  Rrp45,  Rrp41  and  Rrp42.  In  addition  a  negative-stain  electron 
microscopy model of the yeast exosome at 20 Å resolution showed how Rrp44 associates with 
an 8-subunit exosome (missing the Csl4 protein) (Wang et al., 2007). From interpretation of the 
electron density map, the position of Rrp44 was located at the bottom of the RNase PH ring at 
the postulated exit-site of the RNA. Lorentzen et al. (2008) solved the crystal structure of yeast 
Rrp44  and  showed  that  the  presence  of  the  other  9-subunits  modulates  the  hydrolytic 
exonuclease activity of Rrp44. The 10-subunit exosome complex was not able to unwind RNA 
and can  only fully degrade  ssRNA. However,  Rrp44 alone  can  easily  degrade  duplex  RNA 
molecules with a 3' overhang.
Figure 26:  Model  for RNA recognition and degradation by the  archaeal  and 
yeast  exosome.  A:  Archaeal  exosome.  The  RNase  PH  ring  with  the  processing 
chamber is shown in green, the RNA binding cap proteins are shown in red. B: Yeast 
exosome.  The  RNAse  PH ring  without  active  sites  is  shown in  green,  the  RNA 
binding cap proteins are shown in red and the hydrolytic exoribonuclease Rrp44 in 
blue.  The proposed path of the RNA is shown in yellow. Active sites are indicated 
with a star. The model for the eukaryotic exosome is still speculative.
From  all  this  recent  data  the  following  model  can  be  proposed  (figure  26):  the  overall 
architecture of the 9-subunit core of the exosome seems to be essential for correct functioning of 
the complex, as no catalytic activity could be detected in vitro. The RNA is proposed to bind to 
the exosome cap proteins in a similar way compared to the archaeal exosome. As no active site is 
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existent in the chamber of the RNase PH ring, the RNA possibly leaves the exosome at the PH 
pore, where it may be directly guided to the active site of the attached Rrp44 protein. Therefore, 
the 9-subunit complex would function as regulator and could influence substrate specificity for 
its active subunit Rrp44.
In addition to the Rrp44 protein, the exosome can associate with a second exonuclease in the 
nucleus, the Rrp6 protein. Rrp6 participates both in RNA processing and quality control. The 
structure of yeast Rrp6 has a conserved RNase D core with a flanking helicase and RNase D C-
terminal  domain.  The  N-terminal  domain  is  proposed  to  mediate  the  interaction  with  the 
exosome core.  Rrp6 has  distributive  exonucelase  activity  and was  shown to be  involved in 
degradation of unstructured polyadenylated RNAs (Carneiro et al., 2007). This activity is not 
affected on assembly with the 10-subunit exosome (Liu et al., 2006). Degradation of structured 
RNA substrates by Rrp6 was shown to be promoted by the cofactor protein Rrp47 (Stead et al., 
2007). Rrp47 is a nucleic acid binding protein and seems to facilitate binding to structured RNA 
elements. Rrp6 is not an essential gene, but its deletion results in many RNA processing defects 
(Wyers et al., 2005).
This observation suggests that although partly overlapping in function, Rrp44 and Rrp6 have 
different substrate specificities in vivo. 
6.3.3 RNA Polymerization Activity of the Archaeal Exosome
Polyadenylation is an important post-transcriptional modification of prokaryotic, eukaryotic and 
organellar  RNA.  In  bacteria  and  organelles,  such  as  mitochondria  and  chloroplasts, 
polyadenylation is transient and occurs mainly on RNAs as part of their decay pathway (Dreyfus 
and Regnier, 2002; Kushner, 2004). Also in human mitochondria non-abundant, polyadenylated 
RNA fragments were identified (Slomovic et al., 2005). In general, the mRNA decay process 
consists  of  endonucleolytic  cleavage,  addition  of  degradation-stimulating  poly(A)-tails  or 
poly(A)-rich sequences to the cleavage product and subsequent exonucleolytic degradation. In 
contrast to this form of degradation-stimulating polyadenylation, stable poly(A)-tails are added 
to  mature  3'-end  of  most  nuclear  encoded mRNAs and are  important  for  proper  translation 
initiation, mRNA stability and in some cases nuclear export (Edmonts, 2002). This coexistence 
of stabilizing and degradation-stimulating poly(A)-tails needs a thorough regulation.
The main polyadenylating enzyme in E. coli is the poly(A) polymerase I. However, it was shown 
that for all  heteropolymeric poly(A)-rich tails that were found in cyanobateria,  gram-positive 
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bacteria,  Streptomyces and  Bacillus,  as  well  as  in  spinach  chloroplasts,  PNPase  was  the 
polymerizing enzyme. Therefore the nucleotide composition of a post-transcriptionally added 
extension can indicate  the identity of the responsible  enzyme (Mohanty and Kushner,  2000; 
Bollenbach et al., 2004).
The archaeal exosome is very similar to PNPase, so it is not surprising that heteropolymeric 
RNA tails could be detected in hyperthermophilic and methanogenic archaea (Portnoy et al., 
2005).  Not  all  archaeal  organisms contain  an exosome complex and it  could  be shown that 
heteropolymeric polyadenylation occurs only in organisms containing an exosome (Portnoy and 
Schuster, 2006). 
Unlike RNA polymerases,  PNPase and the archaeal  exosome do not  require  a  template  and 
cannot copy one. When they are supplied with a mixture of ribonucleotide diphosphates (NDPs), 
the ensuing polymerization reaction forms a tail with random sequence. As described above, the 
enzymes can not only catalyze 5'  → 3' polymerization, but also processive 3'  → 5' phosphate 
dependent RNA degradation (Büttner et al., 2005; Grunberg-Manago, 1999). As a phosphorylase 
they  use  phosphate  to  cleave  the  phosphodiester  bond.  In  contrast  to  hydrolysis,  the 
phosphorolysis  reaction is very close to equilibrium and therefore most reversible.  In vitro the 
direction of activity – either degradation or polymerization – can be controlled by the relative 
concentrations of NDPs and phosphate. 
The molecular mechanism of RNA polyadenylation and degradation has been most intensively 
studied in  E. coli.  It  was shown that  PNPase is  mainly active in  degradation and only to  a 
substantial  degree  it  is  active  in  polymerizing  heteropolymeric  tails  (Mohanty and  Kushner, 
2000; Deutscher and Li, 2001). In contrast,  in spinach chloroplasts, cyanobacteria and gram-
positive bacteria the exosome is thought to be the major polyadenylating enzyme (Rott et al., 
2001; Slomovic et al., 2006). 
6.4 Cofactors of the Exosome Complex
The exosome is involved in the maturation and degradation of many different RNAs and it soon 
became obvious that it needs specific cofactors which help to distinguish between all these RNA 
species. In the last years a diverse array of activators and cofactors have been identified that 
activate  the exosome on defined classes  of transcripts.  The most  important  activators in  the 
context of a yeast cell are shown in figure 27. 
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6.4.1 Mtr4 and the TRAMP Complex in the Nucleus
To access the active site of the exosome, RNA substrates have to pass through a narrow pore that 
makes it impossible for double-stranded or structured RNA to be degraded. The DExH-box RNA 
helicase Mtr4 (also known as Dob1) has nucleic acid dependent ATPase activity, can unwind 
duplex RNA in the 3'  → 5'  direction and binds to single  stranded RNA, especially to short 
poly(A) substrates (Bernstein et  al.,  2008). Mtr4 was shown to be required for most nuclear 
activities of the exosome (LaCava et al., 2005; Vanacova et al., 2005). Mtr4 is believed to assist 
the exosome as it moves through structured regions of its RNA substrates and thereby enables 
the RNA to reach the active site behind the exosome pore.
Figure 27: Activation of the exosome by different cofactors in a yeast cell. Many 
different  substrates  and  activating  cofactors  have  been  identified  to  activate  the 
exosome in the nucleus and the cytoplasm of a yeast cell. The various pathways are 
described in chapter 6.4 (adapted from Houseley et al., 2006).
The action of Mtr4 on some RNAs occurs in the context of the TRAMP complexes,  which 
consists of a Poly(A) polymerase (Trf4 or Trf5), a zinc-knuckle protein (Air1 or Air2) and the 
Mtr4 protein (LaCava et al., 2005; Wyers et al., 2005; Vanacova et al., 2005; Kadaba et al., 2004 
and 2006). The TRAMP complex is thought to bind RNA through the zinc-knuckle, putative 
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RNA-binding domains that are present in Air1 and Air2. Mtr4 might then actively recruit the 
exosome to the RNA, as its depletion leads to RNA hyper-adenylation in vivo, which indicates 
that polyadenylation has been uncoupled from degradation (Houseley and Tollervey, 2006). The 
Trf4/5 protein adds short poly(A) tails to the substrate, thereby forming a favorable substrate for 
the exosome, and Mtr4 helps to dissolve RNA secondary structures. 
Mtr4 processes a diverse array of pre-RNAs together with the exosome: maturation of the 5.8S 
ribosomal RNA and processing of snRNAs such as the U4 small nuclear RNA (Allmang et al., 
1999). As part of the TRAMP complex it is additionally involved in the degradation of defective 
tRNAs and precursor ribosomal RNAs before they are exported to the cytoplasm.
Two distinct  forms  of  TRAMP complexes,  TRAMP4 and TRAMP5 have been identified  in 
yeast. They show clear substrate preferences in vivo, but their mode of selectivity is still unclear. 
Both the exosome and the TRAMP4 complex interact with an additional RNA binding protein 
complex  called  the  nuclear  pre-mRNA  down-regulation  complex  1  (Ndr1)  (Vasiljeva  and 
Buratowski, 2006). This complex consists of the RNA helicase Sen1 and the proteins Ndr1 and 
Nab3 (nuclear polyadenylated RNA-binding) that recognize specific sequence motifs on RNAs 
(Steinmetz and Brow, 1998;  Carroll  et  al.,  2004).  This complex is  required for transcription 
termination of snRNA and snoRNA genes (Steinmetz et al., 2001). In vitro the Nrd-complex can 
directly stimulate exosome degradation of substrates with Ndr1- and Nab3-binding motifs.  In  
vivo it probably helps to bring the exosome to specific RNA substrates. 
6.4.2 The Ski Complex 
In the cytoplasm the exosome needs the specific cofactor Ski7,  a GTPase with homology to 
translation factors for most of its activities (Araki et al., 2001). In addition, the Ski2, Ski3 and 
Ski8 proteins from a complex known as the Ski complex are involved in most of the cytoplasmic 
activities of the exosome:
The  ski (superkiller) genes were identified via mutations that cause overexpression of a killer 
toxin encoded by the endogenous double-stranded RNA (Toh et al., 1978). It could be shown that 
not  only the  exosome,  but  the  proteins  Ski2,  Ski3  and Ski8  are  required  for  the  3'-mRNA 
degradation (Anderson and Parker, 1998).  Ski2p is a putative RNA helicase with homology to 
Mtr4 (Widner and Wickner, 1993), Ski3p is a tetratricopeptide repeat (TPR) protein (Rhee et al., 
1989) and Ski8p contains five WD-40 (beta-transducin) repeats (Matsumoto et al., 1993). The 
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three Ski proteins form a stable complex, which is localized in the cytoplasm (Brown et al., 
2000).  Mutations  in  the  three  genes  inhibit  3'  →  5'  mRNA decay,  but  do  not  affect  other 
functions of the exosome (Anderson and Parker, 1998). Therefore the Ski-complex was proposed 
to be the cofactor of the exosome in the degradation of mRNAs in yeast. 
Ski7, another member of the Ski proteins, is permanently associated with the exosome in the 
cytoplasm.  The  ski7 gene was initially identified as one of the  ski gene family (Benard  et al., 
1999). It was shown that Ski7 is also required for  3'  → 5' mRNA degradation and acts in the 
same pathway as the Ski-complex, because deletion of the ski7 gene caused impaired 3'-mRNA 
decay similar to ski2, ski3 or ski8 deletions (van Hoof et al., 2002). When introducing a mutation 
in one of the genes of the Ski-complex, the complex did not assemble any more. In contrast, the 
Ski complex was still intact in the ski7 mutant, suggesting that Ski7 is not a member of the Ski 
complex and is not required for the formation of the complex (Brown et al., 2000). Therefore it 
seems that the role of Ski7 in mRNA degradation differs from the rest of the Ski complex. 
The Ski complex together with the exosome and Ski7 function in the nonsense-mediated decay 
and the non-stop decay mRNA surveillance pathways (Mitchell and Tollervey, 2003; Lejeune et 
al., 2003; van Hoof et al., 2002). 
6.4.3 Sequence Specific Cofactors
Some  cofactors  were  identified  that  recruit  the  exosome  to  RNA substrates  with  specific 
sequences.  They include the Nrd1 protein (see 6.4.1), which enhanced the RNA degradation 
activity of the exosome in vitro and in vivo (Arigo et al., 2006; Vasiljeva and Buratowski; 2006). 
The precursors of many RNA species contain Ndr1-binding sites, which probably function as 
targets for exosome-mediated degradation (Steinmetz et al., 2001). It is likely that during normal 
processing  of  RNAs  with  Ndr1  binding  site,  this  binding  site  is  removed  and  hence  only 
correctly processed RNAs are protected from exosome-mediated degradation. 
In human cells, ARE (AU-rich elements) mediated degradation is an important mRNA turnover 
pathway that involves the recruitment of the exosome (Mukherjee et al., 2002). AREs are found 
in  the  3'-untranslated  region  of  many  mRNAs  that  code  for  proto-oncogenes,  nuclear 
transcription  factors  and  cytokines.  They  represent  the  most  common  determinant  of  RNA 
stability in mammalian cells and are known to target mRNAs for rapid degradation (Barreau et 
al.,  2005).  Mukherjee  et  al.  (2002)  suggested  that  certain  subunits  of  the  human  exosome 
specifically bind to AREs causing an ARE-dependent degradation of mRNAs. Other studies have 
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shown that  several  ARE-binding  proteins,  for  instance  TTP (Tristetraprolin)  and KSRP (KH 
splicing regulatory protein), are physically associated in vitro with the exosome and are required 
for  preferential  degradation of  ARE-containing mRNAs by the  exosome (Chen et  al.,  2001; 
Gherzi et al., 2004). Tran et al. (2004) proposed the involvement of the RNA helicase RHAU. 
RHAU displaces mRNA stabilizing proteins from the ARE and then recruits the exosome to the 
RNA to facilitate mRNA decay. ARE-mediated decay can also occur in yeast, where the activity 
requires a TTP homolog – the role of the exosome has not yet been reported. 
It is still not much known about the way all these cofactors are able to activate the exosome. 
However, a physical recruitment of the exosome to specific RNA substrates seems to play a key 
role in stimulating RNA degradation both in the nucleus and the cytoplasm.
6.5 Aim of the Project
Exosomes occur in archaeal and eukaryotic cells as main 3' → 5' exonucleases that are involved 
in the maturation and surveillance of many different types of RNA. Recent structural studies 
revealed the atomic structure of the archaeal and the human exosome complex (Büttner et al, 
2005;  Liu  et  al.,  2006).  The  archaeal  exosome  possesses  phosphate  dependent  exonuclease 
activity and its active site is located inside of the 9-subunit core complex. In eukaryotes, this 
active sites are not functional any more, but an additional subunit, Rrp44, is bound to the 9-
subunit core and provides hydrolytic exonuclease activity. However, although the position and 
structure of the active sites changed from archaea to eukaryotes, the overall structure of the core 
exosome is highly conserved and extremely similar. This points to the fact that the architecture of 
the  exosome 9-subunit  core  has  a  regulatory  function,  which  seems  to  be  unchanged  from 
archaea to humans. 
Based on the structural insights from Büttner (2007), the aim of this thesis was a more detailed 
investigation of the archaeal exosome. Structural as well as biochemical methods will be used to 
reveal the mode of function and the enzymatic activities of the exosome complex.
Using Small  Angle X-ray Scattering the known crystal  structures will  be compared with the 
conformations of the Rrp4 exosome, Csl4 exosome as well as the 6-subunit complex in solution. 
The atomic structure of the exosome complex with a bound RNA substrate will be determined 
and the RNA-exosome structure together with biochemical data will be used to propose a model 
for the mode of enzymatic degradation. 
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7 Results – Exosome
7.1 Exosome Structures in Solution
The crystal structures of the two different 9-subunit archaeal exosome complexes were solved 
(Büttner et al., 2005) and are shown in chapter 6, figure 25. The three dimensional organization 
of a protein in a crystal can differ from its shape in an aqueous solution. Therefore SAXS studies 
were performed to determine a low resolution structure of the exosome complexes in solution 
and under physiologic conditions. The complexes were purified as described in chapter 2 and 
three different concentrations (5, 10 and 15 mg/ml) were measured at the SIBYLS beamline 
(ALS, Berkeley, USA). No aggregation and intermolecular forces between the complexes could 
be observed. With numerous consecutive measurements of the same sample it could be shown 
that the scattering of exosome samples was not influenced by long exposure to high energy X-
ray radiation.
The obtained scattering curves have a shape that is typical for globular proteins and are shown in 
figure 28. 
Figure  28:  SAXS  curves  and  pair  distribution  functions  of  three  archaeal 
exosome complexes. The curves of the 6-subunit exosome are shown in red, for the 
9-subunit Csl4-exosome in green and for the 9-subunit Rrp4 exosome in yellow. 
Using the Guinier approximation for small s-values, the radii of gyration were determined. The 
three complexes have the following  Rg: 6-subunit complex:  46.2  Å; 9-subunit Csl4 exosome: 
41.4  Å and 9-subunit Rrp4 exosome: 39.6  Å. The pair distribution functions were calculated 
with GNOM and are shown in figure 28. Using GASBORp for the 9-subunit complexes and 
GASBORi for the 6-subunit  complexes, 15 structures were modeled with the ab initio dummy 
residue approach for all three complexes. For the modeling process a three-fold symmetry was 
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assumed. The obtained structures were aligned and averaged using DAMAVER. The resulting 
bead models were superimposed with the equivalent crystal structures and are shown in figure 
29. 
 
               
               
Figure  29:  Low  resolution  structures  of  exosome  complexes  in  solution 
superimposed with  the  equivalent  crystal  structure.  The 6-subunit  exosome is 
shown in red, the 9-subunit Csl4 exosome in green and the 9-subunit Rrp4 exosome 
in yellow. For all three complexes the structures are shown from the top and from the 
side. Superposition was done with SUPCOMB.
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7.2 Crystal Structures of the Archaeal Exosome
7.2.1 Csl4-Exosome Wild Type with RNA Bound to the Active Site
The archaeal exosome subunits Rrp41, Rrp42 and Csl4 were coexpressed in  E. coli cells and 
purified as described in chapter 2. The correct formation of a 9-subunit complex was verified 
using  size-exclusion  chromatography.  The  protein  was  concentrated  to  20  mg/ml,  which 
corresponds  to  approximately  90  µM 9-subunit  complex.  Synthesized  RNA molecules  with 
different length (from 6 bases to 12 bases) were added to a final concentration of 0.4 mM RNA. 
Crystallization screens with 0.3 µl + 0.3 µl drops and 50 µl reservoir solution resulted in the 
growth of different crystal forms in different conditions. Several conditions were refined and the 
obtained crystals were tested for diffraction. Best diffracting crystals grew in 100mM Na-acetate, 
pH 4.6;  100mM NaCl and 30% MPD and are shown in figure 30A. In parallel,  the protein 
complex was crystallized without RNA in the same condition and crystals were soaked with 
RNAs of different lengths over night. All obtained crystals were directly flash frozen in liquid 
nitrogen and data sets were recorded at the PX beamline (SLS, Villigen, CH) and the ID-14-2 
(ESRF, Grenoble, F). Datasets diffracted to 2.4 Å – 3 Å and indexing with XDS determined a 
unit cell of a = 138.27 Å, b = 138.27 Å, c =  262.27 Å, α = 90°, β = 90°, γ = 90° and the space 
group P4322. The structures were solved with molecular replacement using the atomic structure 
of the Csl4-exosome (pdb-code 2BA1) as search model. For further details of data collection see 
appendix table A2.
Difference electron density maps were calculated and additional electron density for some RNA 
bases in the active site became visible (figure 30 C and D).  The crystals  produced with co-
crystallization or soaking with RNA substrates smaller than 10 bases all resulted in a comparable 
density map. They possessed the same space group, diffracted to similar resolutions and differed 
only in the first decimal place of the unit cell constants. The best electron density was used for 
model  building and refinement.  The obtained difference density map is  shown in figure 30. 
Clearly, an RNA molecule is bound to all three active sites. A model for the RNA was manually 
built into the density using COOT (figure 30) and refinement was done with CNS and PHENIX. 
Density for four bases was clearly visible in the active sites, for the following base only parts of 
the density could be detected. This observation was independent from the length of used RNA: 
even in crystals containing an 8-mer RNA molecule electron density for not more that six bases 
could be identified. Crystals that were soaked with a 10- or 12-mer RNA dissolved after some 
minutes. This points to a binding region of the RNA that interferes with crystal packing. 
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Figure 30: Solving the atomic structure of RNA (CCCCUC) bound to the active 
site  of  the archaeal  exosome.  A:  Co-crystals  of the exosome-RNA complex.  B: 
Diffraction pattern of the crystals  shown in A.  C-F:  Csl4-exosome complex with 
additional electron density (blue, |Fo| - |Fc| map, 1σ contour) in the active site in side-
view (C), in bottom view (D) and a closeup of one active site (E). In panel F a model 
for a 6-mer RNA is built into the obtained density, residues Y70 and D180 are shown 
in sticks (brown). Color code of exosome subunits: Rrp41 – light green; Rrp42 – dark 
green and Csl4 – orange. 
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In agreement to former results (Büttner et al., 2005), which showed that the proposed active site 
of Rrp42 is non-functional, RNA could only be detected in the active sites of the Rrp41 protein.
The RNA is situated in a binding cleft (figure 31) that involves both subunits of one hetero-dimer 
of  Rrp41 and Rrp42.  This  finding explains,  why the  Rrp41 subunit  alone  is  not  capable  of 
degradation of RNA, but needs the presence of Rrp42 (Lorentzen et al., 2005). The aspartate 180 
that was shown to be essential for exosome activity is located close to the 3' phospho-diester 
bond to catalyze the degradation reaction. 
Figure  31:  RNA binding  cleft  of  the  archaeal  exosome  with  a  6-mer  RNA 
molecule. The Rrp41 subunits is shown in light green and the Rrp42 subunit in dark 
green. The interactions between the RNA and protein are mainly via the backbone 
and the bases point away from the protein surface. 
The RNA is recognized mainly via electrostatic interactions between the phosphate backbone 
and a set of arginine residues. In addition, π-stacking between the tyrosine 70 of Rrp42 and the 
fourth base of the RNA (counting from the active site) stabilized the position of the RNA. All 
these  interactions  are  sequence  independent,  which  explains  why the  exosome  degrades  its 
substrates in a sequence inspecific manner. 
Interactions between the 2'-OH of the ribose and the exosome can explain the specificity of the 
exosome for RNA in contrast to DNA, where this OH-group is missing. An important contact is 
detectable between arginine 114 and the OH-group of the fourth base. 
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7.2.2 Csl4-Exosome Y70ARrp42 with RNA Bound to the Active Site
From the analysis of the atomic structure of the exosome-RNA complex, the tyrosine residue 70 
of the Rrp42 protein was proposed to play an important role in RNA binding. Therefore the 
tyrosine was mutated to an alanine. The exosome (Y70ARrp42) was expressed and purified in the 
same way as the wild-type exosome and the protein was co-crystallized with the same RNA 
molecule (CCCCUC). The structure was solved as it was done with the wild-type complex. In 
this mutant version, RNA could also be detected in all three active sites. In the wild-type protein 
four bases were clearly visible and two more bases only partly. In the Y70ARrp42 mutant of the 
exosome, only for the first four bases electron density could be observed, and the intensity of this 
density was lower in all three active sites. This points to a decreased affinity of the RNA to the 
mutant exosome and a role of tyrosine 70 in RNA binding. A closeup view of the superposition 
of both structures in the region of tyrosine 70 is shown in figure 32. 
Figure  32:  Closeup  view  of  Rrp42  tyrosine  70. The  RNA from the  wild-type 
structure is shown in red sticks, the tyrosine in green. The RNA from the mutant 
structure and the alanine that replaces the tyrosine is shown in yellow.
7.2.3 Crystal Structure of the Archaeal Csl4 S1 and Zn-ribbon Domain
To learn more about the role of the exosome cap proteins, the Csl4 protein was purified on its 
own and crystallization screens were setup. The full-length protein did not result in any crystal 
growth,  so  the  possibly flexible  N-terminal  domain  (residue  1  –  49)  was  removed  and this 
truncated version of Csl4 was purified. The protein was concentrated to 5.5 mg/ml and screened 
for crystallization conditions. Crystals grew in 100 mM HEPES, pH 7.5, 20% PEG 4000 and 
10% isopropanol. The condition was refined to 100 mM HEPES pH 7.8; 18% PEG 4000, 10% 
isopropanol and 10% glycerol and crystals were directly flash frozen in liquid nitrogen. A dataset 
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was  recorded  at  the  PX beamline  (SLS,  Villigen,  CH).  The  crystal  diffracted  to  1.8  Å and 
indexing with XDS determined a unit cell with a = 42.02 Å, b = 75.62 Å, c = 76.61 Å, α = β = γ 
= 90° and the space group P212121. The structure was solved with molecular replacement using 
the  S1  and  Zn-ribbon  domain  of  the  exosome-bound  Csl4  protein  as  search  model.  All 
parameters of structure solution and refinement are summarized in table A2 in the appendix. To 
compare the obtained structure with the exosome-bound Csl4, both structures were superimposed 
(figure 33).  Clearly the  two RNA binding  domains  (S1 and Zn-ribbon)  do not  change their 
conformation when they are isolated and not bound to the exosome. This may point to a possible 
role of the Csl4 protein, when isolated from the exosome complex. 
A  B 
Figure 33: Crystal structure of the archaeal Csl4 protein lacking the N-terminal 
domain (A). The zinc atom is shown in magenta.  B: Superposition of the isolated 
S1- and Zn-ribbon domain with the archaeal exosome shows the same overall fold. 
The surface representation of the exosome 6-subunit core is shown in light (Rrp41) 
and dark (Rrp42) green, the exosome bound Csl4 is shown in orange and the isolated 
S1- and Zn-ribbon domains in brown.
  
7.3 The Archaeal Exosome Bound to a Large RNA Molecule
7.3.1 Preparation
The binding of RNA to the active site of the archaeal exosome complex was analyzed with 
structural methods by determination of the atomic structure described above. 
More insight into the role of the cap proteins in RNA binding and recognition was gained using 
biochemical assays. Structural information about the cap proteins in complex with RNA would 
increase the knowledge and could help to better understand the duty of the conserved cap protein 
as part of the exosome complex. All trials to crystallize the exosome with in vitro synthesized 
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RNA bound to the cap proteins failed. Either crystals did not grow at all or the RNA was only 
found in the active site. The truncated cap proteins (S1- and Zn-ribbon-domain of Csl4 or S1- 
and KH-domain of Rrp4) were also used for crystallization setups with short RNA molecules and 
no crystals could be obtained.
A totally different  approach was therefore  used to  achieve structural  results  of  the exosome 
complex with RNA bound to the cap proteins. During the purification of recombinantly produced 
exosomes, high amounts of nucleic acids were detected to be bound to the complex. Therefore 
the complex was washed with a buffer containing a high salt concentration during Ni-affinity 
purification.  With this washing step,  pure protein without the contamination of nucleic acids 
could be obtained.
For the following analyses the exosome complex was purified without this high-salt washing 
step. The resulting protein-nucleic acid complex was stable up to 600 mM salt on the anion 
exchange column and eluted as a single peak from the size exclusion chromatography column. 
For analysis the complex was applied on a 2 % agarose gel in loading buffer containing 8m urea. 
The nucleic acid could be stained with ethidium bromide and traveled in the gel as one single 
band (appendix 9.6). To determine the length of this RNA, the RNA was separated from the 
protein using a buffer containing 8M urea and the NucleoSpin RNA clean-up kit (Macherey-
Nagel,  Düren).  The  isolated  RNA  was  dephosphorylated  with  alkaline  phosphatase  and 
radioactively  labeled  by  transformation  of  the  γ-phosphate  from  γ-32P-ATP  with  T4 
polynucleotide kinase. The labeled RNA was analyzed on a denaturing PA gel and the size was 
estimated to be between 50 and 70 bases using a calibration curve from RNAs with known 
length.
7.3.2 Structural Analysis in Solution
The obtained nucleic acid-exosome complex was used for SAXS studies. Therefore the complex 
was concentrated to an absorption at 280 nm of A280 =  55 and measured in a 1:0, 1:1 and 1:2 
dilution  to  evaluate  the  concentration  dependency of  scattering.  The  complex  did  not  show 
concentration dependent aggregation and was not affected by long exposure to high-energy X-
rays. The obtained scattering curve and the pair distribution function are shown in figure 34. The 
radius of gyration was determined to be 46.8  Å using the Guinier approximation for small s-
values. Thus the Rg is substantially larger that the one for the Rrp4 exosome complex without 
RNA, which was determined to be 39.6  Å.
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Figure 34: SAXS curves  and pair distribution function of  the Rrp4 exosome 
(green)  compared to  the  RNA bound complex (orange).  The  Rg for  the  RNA 
bound complex was determined to be 46.8  Å.
10 different ab initio models were calculated with GASBORp from the pair distribution function 
shown in figure 45, aligned and averaged. The resulting bead model was superimposed with the 
crystal structure of the Rrp4 exosome and is shown in figure 35.
  
Figure 35: Superposition of the Rrp4-exosome crystal structure with the SAXS 
structure of the Rrp4-exosome-RNA complex.  The bead model (light blue) was 
calculated from the pair distribution function shown in figure 45 and 10 models were 
aligned and averaged. The complex is shown in side and top view. (Rrp41 – light 
green; Rrp42 – dark green; Rrp4 – red).
7.3.3 Crystal Structure of the Complex
In the same way as the sample for SAXS measurements, a second batch was prepared for crystal 
setups. Cubic crystals grew in 100 mM Tris pH 7.5; 100 mM NaCl; 50 mM MgCl2 and 1% PEG 
4000. Crystals were soaked in reservoir solution with 15 % 1,4-butanediol as cryoprotectant and 
flash frozen in liquid nitrogen. The crystals diffracted to 3 Å and a data set was recorded at the 
PX beamline (SLS, Villigen, CH).
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Indexing with XDS determined a unit cell of a =  b = 112.77 Å, c =  179.25 Å, α =  β =  90°, γ = 
120° and the space group R3. Molecular replacement with PHASER using the 9-subunit Rrp4 
exosome as  search  model  did  not  lead  to  a  reasonable  result.  However,  with  the  6-subunit 
complex  as  search  model,  phases  could  be  obtained.  This  electron  density  map  had  high 
similarity to the map from the 6-subunit exosome, but showed additional density on top of the 
core ring, at the position where normally the cap proteins are located (see figure 36). Although 
this electron density was clearly visible, it was not good enough to manually built an atomic 
model into it.  
Figure 36: 2 |Fo| - |Fc| electron density map after molecular replacement with the 
6-subunit exosome as search model. Clearly a protein is bound on top of the core 
exosome.
After molecular replacement the phase information is usually not very good for the parts of the 
molecule  that  are  distant  from the  search  model.  Therefore  a  second approach was used  to 
improve the additional electron density. After searching with the 6-subunit core, single subunits 
of the Rrp4 protein (N-terminal domain, S1-domain and KH-domain) were used for an additional 
search round. Only the S1-domain was found by PHASER and was located at a slightly changed 
position compared to the apo complex. In the regions surrounding the S1-domain there was still 
additional density visible. Especially the helices of the KH-domain could be identified and were 
manually modeled into the density using COOT. Rigid body modeling followed by refinement 
with CNS resulted in the model shown in figure 37. Superposition of the structure with the 
already known Rrp4 exosome apo structure shows a tilting of the cap protein towards the pore of 
the processing chamber (see figure 37).
Still there is more additional density visible for the N-terminal domain, the structure has to be 
further refined and more parts of the model have to be fitted into the density. 
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Figure 37: Superposition of the crystal structure of the apo Rrp4 exosome (pdb-
code 2BA0) with the preliminary atomic model from the Rrp4 exosome purified 
with endogenous E. coli RNA. The Rrp4 protein from the apo structure is shown in 
red and the S1 and KH domains from the new structure are shown in salmon. 
7.4 Enzymatic Activities of Archaeal Exosome Complexes
The archaeal exosome possesses three active sites within the processing chamber (Büttner et al., 
2005). The complex is known to catalyze two different reactions: either the phosphate dependent 
3' → 5' degradation of single stranded RNA molecules or the reverse reaction, the addition of 
single bases to the 3'-end of a single stranded RNA molecule using a nucleotide-di-phosphate. In 
this thesis both activities were studied in detail by the use of denatured polyacrylamide (PA) 
gelelectrophoresis.
7.4.1 Variants of Exosome Complexes Used for Activity Assays
For the analysis of the enzymatic activities, different variants of the archaeal exosome were used. 
First, the three wild-type exosome complexes were studied: 6-subunit exosome, Csl4 9-subunit 
exosome and Rrp4 9-subunit exosome. Second, mutant versions were tested: the tyrosine mutant 
Y70A (see 7.1.2) and the neck-mutation R65E (Büttner et al., 2005). Additionally, an interface 
mutation was introduced (K51ERrp41) that leads to formation of only the Rrp41/Rrp42 dimer and 
destroys the hexameric ring. The complex was purified analogous to the wild-type protein and 
the existence of a dimer was tested by size exclusion chromatography. The different variants are 
shown schematically in figure 38.
As negative control, the active site mutation D180ARrp41 was used.  
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Figure 38: Exosome variants that were used for enzymatic activity assays. A-C: 
Wild-type exosome complexes:  6-subunit  exosome (A);  Csl4-exosome (B);  Rrp4-
exosome (C). D+E: Putative RNA binding mutants. Neck mutant (R65ERrp41) (D) and 
tyrosine mutant (Y70ARrp42) (E). F: Interface mutant (K51ERrp41) resulting in a single 
Rrp41/Rrp42 dimer. 
7.4.2 RNA Degradation and Polymerization Assays
7.4.2.1 RNase Activity of the Archaeal Exosome
To gain insights into the mode of RNA degradation, exosome complexes were incubated with 
RNA substrates and the reaction products were monitored with time. As radioactively labeled 
RNA with α-32P-phosphate group at the 5'-end was used, not the cleaved nucleotide diphosphate 
but the remaining RNA molecule could be detected. The exosome complexes originate from the 
thermophile organism Archaeoglobus fulgidus, thus the assays were performed at 50°C. 
Figure 39 shows the denaturing gel of an RNase assay with a 30mer poly(A) RNA as substrate. 
The three different exosome complexes 6-subunit exosome, Csl4 exosome and Rrp4 exosome 
were tested for activity in the presence of 10 mM MgCl2 and 10 mM phosphate; only 10 mM 
MgCl2 or none of both. 
The Csl4 exosome is  degrading the polyA-RNA faster  than the Rrp4 exosome does.  The 6-
subunit exosome is also capable of degrading the substrate, but with even lower activity. The 
final product of degradation is a three-mer of RNA (not visible on this gel, see figure 40). Clearly 
the exosome is also able to degrade RNA in a phosphate independent way with much lower 
activity and it needs a bivalent cation for catalysis. It could be shown that the exosome works 
with Mn2+ in a similar way as Mg2+. The active site mutant D180G as well as the double mutant 
D180G-R65A did not show any RNase activity. 
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The same experiment was done with single stranded DNA and no activity could be observed 
with all complexes.
     30mer
     25mer
     20mer
Figure  39:  Denaturing PA gel  for the  analysis  of  RNase activity  of  different 
exosome complexes. Radioactively labeled RNA was visualized. Every complex was 
incubated with 10 mM MgCl2 and 10 mM phosphate (1); only with 10 mM MgCl2 
(2)  and  with  none  of  both  (3).  Samples  were  taken  after  2 min  and  6  min.  For 
clearness only the upper part of the gel is shown. The final product of degradation is 
a three-mer of RNA (not visible on this gel, see figure 40)
7.4.2.2 Polymerization Activity of the Archaeal Exosome
In  addition  to  the  phosphate  dependent  RNase  activity,  the  archaeal  exosome  is  capable  of 
catalyzing the reverse reaction. Thereby it uses a nucleotide-di-phosphate and adds it to the 3'-
end of a single stranded RNA molecule. To analyze this enzymatic activity, the exosome was 
incubated in  the same conditions,  as  for  monitoring  RNA degradation  – just  by exchanging 
phosphate  with  ADP.  A denaturing  polyacrylamide  gel  showing  both  the  degradation  and 
polymerization activity is shown in figure 40. 
The length of the different RNA degradation products is known and the distance they cover in 
the gel can be measured. With this data it is possible to create a calibration curve and estimate 
the length of polyadenylated RNA molecules. From the gel shown in figure 40 the length of 
polyadenylated RNA was estimated to be approximately 130 bases. 
7 Results – Exosome 83
polyadenylated RNA
30mer RNA
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Figure 40: RNA degradation and polymerization 
activity  of  archaeal  exosome  complexes.   The 
proteins were incubated with phosphate or ADP. Lane 
1+2: 10mM phosphate – incubation for 1 min and 30 
min;  lane 3:  10mM ADP – incubation for  30 min; 
lane 4: none of both. Exosome complexes used: (1) 
Csl4  exosome  wild-type;  (2)  Csl4  exosome 
Y70ARrp42;  (3)  Csl4  exosome  R65ERrp41;  (4)  Csl4 
exosome D180G+R65ERrp41; (5) no protein. 
To test for substrate specificity of the archaeal exosome, the same experiment was repeated with 
10 mM of ADP, CDP, GDP and UDP. The experiment was performed with all three exosome 
wild-type complexes and the result is shown in figure 41. Clearly the exosome uses all different 
nucleotide-di-phosphates, but with different preferences. Additionally, a difference in substrate 
preference can be seen for the different exosome complexes. 
It could be shown that the archaeal exosome is able to degrade RNA from the 3'-end in the 
presence of phosphate and add nucleotides to the 3'-end in the presence of NDPs. In the living 
cell  normally a mixture of phosphate and NDPs is  available for the exosome. Therefore the 
activity of the archaeal exosome was tested in the presence of both phosphate and ADP (see 
figure 41B). The polyadenylation reaction seems to be energetically favored in comparison to the 
degradation  reactions:  In  the  reaction  mix  containing  the  same  concentration  of  ADP and 
phosphate, the reaction product is an RNA molecule, which is larger than the initial 30mer.
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A B
     30mer RNA →        ← 30mer RNA
     (1)        (2)
Figure 41: Polymerization activity of the archaeal exosome. A: All three exosome 
wild-type complexes can use the four different nucleotide-di-phosphates as substrate 
to add bases to the 3'-end of a polyA-RNA. 250 nM exosomes were incubated with 
10 mM NDPs for 1 h. B: Polymerization and degradation activity of the exosome are 
competing  with  each  other.  (1)  The  Csl4  exosome  was  incubated  with  20  mM 
phosphate  and  10 mM  ADP.  (2)  The  Csl4  exosome  was  incubated  with  10  mM 
phosphate and 10 mM ADP. For both reactions four time points are shown: 45 s, 1.5 
min, 2.25 min and 3 min. The polymerization reaction seems to be  energetically 
favored.
7.4.3 Quantification of RNase Assays
To gain more insights into the mode of RNA degradation of the archaeal exosome, RNase assays 
were performed as described above. For a better resolution up to 35 time points were taken with 
time intervals that allow monitoring of the reaction in more detail (see figure 40). In the next 
chapter two possible models are introduced to describe the degradation reaction and are then 
compared to the experimental data.
7.4.3.1 Theoretical Models for RNA Degradation
At first glance, an obvious model for the RNase activity of the archaeal exosome would be a 
simple  degradation reaction  that  is  only described  by the rate  constant  for  cleavage kc.  The 
reaction  could  then  be  described  by  the  following  set  of  equations,  considering  the  initial 
substrate is an RNA with 30 bases:
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d [RNA30]
dt
=−k c30⋅[RNA30]
d [RNA29]
dt =kc 30⋅[RNA30]−kc 29⋅[RNA29]
⋮
d [RNA4]
dt
=k c5 ⋅[RNA5]−k c4⋅[RNA4]
d [RNA3]
dt
=k c4⋅[RNA4]
with [RNAn]: concentration of the n-mer RNA and kc(n): cleavage rate for degradation of the n-
mer RNA. 
Using these equations, the degradation process can be simulated with a different cleavage rate 
for each RNA length. This model will be termed cleavage-only model and an example for a 
simulation  using  this  model  is  shown  in  figure  42.  The  simulation  was  calculated  using 
MATLAB and the scripts are shown in the appendix 9.4.
Figure  42:  Simulation  for  RNA degradation  described  by  the  cleavage-only 
model.  Different  values  for  the  cleavage  rate  were  assumed  for  all  27  steps  of 
degradation. The inset shows an enlargement of the curves for small times.  (Color 
code:  30/23/16/9mer;  29/22/15/8mer;  28/21/14/7mer;  27/20/13/6mer;  26/19/12/5mer; 
25/18/11/4mer; 24/17/10/3mer)
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Since the cleavage-only model is extremely simple, a second and more comprehensive model 
was proposed: This model does not only account for cleavage reactions, but also for association 
and dissociation of the RNA to and from the exosome complex. In addition, the reverse reaction 
of the degradation, the polyadenylation, can be included into the model: this reaction needs ADP, 
which  is  formed  during  the  degradation  reaction.  Therefore  polyadenylation  may  become 
important towards the end of the experiment. The change of RNA concentration with time for the 
initial RNA molecule, the 30mer, can be described with the second model, termed cleavage-and-
binding model, by the following equations:
d [RNA30, free]
dt
=−k a 30⋅[RNA30, free]k d 30 ⋅[RNA30,bound ]
d [RNA30,bound ]
dt
=k a 30 ⋅[RNA30, free ]−k d 30⋅[RNA30,bound ]−k c30 ⋅[RNA30,bound ]k p29⋅[RNA29,bound ]
with [RNAn,free] and  [RNAn,bound]: concentration of free and bound  n-mer RNA.
The four rate constants used for these equations are (where n is again the length of the described 
RNA):
kc(n) = cleavage rate – describing the degradation of an RNAn molecule to the product RNAn-1
ka(n) = association rate – describing the association of an RNAn molecule to the exosome
kd(n) = dissociation rate – describing the dissociation of the RNAn molecule from the exosome
kp(n) = polymerization rate – describing the reaction of addition of a base to the substrate RNAn
It has to be considered that the denaturing gels do not allow for discrimination of free and bound 
RNA. The intensity of the observed band corresponds to the sum  [RNAn,free] + [RNAn,bound] of 
free and bound RNA.
For 29 mer to 4 mer RNA, the amount of bound RNA does not only decrease due to degradation, 
but it additionally increases due to being the degraded product of RNA+1. Furthermore, the RNA 
can decrease due to the polymerizing reaction. Therefore the equations have to be extended as 
follows:
d [RNA29, free ]
dt
=−k a 29 ⋅[RNA29, free ]k d 29⋅[RNA29,bound ]
d [RNA29,bound ]
dt
=k a 29⋅[RNA29, free]−k d 29⋅[RNA29,bound ]−k c 29⋅[RNA29,bound ]k p28⋅[RNA28,bound ]
k c30⋅[RNA30,bound ]−k p29⋅[RNA29,bound ]
Since the 3mer is not degraded further, the corresponding reactions are described by:
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d [RNA3, free ]
dt
=−k a 3 ⋅[RNA3, free ]k d 3⋅[RNA3,bound ]
d [RNA3,bound ]
dt
=k a 3⋅[RNA3, free]−k d 3 ⋅[RNA3,bound ]kc 30⋅[RNA30,bound ]−k p 3⋅[RNA3,bound ]
The  cleavage-and-binding  model  contains  four  different  types  of  rate  constants,  namely 
cleavage, association, dissociation and polymerization rate constants. In principle, each of these 
rate constants can depend on RNA length, resulting in 4 x 28 fit parameters. However, in order to 
ensure a fair comparison between the cleavage-only model and the cleavage-and-binding model, 
the latter should not contain more fit parameters than the former. Moreover, from a biochemical 
point of view it is very likely that some of these rate constants are independent of RNA length. 
An example for a simulation of the degradation reaction using the cleavage-and-binding model 
with only 23 model parameters is shown in figure 43  (for the MATLAB scripts see appendix 
9.4).
Figure  43:  Simulation  for  RNA degradation  described  by  the  cleavage-and-
binding  model.  The  cleavage  rate  was  kept  constant  and  different  binding  and 
dissociation  rates  were  assumed  for  the  last  10  steps  of  degradation.  The 
polymerization rate was assumed to be zero. The inset shows an enlargement of the 
curves for small time points. (Color code: 30/23/16/9mer; 29/22/15/8mer; 28/21/14/7mer; 
27/20/13/6mer; 26/19/12/5mer; 25/18/11/4mer; 24/17/10/3mer)
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By fitting both models to the experimental data, it is possible to check whether one of the models 
describes the RNA degradation by the exosome  (at least to first order). 
7.4.3.2 Experimental Data
A  Csl4 exosome B  Rrp4 exosome   C  6-subunit exosome
  
D  Csl4 exosome R65E   E  Csl4 exosome Y70A      F  2-subunit exosome
   
Figure 44: RNase assays of the different exosome variants with a 30mer poly(A) 
RNA as substrate. The exosome variants used in this assays are shown in figure 34. 
Radioactively  labeled  degradation  products  were  visualized  in  a  denaturing 
polyacrylamide gel.
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RNA degradation of a 30mer poly(A)  substrate by the different exosome variants described in 
figure 38 was monitored by denatured PA gel electrophoresis as described before. 30nM (Csl4-
exosome,  Rrp4-exosome  and  interface  mutant)  or  60nM (6-subunit  exosome,  R65ERrp41 and 
Y70ARrp42 Csl4-exosome) of the complexes were mixed with 120nM radioactively labeled RNA. 
The first eight samples were taken every 10 seconds. Then the time interval was subsequently 
increased. The last sample was taken after 30 min. The resulting gels are shown in figure 44.
Every single band on the gel was quantified using the ImageQuant software. The background 
was subtracted. From the intensities of the bands the percentage of the RNA of a certain length 
relative to the amount of total RNA at a certain time was calculated. Figure 45 shows an example 
for the concentration distribution of all RNA species over time for the Csl4-exosome, determined 
from the gel shown in figure 44A.
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Figure 45: Degradation of a 30mer polyA-RNA by the Csl4-exosome. The amount 
of the different RNAs that emerge during the reaction are shown as percentage of 
total RNA and are plotted against time. RNAs of a length from 29mer to 15mer can 
hardly be detected. The final product of the reaction is a 3mer. 
The other five gels were analyzed in the same way. The plots are shown in the appendix 9.5. 
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7.4.3.3 Data Analysis and Rate Constants
In order to analyze the experimental  data and to fit  the models described in 7.3.3.2, several 
MATLAB scripts were written (see appendix 9.4). The MATLAB function ode15s was used for 
the simulation of the differential equations. A least squares fit was performed by minimizing the 
quadratic  differences  between  simulated  curves  and  experimental  data  with  the  MATLAB 
function  fminsearch.  fminsearch finds the minimum of a scalar function of several parameters, 
starting at an initial estimate. The correct initial estimated had to be found iteratively. 
First,  the  cleavage-only-model  was  considered.  Even  when  all  27  cleavage  constants  were 
presumed to be different, a good fit could not be achieved  (see figure 46).
To proof that the second model, the cleavage-and-binding model, describes the experimental data 
better, 24 different constants were used to fit the model to the data. The following constraints 
were imposed, to reduce the theoretically possible set constants:
For simplicity the polymerization rate was assumed to be kp = 0, which is reasonable for high 
phosphate concentrations (10 mM phosphate in this assay compared to 3.6 µM ADP, when all 
RNA molecules would be totally degraded). 
In addition the cleavage rate was assumed to be independent of the length of RNA and thus does 
not change during the reaction. Finally association and dissociation rates were assumed to stay 
constant for the first 15 reactions, meaning that they are identical for the 30mer – 15mer. The 
resulting fit for the Csl4-exosome is shown in figure 46. 
Figure 46: Fit of the data from RNA degradation by the Csl4-exosome using the 
cleavage-only model (left) and the cleavage-and-binding model (right).  Clearly 
the cleavage-and-binding model fits the experimental data better than the cleavage-
only model. The color code for the different RNAs is the same as shown in figure 41.
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In view of the extremely poor result of the cleavage-only-model, we will restrict our analysis in 
the following to the cleavage-and-binding model. The corresponding fits for the other exosome 
variants are shown in the appendix 9.5 and the determined rate constants are given in table 5. To 
estimate the quality of the fits, the coefficient of determination R2 was calculated. R2 describes 
the proportion of variability in a data set that is accounted for by the model. Accordingly, for R2 
= 1 the model perfectly fits the data, whereas an R2 of zero indicates that the model totally fails 
to explain the data. The definition of the coefficient of determination is
R2=1−
SS err
SS tot
where SStot is the total sum of squares and SSerr is the residual sum of squares and
SS tot=∑
i=1
n
[[RNA30]
expt i−〈[RNA30 ]
exp〉 ]2∑
i=1
n
[[RNA29]
expti−〈[RNA29]
exp〉]2⋯
⋯∑
i=1
n
[[RNA3]
expt i−〈[RNA3]
exp〉 ]2
SSerr=∑
i=1
n
[[RNA30]
expt i−[RNA30]
fit t i]
2∑
i=1
n
[[RNA29 ]
expt i−[RNA29 ]
fit t i]
2⋯
⋯∑
i=1
n
[[RNA3]
expt i−[RNA3]
fit ti]
2
Here [RNAN ]
expti and [RNAN ]
fitt i are the measured and fitted concentrations of the  N-
mer at time ti and 〈[RNAN ]
exp〉=∑
i=1
n
[RNAN ]
exp ti/n is the time average of the concentration of 
the N-mer. The calculated R2-values for every fit are given in table 5.
In  all  cases  the  dissociation  rate  increased  with  decreasing  RNA size.  An  example  for  the 
dissociation rates is shown in figure 47 for the Csl4 exosome complex wild-type and Y70ARrp42 
mutant. The dissociation rate is very low for long RNAs and increases with decreasing RNA 
size. As expected the RNA binding mutant  Y70ARrp42  has overall higher dissociation rates than 
the wild-type.
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Table  5:  Rate  constants  derived  from fitting  the  cleavage-and-binding  model  to  the 
experimental data.
complex kc
ka and kd for different RNA lengths
R2
30-15 14+13 12 11 10 9 8 7 6 5 4
6-subunit 
exosome 10
bind 0.022 0.022 0.0005
0.000
1 0.053 0.054 0.05 0.05 0.05 0.031 0.31 0.97
diss 0.27 0.27 0 0.14 6.6 8.3 10.0 14.7 12.6 13.6 30
Csl4 
exosome 12.4
bind 0.019 0.019 0.0007 0.001 0.0032 0.003
0.003
9 0.005 0.004 0.005 0.01 0.94
diss 0.85 0.85 0.53 1 4.77 5.84 7.97 15.3 17.35 16.69 57.35
Rrp4 
exosome 0.30
bind 0.007 0.007 0.0001
0.000
1 0.0001 0.0007
0.000
7
0.000
7
0.000
1
0.000
1
0.000
1
0.96
diss 0.022 0.022 0.002 0.0035 0.007 0.028 0.066 0.109 0.052 0.059 0.234
2-subunit 
exosome 2.3
bind 0.03 0.03 0.002 0.001 0.145 0.144 0.127 0.10 0.1 0.101 0.093
0.96
diss 1.49 1.49 2.15 4.2 5.9 4.9 7.1 10.5 14.1 14.7 31
Csl4 exo 
R65ERrp41 15.6
bind 0.003 0.003 0.0001
0.000
1 0.083 0.92 0.068 0.075 0.185 0.053 0.049
0.95
diss 0.96 0.96 0.81 0.88 0.39 1 6.01 17.67 87.83 43.78 147.89
Csl4 exo 
Y70ARrp42 15.9
bind 0.013 0.0005 0.003 0.003 0.003 0.003 0.003 0.003 0.003 0.003 0.002
0.91
diss 1.46 1.2 3.88 20.34 26.31 30.41 30 37.12 34.98 41.2 78.7
The rates are all given in 1/s. R2 was calculated as described. kc = cleavage rate; ka = association 
rate and kd = dissociation rate.
Figure 47: Dissociation rate determined from fitting the cleavage-and-binding 
model to the experimental data from denaturing PA gels. The change of rates with 
RNA length  is  shown for  the  wild-type Csl4  exosome (green)  and the  Y70ARrp42 
mutant (orange).
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7.5 RNA Binding to Exosome Complexes
To learn more about the role of the cap proteins for RNA binding, recognition and subsequent 
degradation or polymerization, electrophoretic mobility shift assays (EMSA) were performed. 
Exosome proteins were incubated with the radioactively labeled RNA molecule for 10 min and 
the protein-RNA complex was separated from the free RNA in a native PA gel. Not only the 9-
subunit complexes were tested, but also the cap proteins alone. 30mer RNAs with three different 
sequences were used: a polyA RNA, a polyU RNA and polyCCU RNA. The resulting gels are 
shown in figure 48. The different RNAs show different affinities to the 9-subunit complexes. 
Mutation of the arginine 65, which reaches into the neck of the exosome strongly decreases 
affinity, but does not abolish it. The cap proteins alone also bind RNA, but with weaker affinity. 
Figure 48: RNAs with different sequences have different affinities to exosome 
proteins. 30mer RNA molecules with three different sequences were incubated with 
the two 9-subunit  exosome complexes  and with the cap proteins  alone.  Both the 
arginine  65  in  the  neck  of  the  complex  and  the  cap  proteins  seem to  influence 
substrate binding.
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8 Discussion – Exosome
With the combination of biochemical assays, structural biology and theoretical modeling new 
insights into the enzymatic activity of the exosome and especially its mode of degradation could 
be obtained. With SAXS the known crystal structures could be verified, with crystallography the 
binding of RNA to the active site could be resolved to atomic resolution and the results form 
biochemical assays allow for the proposal of a model for degradation. All obtained results are 
discussed in the next section in detail. 
8.1 Low Resolution Structures of Exosome Complexes in Solution
The  crystal  structures  of  the  two  different  archaeal  9-subunit  exosome  complexes 
(Archaeoglobus)  were  solved  by Büttner  et  al.  (2005)  and of  a  6-subunit  archaeal  exosome 
(Sulfolobus)  by  Lorentzen  et  al.  (2005).  In  addition,  the  crystal  structure  of  the  9-subunit 
complex of the human exosome was solved in 2006 by Liu et al. All structures show a very 
similar overall fold, but they were obtained by X-ray crystallography and it cannot be excluded 
that the structures differ from the shape of the complexes in solution. Ramos et al. (2006) did 
SAXS studies with the Pyrococcus  archaeal exosome to gain insights into the conformation of 
the complex in solution. When measuring the scattering of the Rrp4 protein alone they predicted 
an elongated conformation of the protein in solution. Ab initio modeling of the whole 9-subunit 
complex resulted in a rigid central structure with three extended, protruding and flexible arms 
(see figure 49). Therefore they proposed that in solution a high flexibility is present in the cap 
proteins of all exosome complexes. 
All known crystal structures of exosome complexes with cap proteins show very well ordered 
cap  proteins  and  nothing  hints  to  high  flexibility  in  these  parts.  To  test  the  Archaeoglobus 
exosome complexes for their conformation in solution and especially for potential flexibility in 
the cap proteins, SAXS studies with both 9-subunit exosomes and with the 6-subunit exosome 
were performed. The results for the 9-subunit complexes show very high similarity to the crystal 
structures  and it  does  not  seem that  bigger  parts  of  the  proteins  possess  intrinsic  flexibility 
(figure 49). 
As the sequence homology between the archaeal exosomes is very high, it is quite likely that 
under our conditions also the Pyrococcus exosome would have a similar structure in solution as 
the Archaeoglobus homolog.
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Figure 49: Comparison of the SAXS structure of the pyrococcus Rrp4 exosome 
(grey) from Ramos et al, (2006) with the crystal structure and SAXS structure of 
the archaeoglobus Rrp4 exosome (blue). The structures are scaled to compare the 
size. Clearly the archaeoglobus Rrp4 exosome has the same overall fold in solution 
compared to the crystal structure and the two SAXS structures are very different. 
The 6-subunit exosome has a slightly different conformation in solution compared to the crystal 
structure. We do not have the crystal structure of the  Archaeoglobus 6-subunit exosome. But 
comparison of the two core rings obtained from the different 9-subunit exosomes shows one 
difference: the end of the C-terminal helix of the Rrp41 protein is in one complex stretched and 
in the other one bent. Exactly at the position where we could identify this structural difference, 
we can see additional density in the SAXS structure. The SAXS model leads to the conclusion 
that the C-terminus of the Rrp41 protein is unstructured as long as no cap protein is bound and 
folds only upon binding of either Rrp4 or Csl4.
Summarized  we  propose  that  under  physiological  conditions  and  in  the  living  cell  the  cap 
proteins bind to the exosome in a way that is not significantly different to the crystal structures. 
8.2 The Atomic Structure of RNA Bound to the Exosome Active Site
The archaeal exosome was crystallized with a short RNA molecule bound to all three active sites. 
As no phosphate was added to the crystallization solutions,  a stable RNA complex could be 
formed even with the wild-type protein. Different lengths of RNA (6 – 12 bases) were used for 
crystallization setups and soaking experiments. Addition of a 6mer or an 8mer to the exosome 
resulted in both cases in clear electron density for four bases in all three active sites and for some 
weak density for two more bases. This could be seen for cocrystallization as well as for soaking 
experiments.
When longer RNA was used (10 bases and more) no crystals could be obtained and soaking of 
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these  RNAs into  crystals  of  the  native  complex  resulted  in  dissolving  of  the  crystals.  This 
indicates, that binding of the longer RNA molecules to the protein complex somehow destroyed 
crystal packing. As the cap proteins are involved in crystals contacts, it is possible that these 
larger RNA molecules reached out of the processing chamber and bound to the cap proteins 
whereupon they interfered with crystal packing. 
Obviously the first four bases of the RNA substrate bind very tightly to the active site of the 
exosome. The RNA is located in a horizontal binding cleft with the active site at one end. The 
four bases that are positioned in this cleft are clearly visible. For the next bases only parts of the 
electron density are visible, therefore the following five to six bases seem to be flexible. From 
the  10th base  on  the  RNA seems  to  have  contacts  to  the  upper  parts  of  the  exosome  and 
supposedly to the RNA binding elements of the cap proteins.
A set of arginine residues are located in the binding groove and charged interactions ensure tight 
binding of the first four bases. A closer look at  the active site with bound RNA shows that 
residues  from both  the  Rrp41  and  the  Rrp42  protein  are  involved  in  binding  of  the  RNA 
molecule. This explains why the Rrp41 protein alone is not capable of degrading RNA and why 
the Rrp42 protein is needed for catalytic activity. Moreover the structure explains the sequence 
unspecificity of the exosome, as all interactions between the RNA and the protein are mainly via 
the  phosphates  from the  RNA backbone  and  not  via  characteristic  features  of  single  bases. 
Interactions with the 2'OH-group of the ribose, which is missing in DNA, can explain how the 
exosome distinguishes between DNA and RNA and why only RNA is a substrate.
The only obvious interaction between the complex and an RNA base is a sequence unspecific π-
stacking of tyrosine 70 from the Rrp42 protein with the fourth base. Mutation of this tyrosine 
residue and structural analysis revealed a lower intensity of electron density for the first four 
bases of the RNA and no density at all for the 5th and the 6th base. This supports the assumption 
that this residue is important for RNA binding to the complex and correct  orientation of the 
substrate  towards  the  active  site.  Because  of  these  structural  observations  concerning  the 
tyrosine,  biochemical  activity  assays  with  the  mutant  Y70ARrp42 were  carried  out  and  are 
described below. 
Still the question remains, if the RNA reaches the active site through the top of the proteins via 
involvement of the cap proteins, or through the bottom of the complex, which is much closer to 
the  active  site.  RNA-exosome  complexes  with  longer  RNA molecules  were  crystallized  by 
Lorentzen et al. (2007) and Navarro et al. (2008). Lorentzen used the Sulfolobus Rrp4 exosome 
and an RNA molecule with secondary structured parts at the 5'-end, which is designed to be only 
partially trimmed rather than totally degraded. Navarro used the Pyrococcus 6-subunit exosome 
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and a 10mer poly(A) RNA. Both groups could see the four bases in the active site, very similar 
to the structure obtained in this thesis. In addition they found electron density for one RNA base 
at the narrowest constriction of the central channel, in the neck of the processing chamber. At this 
position a conserved arginine residue points towards the pore and binds the RNA base via a 
charged interaction. These results support the theory that the path of the RNA is via the cap 
proteins and the neck to the processing chamber and the active sites. 
8.3 Atomic Structure of the Isolated Csl4 S1- and Zn-ribbon-domains
Two different cap proteins of the archaeal exosome complex are known: the Rrp4 protein that 
possesses high homology to the eukaryotic Rrp4 and Rrp40 proteins and the Csl4 proteins, which 
has only one homolog of the same name in eukaryotes. The cap proteins are very similar in the 
composition of one small N-terminal domain and two RNA binding domains. Both possess a S1-
domain, Rrp4 an additional KH-domain and Csl4 an additional Zn-ribbon domain. Still there is 
one  striking  difference  when looking  at  the  positions  of  the  genes  for  these  proteins  in  the 
genome: the  rrp4 gene is located directly next to the genes for the core ring of the exosome 
rrp41 and rrp42. The csl4 gene in the contrary is located in a different operon. This means that 
the mRNA level and thus also the expression level of the Rrp41, Rrp42 and Rrp4 proteins is 
expectedly relatively similar in the cell. The amount of Csl4 protein however is regulated by a 
different promoter and can therefore differ from the amount of exosome core. This can be an 
indicator for a role of the Csl4 protein independent from the exosome – especially when more 
Csl4 than core is available in the cell. 
To analyze if Csl4 is actually able to fold properly when it is not bound to the exosome, the 
structure of the S1 and Zn-ribbon domain was solved. The atomic structure of the isolated S1 and 
Zn-ribbon domain of the Csl4 protein shows the same fold as the exosome bound version. Not 
only is the fold of the two domains identical, but also their orientation relative to each other is 
not changed. 
This finding could suggest a possible role for Csl4: under certain conditions the csl4 gene may be 
stronger transcribed than the rest of the exosome and Csl4 exists in the cell in an isolated form. 
Then it may bind RNAs that are substrates for the exosome. Possibly it can thereby recruit the 
RNA to  the  exosome  complex.  The  Csl4-RNA complex  might  have  higher  affinity  to  the 
exosome core than Csl4 alone. Thus the two Csl4 proteins could be exchanged and the RNA is 
thereby positioned in a way that it can reach the active site and is further processed or degraded. 
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8.4 The Exosome with a Substrate from E. coli Cells
It is very difficult to achieve homogeneous complexes of RNA bound to the cap proteins of the 
exosome. This is due to the many different RNA binding sites within the caps as well as to the 
fact that the exact sequences of substrates for the exosome are not known. So it is very difficult 
to synthesize a physiological substrate for usage in structural studies. 
Therefore a totally different approach was used to gain information about the role of the cap 
proteins in substrate recognition and binding. For this experiment the Rrp4 exosome was chosen, 
as it showed a much higher affinity to RNA compared to the Csl4 exosome in the assays. The 
complex was overexpressed in E. coli cells and purified together with the RNA substrate, which 
bound to it within the bacterial cell. After thorough purification of the complex it was used for 
SAXS studies as well as crystallization setups.  
The structure of this complex in solution shows a clear difference to the Rrp4 exosome without 
RNA. Without RNA a clear hole could be observed in the middle of the exosome ring, where the 
RNA is  supposed to  enter  the  processing  chamber.  This  hole  is  not  visible  anymore  in  the 
presence of RNA. Furthermore additional density could be observed on top of the exosome and a 
tail is sticking out. Looking at  the difference density that  is only present in the RNA bound 
structure, is looks like the RNA molecule is protruding from the processing chamber through the 
S1-pore, clings to the Rrp4 protein until the rim of the exosome and has a flexible end.
To resolve this structure to an atomic level, the same complex was crystallized. Using the whole 
Rrp4 exosome as search model, no phases could be obtained with molecular replacement. Only 
with the 6-subunit exosome and the isolated S1-domain a reasonable electron density map could 
be calculated. Density for the two missing domains was visible in the difference map and both 
domains could be modeled. Still this structure is not yet refined to its final state. It is already 
obvious  that  the  Rrp4 protein  changed its  conformation  to  a  considerable  degree.  From the 
current density map it cannot be said whether RNA is visible in the structure. It can be speculated 
that the conformational change in the Rrp4 proteins is induced by a bound RNA molecule. The 
RNA may not be bound homogeneously or may be too flexible to be visible in a crystal structure. 
Moreover  it  is  still  not  known  whether  more  than  one  RNA species  are  present  and  the 
identification  of  this  bound  molecule  is  inevitable.  More  refinement  and  model  building 
procedures of the structure could help to improve the structure and the it could still be possible 
that electron density for bound RNA appears during these steps. 
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8.5 Enzymatic Activities of the Exosome
The bacterial PNPase (Polynucleotide Phosphorylase) and the archaeal exosome are homologous 
concerning their structure and their catalytic activity. Both complexes have a similar overall fold 
and are able to degrade single stranded RNA from the 3'-end, but cannot cope with structured 
substrates without the help of cofactors (Büttner et al., 2005; Lorentzen et al., 2005). In addition, 
both complexes are able to catalyze the reverse reaction. For the archaeal exosome it could be 
shown that it polyadenylates RNAs at the 3'-end in vitro (Büttner et al., 2005). Some archaeal 
organisms  do  not  possess  an  exosome and in  these  organisms  no  polyadenylation  could  be 
observed  (Portnoy  and  Schuster,  2006),  therefore  the  exosome  is  believed  to  be  the  main 
polyadenylating enzyme in archaea.
Still  the  mode  of  degradation  remained  unclear.  Recent  structural  studies  of  RNA-exosome 
complexes showed one RNA molecule bound to the active site and the neck (Lorentzen et al., 
2007; Navarro et al, 2008). Due to these results it is now quite certain that the RNA binds to the 
cap proteins on top of the exosome and is then recruited into the processing chamber and to the 
active site. 
To gain insights into the different roles of the cap proteins and the mode of RNA degradation and 
polymerization of the archaeal exosome, biochemical activity assays were performed.
For all exosome complexes used in this thesis the RNase assays revealed a 3mer as the final end 
product of degradation. This fits very nicely to the structural results from the Y70ARrp42 mutant: 
this tyrosine strongly stabilizes the RNA in the active site by stacking to the fourth base. As soon 
as the 4mer is degraded to a 3mer, this interaction is lost and the affinity of the RNA to the 
exosome will  be extremely low. The 3mer will  dissociate from the active site and will  most 
probably not associate again.
Additionally, it could be shown that the speed of degradation depends on the composition of the 
cap. For poly(A) RNA the Csl4 exosome showed the highest degradation activity and the lowest 
enzymatic activity was observed for the 6-subunit core exosome without any cap protein bound. 
This hints to a sequence specificity and regulative role of the cap proteins. 
In literature only phosphate dependent RNase activity was described for the exosome so far. In 
this thesis it could be shown that the complex is able to hydrolytically degrade RNA with much 
lower activity as long as magnesium is present in the reaction buffer. Similarly to the phosphate 
dependent degradation, the Csl4 exosome is more active than the Rrp4 exosome and nearly no 
hydrolytic activity could be observed for the 6-subunit exosome. This also points to a regulatory 
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role and possibly sequence specificity in RNA binding of the cap proteins. 
For analysis of the polymerization activity of the exosome, the complex was not only incubated 
with ADP, but also with other nucleotide-di-phosphates. The preference for all tested nucleotides 
is different, but all of them were added to the 3'-end of the substrate RNA. Besides ADP, the 
exosome  easily  incorporates  the  other  purine  base,  GDP.  In  contrast,  incubation  with  the 
pyrimidine bases CDP and UDP results in much shorter polymerized tails. A difference can be 
observed between the 6-subunit/Csl4 exosome and the Rrp4 exosome: They all use the different 
nucleotides in a similar manner, only the Rrp4 exosome added the pyrimidine bases much more 
effectively to the template than the other two complexes. This could hint to a second role of the 
cap proteins: not only could they influence the substrate selectivity of the exosome, but they 
possibly somehow also influence the equilibrium between degradation and polymerization. This 
could only be explained by a possible structural and allosteric effect of the cap proteins on the 
whole complex. 
As in all living cells never either ADP or phosphate exist, but always a mixture of both with 
changing ratios, the activity of the exosome was tested in the presence of a mix of ADP and 
phosphate. The results show that the exosome reaches an equilibrium between degradation and 
polymerization  after  some  minutes.  With  equal  concentrations  of  phosphate  and  ADP,  the 
resulting RNA is longer than the substrate RNA and only with a 10-fold excess of phosphate the 
average  length  of  RNA  stays  the  same.  That  means  that  the  polymerization  reaction  is 
energetically favored over the degradation reaction under the present conditions. This experiment 
was done with the Csl4 exosome and a different result may be achieved with the Rrp4 exosome.
8.6 The Cleavage-and-Binding Model for RNA Degradation
In this thesis denaturing sequencing gels were used to visualize the degradation of RNA by the 
archaeal exosome. In the assays the phosphate concentration was chosen to be very high, to 
ensure that mainly the phosphate dependent degradation is present. The experiment allowed for 
the time resolved monitoring of the reaction, the detection of every single RNA species that is 
formed during the reaction and thereby a closer analysis of the mode of degradation. Two models 
were proposed to characterize the reaction: The first model, the cleavage-only model, describes 
only the degradation of the RNA base by base. The second model, the cleavage-and-binding 
model describes in addition the association and dissociation of every single RNA that occurs 
during the reaction. Furthermore, the possibility that – especially towards the end of the reaction 
when  more  and  more  ADP is  formed  –  the  polyadenylation  reaction  coexists  besides  the 
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degradation was included into the model. 
The two models  were fitted to  the experimental  data  using the same number of  free  fitting 
parameters and clearly the cleavage-only model describes the data very poorly compared to the 
cleavage-and-binding model. Therefore the consideration of association and dissociation of the 
RNA to and from the exosome is essential when describing the degradation reaction. 
During the first cycles of fitting it became clear that the following simplifications can be made:
The  polymerization  rate,  which  theoretically  could  influence  the  whole  reaction  especially 
towards the end, can be assumed as zero. This is reasonable as the phosphate concentration in 
this experiment was very high and even at the point when all RNA is degraded, it still was more 
than 100-times higher than the ADP concentration.
The active site was assumed to be independent from the length of RNA bound to the exosome 
and therefore the cleavage rate was set constant for the whole reaction. From the fitting results is 
became  clear  that  the  association  and  dissociation  rates  are  both  always  constant  for  RNA 
molecules larger than 15 bases. Therefore for the final  fitting procedure these rates were set 
constant for long RNAs. 
Using these constraints the fitting could be done with around 24 different constants. The quality 
of a fit cannot be judged visually. Therefore a parameter to estimate the quality of the fits, the R2-
value was introduced (R2 = 1 is a perfect fit). The R2 values, were for all curves higher than 0.9 
indicating good agreement between the fitted curves and experimental data.
In total 24 different constants were obtained for each complex (see table 5). The results are a first 
order approximation and the model describes a simplification of this very complex system. Still a 
lot of information can be extracted from the results.
To analyze and discuss this information and especially for better comparison, the constants were 
summarized  and  normalized  as  follows:  All  obtained  constants  from  one  experiment  were 
divided by the cleavage rate constant, which results in a normalization of all data to an identical 
kc. In addition, the association and dissociation rate constants for long RNAs (30 – 15 bases) 
were compared to an average of the association and dissociation rate constants for short RNAs 
(10 – 4 bases). That is to say, not the constants for every single RNA that occurs during the 
experiment will be discussed, but we compare only the constants for RNAs longer than 15 bases 
with the constants for RNAs shorter than 10 bases. The calculated rate constants are shown in 
table 6. 
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Table 6: Summarized rate constants obtained from fits of the cleavage-and-binding 
model to the experimental data. 
complex kc
association dissociation
ka long RNAs ka short RNAs kd long RNAs
kd short 
RNAs
6-subunit exosome 1 2·10-3 5·10-3 0.03 1.10
Csl4 exosome 1 1.5·10-3 3·10-4 0.07 0.90
Rrp4 exosome 1 2.3·10-2 1·10-3 0.07 0.175
2-subunit exosome 1 1.5·10-2 0.05 0.66 4.20
Csl4 exosome 
R65ERrp41 1 2·10
-4 0.015 0.06 1.67
Csl4 exosome 
Y70ARrp42 1 8·10
-4 2·10-4 0.09 2.10
Rate constants are normalized to identical cleavage rates. Rates are given in 1/s. kc = 
cleavage rate; ka = association rate and kd = dissociation rate.
The following observations could be made:
For long RNAs the cleavage rate constant is more than one order of magnitude larger than the 
dissociation rate constant. This explains the processivity of the exosome: as soon as an RNA 
molecule is bound to the exosome it will be degraded so quickly that it has no time to dissociate 
again.  For  the  small  RNA molecules  the  dissociation  rate  constant  is  in  the  same  order  of 
magnitude as the cleavage rate constant. This explains why small RNA molecules are degraded 
so much slower compared to the large ones: constant dissociation and association of RNA slows 
down the degradation reaction.
Looking at the association rate constants they seem to be extremely small. This explains why the 
exosome  needs  some  time  until  it  starts  degrading  the  RNA.  An  explanation  could  be  the 
architecture of the exosome: the RNA has to not only bind to the cap proteins of the complex, but 
the 3'-end has to find its way through the S1 pore and the neck of the processing chamber to 
finally reach the active site. It is of course quite unlikely that the RNA finds this way in a normal 
diffusion driven way and it is not surprising that binding of the 3'-end to the active site happens 
only with a low time rate.
Additionally to the wild-type exosome complexes, two proposed RNA binding mutants were 
tested:  the  neck  mutant  R65ERrp41 and  the  tyrosine  mutant  Y70ARrp42.  As  expected,  the 
dissociation rate constants of these mutants are larger and naturally the association rate constants 
are smaller compared to the wild-type proteins. 
To  learn  more  about  the  relevance  of  the  hexameric  architecture  of  the  exosome  core,  an 
interface mutant was created that forms only one dimer of Rrp41 and Rrp42 and cannot form the 
trimer of dimers. This mutant cannot form a processing chamber. The fact that this version of the 
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exosome is still active, proofs that the hexameric ring is not essential for catalytic activity. This 
interface mutant was used with the same concentration of active sites compared to the normal 
hexamer. Therefore three active sites were accessible for the RNA and as association is diffusion 
driven, it makes sense that the association rate is larger than for the “closed” complex. Of course 
the dissociation rate for RNAs of all sizes is larger compared to the wild-type complexes, as the 
RNA is not fixed within the processing chamber but can freely dissociate from the active site. 
Additionally  interesting  is  a  comparison  of  the  absolute  cleavage  rates.  For  most  of  the 
complexes the rate is in the magnitude of 15/s, but for the interface mutant it is only 2/s. It may 
be possible that the formation of the hexameric ring and the existence of the processing chamber 
can influences the cleavage rate by stabilizing the active site and changing its environment. 
Most different compared to the other wild-type complexes are the constants derived for the Rrp4 
exosome. The relative binding rate is surprisingly high. When comparing the absolute cleavage 
rates of all complexes with each other the rate for the Rrp4 complex is 15 times smaller than 
expected. Possibly the Rrp4 protein as a cap changes the architecture of the whole exosome and 
thereby also of the active site. This means the binding of the cap proteins could have an allosteric 
effect on the active site and thus Rrp4 can decrease the cleavage rate compared to Csl4. This is of 
course very speculative and has to be tested in further detail. 
In summary the following conclusion can be drawn from the results:
The data shows that RNA binds to the exosome relatively slow. Still it remains unclear, if the 3'-
end can be threaded through the extremely narrow neck of the processing chamber in such a 
timescale.  Probably the  whole  complex  is  less  rigid  when no  RNA is  bound.  The  interface 
between Rrp41 and Rrp42, which forms the active site, is with 3000 Å2 larger than the interface 
connecting three of these dimers to a hexameric ring (2500  Å2). The smaller interface might 
loosen a little bit and could thereby increase the diameter of the neck. This could enable a faster 
association of the RNA to the active site. As soon as RNA is bound to the complex it will be 
stabilized by ionic interactions between the RNA and mainly arginine residues (e.g. R65Rrp41) 
thus ensuring processivity.
In addition, the importance for RNA binding of the arginine in the neck of the exosome becomes 
much clearer: RNA molecules that are long enough to reach from the active site to the neck, have 
much higher affinity to the complex. As soon as this interaction is lost, the affinity drops strongly 
and the RNA dissociates from the complex easily. Just from qualitative analysis of the denaturing 
gels in figure 40 the difference between the wild-type and the R65ERrp41 mutants are obvious. The 
accumulation of RNAs from 10 to 12 bases cannot be detected with the mutant,  but is only 
visible when in presence of the arginine residue.
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For short RNAs that cannot reach the arginine residue, the tyrosine 70 from Rrp42 is extremely 
important for the affinity: the Y70ARrp42 mutant shows extremely low affinity for RNAs smaller 
10 bases.
The architecture of the exosome is very conserved and it is quite likely that the observations 
about  RNA association  and  dissociation  made  in  this  thesis  might  be  also  relevant  for  the 
eukaryotic exosome.
8.7 Evolution and the Exosome
The role of the exosome in all organisms and especially the differences in enzymatic activity 
between the exosomes from all kingdoms of life from a phosphate dependent to a hydrolytic 
RNase are of widespread interest. This thesis as well as new results from other groups allow 
some speculations and the proposition of a model about the events that changed the exosome 
during evolution and the importance of its architecture.
The changes from the bacterial PNPase to the archaeal exosome are mainly structurally.  The 
enzymatic activities are quite similar as both enzymes catalyze the phosphate dependent 3' → 5' 
degradation of single stranded RNAs as well as the reverse reaction, the addition of nucleotides 
to the 3'-end (Slomovic et al., 2008). Structurally some changes occurred: The bacterial enzyme 
is a homo-trimer that has an RNA binding surface on top and – like the archaeal homolog – the 
active site is located within the processing chamber. The archaeal exosome however consists of 
three polypeptide chains each of which exists as three copies within the complex. Although the 
overall  structure  is  still  relatively similar,  the  RNA binding  surface  changed.  Not  only one 
protein can possibly bind to the core ring, but two different proteins do and it cannot be excluded 
that a mixed complex is also existent. The additional protein, the Csl4 protein, is located in a 
different  operon  in  the  archaeal  genome  compared  to  all  other  three  proteins 
(Rrp41/Rrp42/Rrp4). This can lead to different expression levels of the proteins and can thereby 
have an additional regulatory role. RNA binding experiments carried out in this thesis showed a 
high influence of the arginine residue in the neck of the core ring to the RNA binding affinity. In 
addition, it could be shown that RNAs with varying sequences have different affinities to the 
exosome. The same pattern that was observed for the 9-subunit complexes was found for the 
equivalent cap proteins alone, just with lower affinity. This supports the idea that the two cap 
proteins bind to different RNA substrates and that a change in their expression level can shift the 
substrate specificity of the exosome. 
The change from one version of RNA binding surface on top of the exosome in the bacterial 
PNPase to two versions in the archaeal exosome is continued: in eukaryotes a third RNA binding 
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protein that binds on top of the exosome and is homolog to Rrp4 was identified. In comparison 
to archaea, where exosome complexes with only Rrp4 or only Csl4 can exist, in eukaryotes only 
mixed complexes with all three different cap proteins were found. Moreover the whole exosome 
is much more complex, as no protein is present in more than one copy, but six different proteins 
form the core ring. Summarized this means a change of four possible proteins in the archaeal 
complex to a set of at least nine different proteins in eukaryotes. 
The  most  important  change happened from archaea  to  eukaryotes  concerning  the  enzymatic 
activity of the exosome. The following events could have led to these discrepancies:
The reaction of phosphate dependent cleavage of the phosphodiester  bond is  different to the 
hydrolytic  cleavage  regarding  their  thermodynamic  equilibrium.  In  the  phosphate  dependent 
reaction  the  reverse  reaction  is  much  more  probable  whereas  in  the  hydrolytic  reaction  the 
reverse  reaction  happens  hardly  ever.  For  a  biological  organism  the  phosphate  dependent 
cleavage is thus a reaction that has to be thoroughly regulated. Obviously the development of a 
hydrolytic RNase as an additional part of the exosome complex facilitated the regulation of RNA 
degradation. 
Figure 50: Changes in exosomes during evolution. Black stars indicate the active sites 
that changed from phosphate dependent RNase activity within the processing chamber 
(green)  to  hydrolytic  RNase activity in  the additional  subunit  Rrp44 (blue).  Different 
varieties of cap proteins (red, orange and pink) emerged during evolution from an internal 
RNA binding surface in the bacterial PNPase and two different cap proteins in archaea to 
a  set  of  three  different  caps  in  eukaryotes.  The  path  of  the  RNA in  the  eukaryotic 
exosome is still speculative. 
It seems that is was easier to enable the phosphate dependent active site and introduce a new 
hydrolytic active site instead. Thus the active site within the processing chamber was disabled 
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and the complex was expanded to a 10-subunit  core.  This idea is supported by the fact  that 
phosphate  dependent  RNases  exist  in  eukaryotes  only  in  mitochondria  and  chloroplasts.  In 
bacteria and archaea the exosome had the additional task of synthesizing poly(A)-rich tails. It 
could be shown that the enzyme uses all nucleotide-di-phosphates that are available and can add 
them to the 3'-end of RNA. It is quite likely that the development from enzymes that produce 
hetero-polymeric tails to specific poly(A) polymerases happened in parallel to the change from 
phosphorolytic to hydrolytic RNases. 
The  availability of  atomic  structures  of  both  the  archaeal  and  the  human exosome helps  to 
understand, why all nine core subunits of the exosome are essential for survival in all organisms 
although none of them possesses any enzymatic activity in eukaryotes. As shown in figure 25 the 
overall structure of the two exosome complexes is extremely similar. As they do not have the 
same enzymatic activity, the architecture seems to play a very important role for its functions in 
RNA surveillance. Through the emergence of new polyadenylating enzymes and new hydrolytic 
RNases, the enzymatic activity of the exosome was not needed anymore. However not only the 
active site alone is  an important feature of the exosome, but the cap proteins play a role in 
substrate  binding  and  recognition.  In  addition,  the  architecture  of  the  processing  chamber 
disables the complex to degrade structured RNA molecules. The degradation of these substrates 
is instead regulated by additional cofactors like helicases. Recent results about the Rrp44 protein 
(Lorentzen et al., 2008) support this theory: the yeast Rrp44 protein alone degraded all RNA 
molecules, even when secondary structures were present. In complex with the 9-subunit exosome 
however,  only  single  stranded  RNA  was  degraded.  Therefore  it  is  very  likely  that  the 
mechanisms of the exosome in RNA binding, substrate specificity and regulation did not change 
from archaea to eukaryotes. Only the position of the active site and the mode of degradation 
changed – and a different group of enzymes took over the task of addition of poly(A)-tails to 
RNAs. 
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9 Summary
The comprehensive analysis of complex biological processes cannot be achieved using only one 
single biochemical technique. In this thesis two different protein complexes were analyzed, both 
structurally and biochemically.  The results  obtained demonstrate the benefits  of using hybrid 
methods to address challenging biological questions. 
The DisA protein (DNA integrity scanning protein A) is known for its involvement in DNA 
damage checkpoint initiation in  Bacillus subtilis by controlling sporulation.  From the crystal 
structure  of  DisA the  oligomeric  organization  of  the  complex  could  not  be  unambiguously 
determined.  Structural  studies  of  the  complex  under  physiological  conditions  revealed  an 
octameric organization with four nucleotide binding sites in the center of the complex and two 
DNA  binding  surfaces  at  the  opposing  ends.  Unexpectedly,  DisA  was  found  to  possess 
diadenylate cyclase activity and synthesizes a novel cyclic nucleotide, c-di-AMP. This molecule 
is reminiscent of, but distinct from c-di-GMP, an emerging prokaryotic regulator of complex 
cellular processes. Diadenylate cyclase activity was shown to be unaffected by linear DNA or 
DNA ends but strongly suppressed by branched nucleic acids such as Holliday junctions.
These  results  indicate  that  DisA synthesizes  c-di-AMP as  a  signal  for  DNA structures  that 
interfere with chromosome segregation. Homologies between the nucleic acid binding domain of 
DisA and proteins with unknown functions in archaea and prokaryotes imply a more general role 
for c-di-AMP as novel second messenger.
The exosome, the second protein studied, is a multisubunit 3' → 5' exoribonuclease complex that 
participates in degradation and processing of cellular RNA. Archaeal exosomes consist of three 
active  and  three  inactive  RNase  PH  subunits  that  form a  hexameric  ring  and  a  processing 
chamber (Rrp41 and Rrp42). Two different RNA binding proteins (Rrp4 and Csl4) can bind as a 
trimeric cap to this core structure, form an RNA binding surface for the substrate and thus recruit 
and deliver the RNA to the active sites. The combination of structural studies with biochemical 
activity assays allowed the proposal of a model for RNA degradation. The data revealed that the 
process of binding and dissociation of RNA to and from the exosome strongly influences activity 
and that the architecture of the processing chamber is crucial for the processivity of the enzyme. 
Additionally, the results indicate that by binding different RNA substrates the two cap proteins 
Rrp4 and Csl4 influence the overall activity and the specificity of the complex.
Biochemical assays, structural biology and theoretical modeling, together with the latest results 
from other research groups, support a model that describes the evolution of the exosome and 
exosome-like complexes: Whereas the enzymatic activity changed from a phosphate dependent 
to a hydrolytic RNase, the structure of the complex is very conserved from bacteria to human. 
Therefore,  the  observed  influence  of  the  architecture  on  the  biochemical  properties  of  the 
exosome, like specificity and processivity, are likely to be also conserved. 
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10.1 Summary of SAXS measurements
  Table A1: Summarized results of SAXS measurements
protein DisA 6-subunit 
exo
Rrp4 exo Csl4 exo Rrp4 exo + RNA
beamline SIBYLS, ALS SIBYLS, ALS SIBYLS, ALS SIBYLS, ALS X33, DESY
protein conc. 2, 6, 8 mg/ml 5, 10, 15 mg/ml 5, 10, 15 mg/ml 5, 10, 15 mg/ml A280 = 13.75, 27.5, 55
Rg [Å] 52.8 46.2 39.6 41.4 46.8 
Dmax [Å] 176 134 119 117 200
modeling program GASBORp GASBORi GASBORp GASBORp GASBORp
number of 
averaged models 10 15 15 15 10
10.2 Summary of X-ray Crystallographic Experiments
Table A2:  Data collection, structure solution and refinement statistics
Csl4-exosome
+ RNA
Csl4-exosome 
Y70ARrp42 + RNA
Csl4
S1-ZnR domain
Rrp4-exo
+ RNA
DATA COLLECTION
space group P4322 P4322 P212121 R3
cell dimensions
a = b= 138.2  Å;
c = 262.0  Å
α = β = γ = 90°
a = b = 137.7 Å;
c = 261.8 Å
α = β = γ = 90°
a = 42.02 Å; b = 75.62 Å
c = 76.61 Å
α = β = γ = 90°
a = b =112.2 Å;
c = 178.6 Å
α = β = 90°; γ = 120°
beamline ID-14-2, ESRF PX I, SLS PX I, SLS PX I, SLS
wavelength 0.933 Å 1.006 Å 1.000 Å 0.972 Å
resolution 2.4 Å 3 Å 1.9 Å 3 Å
Rsym 5.6 % (41.3 %) 6.7 % (31.5 %) 6.7 % (41.9 %) 5.7% (36.8%)
I/σI 18.9 (3.82) 23.7 (6.10) 14.15 (4.90) 20.7 (3.59)
completeness 94.5 % (86.4%) 98.9 % (96.9 %) 91.9 % (83.4%) 92.7 % (78.4 %)
# of unique reflect. 94,417 50,904 18,281 15,872
redundancy 4.90 7.22 5.05 5.06
REFINEMENT
resolution (Å) 85 – 2.4 Å 20 – 3 Å 40 – 1.9 Å
not yet refined to a 
final structure
# of reflect. 99,465 51,207 19,188
Rwork/Rfree 19.4 % / 24.8 % 18.8 % / 26.6 % 22.0 % / 26.3 %
ligand 6mer RNA (CCCCUC) 6mer RNA (CCCCUC) -
water molecules 901 18 96
rmsd
   bond lengths 0.006 Å 0.007 Å 0.006 Å
   bond angles 1.019° 1.036° 1.038°
Values in  parentheses are for highest-resolution shell. Rfree is calculated for a randomly chosen 
5% of reflections.
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10.3 Supplementary Data Concerning DisA
10.3.1 Sequence Alignment 
Figure A1: Sequence alignment of DisA proteins (COG1623) of Thermotoga maritima 
(TmaDisA),  Bacillus  subtilis (BsuDisA)  and  Mycobacterium  tuberculosis (MtuDisA) 
along  with  a  structurally  identified  homolog  from  Bacillus  cereus (hypothetical 
membrane spanning protein COG1624; PDB code 2FB5, residues 76 – 205). Conserved 
residues are  shaded and the secondary structure of TmaDisA is  shown on top of the 
alignment. Notable functional motifs are annotated (DGA and RHR). Residues that bind 
the c-di-AMP are indicated (*). 
10.3.2 Mass spectrometry results, which identified c-di-AMP
  
Figure  A2:  Isolated  product  from  TLC  plates  produced  by  DisA  analyzed  by 
negative  mode  mass  spectrometry  on  a  Bruker  Autoflex  II  MALDI-TOFMS 
instrument.  The left panel is the m/z spectrum of the sinapinic acid ionization matrix 
(control), the right panel shows the sample ionized in sinapinic acid. The prominent peak 
(red *) corresponds to the expected mass of singly charged c-di-AMP (657 Da).
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10.4 MATLAB Scripts
In  order  to  fit  the  models  to  the  experimental  data,  several  scripts  are  needed.  The  scripts 
exsosquares_m1.m (see section 9.4.1)  and exosquares_m2.m (see section 9.4.2)  simulate  the 
differential  equations  of  the  cleavage-only  model  and  the  cleavage-and-binding  model, 
respectively,  and calculate  the  quadratic  differences  between simulated curves  and measured 
data. To minimize the quadratic differences, a second script (exominsquares.m, see below) is 
needed. This script additionally reads in the experimental data.
exominsquares.m
dd=load('-ascii','experimental_data.txt'); % load experimental data
%no experimental data for t=0 -> insert t=0, y_t=1
%Indices of matrix dd have to agree with experimental data
t = [0;dd(2:27,1)]; 
y_t =[1,zeros(1,27);dd(2:27,2:29)];
pstart = [0.022, 0, 0.04, 0.03,  0.4, 15];  %start parameters for finding the minimum
% minimize quadratic differences
perg=fminsearch(@(par) exosquares_mx(par,t,y_t),pstart) %x=1,2 depending on model
10.4.1 Cleavage-only model
exsosquares_m1.m
function squares = exosquares_m1(params, t, y_t)
 
global ks  
 
ks=[...]; % write here fit parameters as params(1), params(2), ...
 
x0 = [1;zeros(27,1)]; %initial condition for t=0
 
[T, X] = ode15s(@reakglei, t, x0); %solve differential equation
 
figure(1) %plotting the experimental data (y_t) and the fits (X)
plot(T,X); 
hold on;
plot(T,y_t,'*','MarkerSize',4);
hold off;
gew=zeros(length(T),28);  %matrix for weighted fit
gew(1,:)=ones(1,28).*T(1)./T(length(T));
for i=2:length(T)
gew(i,:)=ones(1,28).*(T(i)-T(i-1))./T(length(T));
end;
quadrier=(X-y_t).*(X-y_t).*gew;
squares=sum(sum(quadrier)); %quadratic differences between experimental data and fit 
 
function xdot = reakglei(tin, x) %cleavage-only model
 
global ks
 
xdot=zeros(28,1); 
 
xdot(1) =-ks(1)*x(1); %30mer
for i=2:27
xdot(i)=-ks(i)*x(i)+ks(i-1)*x(i-1); %(31-i)mer 
end;
xdot(28)=ks(27)*x(27);%3mer
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10.4.2 Cleavage-and-binding model
exosquares_m2.m
function squares = exosquares_m2(params, t, y_t)
 
global kb kd ks kk 
kb=[ ... ]; % write here fit parameters as params(1), params(2), ...
kd=[ ... ]; 
ks=ones(1,27).*...;
kk=zeros(1,27);
 
x0 = [1;0;zeros(54,1)]; %initial condition for t=0
[T, X] = ode15s(@reakglei, t, x0); %solve differential equation
 
merkonz=zeros(length(T),28); %adding the concentrations of bound and free RNA
freikonz=zeros(length(T),28);
gebkonz=zeros(length(T),28);
for i=1:28
merkonz(:,i)=X(:,2*i-1)+X(:,2*i);
freikonz(:,i)=X(:,2*i-1);
gebkonz(:,i)=X(:,2*i);
end;
save exosome.dat merkonz -ASCII %saving the solution
figure(1) %plotting the experimental data (y_t) and the fits (merkonz)
plot(T,merkonz); 
hold on;
plot(T,y_t,'*','MarkerSize',4);
hold off; 
gew=zeros(length(T),28); %matrix for weighted fit
gew(1,:)=ones(1,28).*T(1)./T(length(T));
for i=2:length(T)
gew(i,:)=ones(1,28).*(T(i)-T(i-1))./T(length(T));
end;
quadrier=(merkonz-y_t).*(merkonz-y_t).*gew; % needed for calculation of quadratic 
differences between experimental data and fit 
 
%different options:
%minimizing only the quadratic differences for 30mer
%squares=sum(sum(quadrier(:,1)))
 
%minimizing the quadratic differences for 30mer (i=17) and for 14mer - 3mer bis 3 (i=28) 
%squares=sum(sum(quadrier(:,21))) + sum(sum(quadrier(:,18:22))); 
 
%minimizing the quadratic differences for 30mer - 13mer 
%squares=sum(sum(quadrier(:,1:16)));
 
%minimizing the quadratic differences for all curves 
squares=sum(sum(quadrier));
%calcualation of coefficient of determination
Sserr=sum(sum((merkonz-y_t).*(merkonz-y_t))); %calculation of R2 (quality of the fit)
SStot=sum(sum((y_t-ones(size(t))*mean(y_t)).*(y_t-ones(size(t))*mean(y_t))));
1-SSerr/SStot %coefficient of determination, will be writen to Matlab console
function xdot = reakglei(tin, x) %cleavage and binding model
 
global kb kd ks kk
 
xdot=zeros(56,1); 
xdot(1)  =-kb(1)*x(1)+kd(1)*x(2); %free 30mer
xdot(2)  = kb(1)*x(1)-kd(1)*x(2)-ks(1)*x(2)+kk(1)*x(4); %bound 30mer
 
for i=2:27 
xdot(2*i-1)=-kb(i)*x(2*i-1)+kd(i)*x(2*i); % free(31-i)mer
xdot(2*i)=kb(i)*x(2*i-1)+ks(i-1)*x(2*i-2)-(kk(i-1)+ks(i)+kd(i))*x(2*i)+kk(i)*x(2*i+2); 
%bound(31-i)mer
end;
 
xdot(55)  =-kb(28)*x(55)+kd(28)*x(56);  %free 3mer
xdot(56)  = kb(28)*x(55)+ks(27)*x(54)-(kk(27)+kd(28))*x(56); %bound 3mer
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Script for drawing the simulated curves with higher resolution
function dummy()
global kb kd ks kk
kb=[...]; %rate constants as determined by fitting
kd=[...];
ks=ones(1,27).*...;
kk=zeros(1,27);
 
x0 = [1;0;zeros(54,1)]; 
dd=load('-ascii','experimental_data.txt');
tmess=[0;dd(2:27,1)]; %times of experimental data
y_t=[1,zeros(1,27);dd(2:27,2:29)]; %experimental data in y_t 
t=linspace (0, 900, 3000)'; %3000 points in between t=0s and t=900s
[T, X] = ode15s(@reakglei, t, x0); %solve differential equation
merkonz=zeros(length(T),28); %adding the concentrations of bound and free RNA
freikonz=zeros(length(T),28);
gebkonz=zeros(length(T),28);
for i=1:28
merkonz(:,i)=X(:,2*i-1)+X(:,2*i);
freikonz(:,i)=X(:,2*i-1);
gebkonz(:,i)=X(:,2*i);
end;
table = [t, merkonz]; %saving the solution
save exosome.dat table -ASCII
figure(1) %plotting the data
plot(T,merkonz); 
hold on;
plot(tmess,y_t,'*','MarkerSize',4);
hold off;
i=28; % plotting only the curve for the i-mer
figure(2)
plot(T,merkonz(:,i)); 
hold on;
plot(tmess,y_t(:,i),'*','MarkerSize',4);
hold off;
 
function xdot = reakglei(tin, x) %cleavage and binding model
 
global kb kd ks kk 
xdot=zeros(56,1); 
xdot(1)  =-kb(1)*x(1)+kd(1)*x(2);   %free 30mer
xdot(2)  = kb(1)*x(1)-kd(1)*x(2)-ks(1)*x(2)+kk(1)*x(4); % bound 30mer
 
for i=2:27 
xdot(2*i-1)=-kb(i)*x(2*i-1)+kd(i)*x(2*i); %free (31-i)mer
xdot(2*i)=kb(i)*x(2*i-1)+ks(i-1)*x(2*i-2)- ...
(kk(i-1)+ks(i)+kd(i))*x(2*i)+kk(i)*x(2*i+2); %bound (31-i)mer
end;
 
xdot(55)  =-kb(28)*x(55)+kd(28)*x(56);  %free 3mer
xdot(56)  = kb(28)*x(55)+ks(27)*x(54)-(kk(27)+kd(28))*x(56);%bound 3mer
10.5 Experimental Data from RNase Assays and Fits
The experimental data and the corresponding fits are shown for all six complexes. The color 
code is for all plots as follows: 
               
30mer 29mer 28mer 27mer 26mer 25mer 24mer
23mer 22mer 21mer 20mer 19mer 18mer 17mer
16mer 15mer 14mer 13mer 12mer 11mer 10mer
9mer 8mer 7mer 6mer 5mer 4mer 3mer
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The  data  was  fitted  using  the  cleavage-and-binding  model  described  in  chapter  7.3.3.  The 
obtained rate constants are given in table 5. 
6-subunit exosome Csl4 exosome
Csl4 exosome Y70ARrp42 Rrp4 exosome
2-subunit exosome Csl4 exosome R65ERrp41
          
50 – 70 bases
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10.6 Denaturing PA Gel and Agarose Gel Showing the RNA Ligand 
A B
A: Denaturing PA gel of the RNA substrate, that 
was purified with the exosome from E. coli cells. 
On the right the bands of an RNase assay are  
shown that were used for the calibrationcurve to 
estimate the size of the RNA at the left. 
B:  Agarose  gel  showing  1µl  and  5µl  of  the
sample  used for  crystal  setups.  The RNA was
stained with ethidium bromide.
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